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Toxoplasma gondii is among the most widespread eukaryotic pathogens known. It chronically 
infects approximately one third of the world’s human population and has been isolated from an 
extremely diverse array of globally distributed mammals and birds. Understanding the structure 
of the worldwide T. gondii population enhances our understanding of the factors that have 
shaped that structure and led to the proliferation of one of the most evolutionarily successful 
pathogens on Earth. Herein we collate genotypic data from global isolates, demonstrating that T. 
gondii possesses a unique population structure in which only a small number of genotypes 
dominate throughout the northern hemisphere, but myriad types coexist in South and Central 
America with none being notably dominant. On average, South American strains were also 
found to be more virulent to mice than their northern counterparts. We propose that the clonal 
population structure in the northern hemisphere is the consequence of the domestic cat-house 
mouse transmission cycle, which has been greatly enhanced by the spread of human agriculture 
in the past 11,000 years, and that this transmission cycle plays a significant role in the selection 
of intermediately virulent T. gondii genotypes.  To test this idea, we compiled strain virulence 
and sequential reinfection data. Simulations based on the composite dataset were used to predict 
patterns of mouse virulence evolution in T. gondii populations. Our results indicate an advantage 
relating to the mouse virulence of particular strain types within the domestic cat–house mouse 
transmission cycle. However, such selective pressure is alleviated in the context of a sylvatic 
cycle, in which most wild intermediate hosts are resistant to T. gondii infection. This suggests 
that highly mouse-virulent parasite types have an adaptive advantage during transmission in 
environments that are rich in wildlife species, such as the tropical rainforests of South America. 
Mouse virulence was found to be closely associated with particular alleles encoding parasite 
proteins ROP5 and ROP18, making these markers valuable tools for predicting virulence of 
future environmental isolates. The results of this study have significant implications concerning 
the evolution of T. gondii in agrarian and urbanized environments and transmission of T. gondii 
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Toxoplasma gondii is a protozoan parasite that appears to be capable of infecting all mammals 
and birds. It has been isolated from a diverse array of host species from throughout the world, 
making it possibly the most ubiquitous eukaryotic parasite on Earth (Dubey 2010). Though the 
parasite is able to infect many animal species, felines are the definitive hosts and sexual 
reproduction occurs only in the feline intestine. This results in the production of infectious 
oocysts which are shed into the environment and may be transmitted to new hosts orally. In the 
majority of hosts, ingestion results in the development of asymptomatic chronic infections which 
persist throughout the host’s lifespan (Dubey 2010, Pusch 2009). Chronic infections are 
characterized by the production of parasite cysts in many tissues of the host. The second major 
means of transmission involves the ingestion of these cysts during carnivory of infected hosts by 
predators or scavengers. In humans, such transmission often occurs through ingestion of 
undercooked meat. Humans are largely resistant to the parasite, experiencing mild symptoms for 
a brief period after initial infection, followed by the development of asympomatic chronic 
infection.  In immunocompromised adults and developing fetuses, the parasite may cause more 
severe illness and potential death (Dubey 2010). Congenital infection in general is thought to 
occur only in cases where the mother becomes infected for the first time during pregnancy, 
though very rare exceptions have been noted (Dubey et al. 2012). In some cases, 
immunocompetent adults may also experience more severe symptoms from infection. This 
manifests most commonly as ocular toxoplasmosis, which may cause vision impairment or 
blindness in some cases (Holland 2003). Severe systemic toxoplasmosis has also been recorded 
in immunocompetent adults, most notably in a number of recent cases in French Guiana which 
required intensive medical care and resulted in several deaths due to organ failure (Darde et al. 
1998, Demar et al. 2007, Carme et al. 2009). Both severe ocular and systemic toxoplasmosis 
have been tentatively linked to atypical parasite strains with high virulence in mice (Grigg et al. 
2001, Bossi and Bricaire 2004, Delhaes 2010).  
 
Mice are particularly susceptible to the parasite and different strains of T. gondii display a wide 
range of virulence in this host. Early genotyping studies in North America and Europe divided 
strains into three archetypal lineages referred to as Type I, Type II and Type III, which could be 
chiefly distinguished phenotypically based on their virulence to mice (Sibley and Boothroyd 
1992, Howe and Sibley 1995). Type I strains are highly virulent and do not typically cause 
chronic infections in mice, rather killing them during the acute phase of infection even at very 
low dosages. Type II and III strains are much less virulent, resulting in chronic infections at 
lower dosages, though Type II strains may also cause mortality at moderate dosages whereas 
Type III strains typically require higher dosages in order to be lethal (Sibley and Boothroyd 
1992, Khan et al. 2009). Type II and III strains have been found to make up the majority of 
North American and European parasite populations, with Type I strains being relatively rare 
(Howe and Sibley 1995). More recent genotyping studies have identified parasite populations in 
the northern hemisphere, including North America, Europe, the Middle East and southeast Asia, 
to be largely clonal in structure, chiefly comprising a small number of highly dominant 
genotypes, most of which are closely related to the Type II lineage (Shwab et al. 2014). 
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Populations in South and Central America, by contrast, display much higher diversity, being 
composed of a wide variety of atypical strain types, none of which are particularly dominant. 
Strains from these regions also have a much greater tendency towards mouse virulence than 
those in the northern hemisphere (Gilbert et al. 2008). In this work, we attempt to 
comprehensively catalogue the global diversity of T. gondii and to understand the evolutionary 
pressures that have shaped parasite populations throughout the world and the implications these 





Toxoplasma gondii belongs to the phylum Apicomplexa, a diverse group of eukaryotic 
microorganisms which share the traits of having complex, intracellularly parasitic life cycles and 
possessing a number of unique organelles at their apical ends that aid in host invasion by 
facilitating secretion of an array of effector proteins into occupied cells (Morrison 2009).  Other 
medically significant members of this phylum include species of Plasmodium -the causal agents 
of malaria,  Cryptosporidium, and Babesia.  In addition to these human pathogens, there are 
numerous apicomplexan genera responsible for important veterinary diseases, such as Neospora 





Unlike other members of the Apicomplexa, which tend to have very narrow host ranges 
comprising only one or a few closely related species, T. gondii has an extremely broad host 
range, apparently extending to all endotherms, or in other words to members of the classes 
Mammalia and Aves (Dubey 2010). Since T. gondii was first isolated from and named for an 
African rodent known as the gundi in 1908 (Kim and Weiss 2008),  it has subsequently been 
identified in the tissues of an extremely diverse assortment of animals ranging from the white-
tailed deer to the striped dolphin to the keel-billed toucan (Shwab et al. 2014). It was not until 
1970 however that members of the family Felidae were identified as the definitive hosts of the 
parasite (Dubey 2009). It is only within the intestinal epithelia of cat species that T. gondii is able 
to undergo sexual reproduction, a strong indication that cats represent the ancestral host in which 





Felids serve as the definitive host for T. gondii in which sexual reproduction occurs. Oocyst 
shedding has been observed in a wide range of feline species, from domestic cats to Siberian 
tigers (Dubey 2010). Transmission occurs by two primary means, namely ingestion of oocysts 
from environmental sources, or ingestion of tissue cysts in infected meat (Figure I-1). The latter 
method allows for transmission between intermediate hosts without necessitating the 
involvement of feline species. The range of intermediate hosts in which T. gondii has been 
identified - including animals as diverse as rats, dogs, sheep, crows, toucans, kangaroos and 
dolphins – is broad enough to suggest that all or nearly all mammals and birds may serve as hosts 
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(Dubey 2010). Within the feline intestine, the parasite differentiates into male and female 
gametocytes, which may fuse to form a zygote, followed by maturation into an oocyst containing 
infectious sporozoites. Oocysts are subsequently released into the intestinal lumen and shed into 
the surrounding environment along with the host’s fecal matter. Oocysts have highly durable 
structures which may survive and remain infectious for long periods of time, on the order of 
many months, under adverse conditions of temperature and aridity (Dubey 2010). One of the 
primary means of infection is through the ingestion of oocysts contaminating food or water 
sources. If ingested by a suitable host, the cyst dissolves upon reaching the small intestine, 
releasing sporozoites which then differentiate into the rapidly multiplying tachyzoite stage upon 
infection of epithelial cells. Infection occurs as the parasite burrows into the interior of the host 
cell via indentation and eventual vesiculation of the plasma membrane. This vesicle is modified 
by secretions from the parasite to generate a protective parasitophorous vacuole (PV).  During 
this acute phase of infection, the tachyzoites spread throughout the host’s body via the 
circulatory system, infecting numerous tissues (Dubey 2010). Depending on the immune 
response of the host and the strain of infecting parasite, this expansion may continue until death 
of the host occurs or, more commonly, suppression of parasite expansion will result in a shift to 
the semi-dormant bradyzoite stage. Bradyzoites form intracellular tissue cysts which may persist 
in a state of equilibrium with the host’s immune response for the duration of the host’s life span 
with minimal turnover, thus establishing a long-term chronic infection (Remington 1965, Pusch 
2009). Tissue cysts represent the second major mode of T. gondii transmission, as ingestion of 
these cysts by a new host via carnivory may result in initiation of a new round of acute infection 
in the same manner as described for oocyst ingestion. With regard to human infection, this 
generally occurs through the consumption of undercooked meat from chronically infected 





For most types of hosts, infection by T. gondii does not result in death, but instead proceeds from 
the acute to the chronic phase of infection. This is generally the case in immunocompetent 
humans, wherein flu-like symptoms including fatigue, muscle and joint pain and slight fever 
often persist for one to several weeks before subsiding. In some cases lymphadenopathy may 
occur which may last for several months  (Dubey 2010). After dissipation of such initial 
symptoms, the chronic phase of infection appears to be capable of persisting indefinitely, most 
likely throughout the life span of the host (Remington 1965, Pusch 2009). Chronic toxoplasmosis 
of humans is common in all regions of the world, with some estimates placing the global rate of 
infection as high as one third of the population (Dubey and Beattie 1998). Infection rates vary 
considerably geographically, however. In the United States, seropositivity has been estimated to 
be between approximately 10 to 38 percent in various studies conducted since the 1960’s.  Lower 
rates have been estimated in the UK, China and Korea at around 8, 11 and 4 percent, 
respectively. By contrast, seropositivity among pregnant women was found to be approximately 
61 percent in France and 84 percent in Madagascar, and between 61 and 92 percent overall in 
Brazil, with prevalence among adolescents in some southern regions of the country as high as 98 
percent (Holland 2003, Dubey 2010). While the majority of infections in immunocompetent 
adults are asymptomatic, in immunocompromised individuals such those with AIDS or those 





















toxoplasmosis is among the leading causes of death in AIDS patients, most commonly due to the 
formation of necrotic brain lesions associated with encephalitis, though pneumonia and other 
systemic forms of the disease may also occur. In these cases, disease is usually a result of 
reactivation of latent infections upon the onset of immune dysfunction (Dubey 2010). 
 
The other major human health concern associated with T. gondii relates to vertical transmission 
of the parasite from mother to developing fetus in utero. This phenomenon is believed in general 
to occur only in cases where the mother becomes infected with T. gondii for the first time during 
pregnancy and the parasite is able to spread transplacentally to the fetus during the acute phase of 
the infection, though cases have been identified in which transmission occurred in women who 
became infected shortly before pregnancy or, in only a few known cases, during chronic 
infection (Dubey et al. 2012). Broadly speaking, a woman chronically infected with T. gondii 
prior to becoming pregnant is not considered at significant risk for vertical transmission of the 
parasite, however (Dubey 2010). In cases where vertical transmission does occur, the severity of 
disease is generally inversely proportional to the developmental stage of the fetus, i.e. more 
mature fetuses generally experience less severe symptoms than those in earlier stages. However, 
it also appears to be the case that congenital infection becomes more likely in the later stages of 
pregnancy. In the most severe cases, fetal toxoplasmosis may result in deformation, severe 
mental impairment or abortion, but the most common manifestation is ocular disease, and the 
majority of children with infected mothers are born without symptoms. In some cases, ocular 
symptoms from congenital infections may not manifest until later childhood or even adulthood 
(Dubey 2010).   
 
Although the immunocompromised are at highest risk for developing severe acute 
toxoplasmosis, many instances of severe disease have also been recorded in immunocompetent 
adults. These most frequently manifest as cases of ocular toxoplasmosis. In this situation, the 
parasite may cause damage to ocular tissue that can result in vision impairment or blindness if 
untreated (Holland 2003). Ocular toxoplasmosis is estimated to occur in about 2 percent of 
infections, and to affect about 1.26 million people in the United States as of the year 2000 
(Holland 2003). In addition to ocular toxoplasmosis, severe systemic toxoplasmosis may also 
occur in healthy adults. Thus far, no definitive link has been demonstrated between parasite 
genotype and disease severity in humans, though circumstantial evidence provides support for 
such an association. In a 2011 study, of 20 tissue samples from a diverse assortment of 
toxoplasmosis patients from multiple hospitals and clinics in Sao Paulo state, Brazil, 18 were 
determined to be infected with the mouse-virulent ToxoDB genotype #65, which makes up only 
a small fraction of Brazilian T. gondii isolates, suggesting a possible association of this genotype 
with human disease. Furthermore, in Brazil severe symptoms were found to be associated with 
congenital ocular toxoplasmosis at a rate five times higher than that of Europe, with statistically 
significant differences in severity and recurrence of lesions observed  (Gilbert et al. 2008).  This 
was hypothesized to be due to the prevalence of highly virulent atypical parasite strains in Brazil 
that are rarely found in Europe. More than 50 particularly severe cases of systemic 
toxoplasmosis in immunocompetent adults have been recorded in French Guiana since 1998. 
This form of the disease, often termed “Amazonian toxoplasmosis” appears to be associated with 
a sylvatic cycle of parasite transmission, through wild definitive and intermediate hosts as 
opposed to domesticated animals, as patients generally reported recent rainforest-related 
activities such as consumption of undercooked wild game or surface water. In cases where 
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parasites have been isolated from patient tissues, isolates were found to possess atypical 
genotypes that were virulent in mice (Darde et al. 1998, Demar et al. 2007, Carme et al. 2009). 
This form of the disease often requires intensive medical care and has resulted in deaths due to 
multiple organ failure (Demar et al. 2077, 2012). Though not yet identified outside of French 
Guiana, it is expected that the strain types responsible may be present in adjacent areas inhabited 
by wild felids (Carme et al. 2009). In a study performed in the United States, two thirds of 
genotyped isolates from patients with ocular toxoplasmosis were found to belong to the virulent 
archetypal Type I or atypical genotypes despite the overwhelming dominance of avirulent Type 
II and III strains in North America (Grigg et al. 2001). Disproportionate association of atypical 
genotypes with severe clinical symptoms has also been observed in Europe (Bossi and Bricaire 





Disease presentation in humans appears to be fairly representative of the majority of host species 
for T. gondii, though a wide range of susceptibility is observed, even among closely related 
species. For example, rats (genus Rattus) are generally resistant to toxoplasmosis, whereas house 
mice (Mus musculus) are highly susceptible compared to most other hosts. In this case, evidence 
suggests that the more effective parasite control in rats compared to mice is dependent on the 
ability of the former species to efficiently respond to infection through caspase-mediated 
apoptosis of infected macrophages (Cavailles et al. 2014). For resistant hosts, the infecting strain 
type of T. gondii does not make an obvious difference with regard to disease outcome. This is 
not the case for mice, for which different parasite strains produce dramatically different levels of 
disease severity. This phenomenon was observed early in the history of T. gondii research, and 
strains were classified as being either virulent or avirulent in mice, virulent strains producing one 
hundred percent mortality from inocula as low as a single parasite, while avirulent strains 
required dosages of thousands to tens of thousands of parasites to induce mortality (Sibley and 
Boothroyd 1992, Khan et al. 2009). When PCR-restriction fragment length polymorphism (PCR-
RFLP)-based genotyping of T. gondii began to be performed in the 1990’s, it was discovered that 
the virulent strains studied all appeared to belong to a single lineage (Sibley and Boothroyd 
1992).  Soon thereafter, the avirulent strains were found to segregate into two distinct lineages. 
The virulent lineage was referred to as Type I, while the avirulent lineages were called Types II 
and III (Howe and Sibley 1995). It was also determined that the Type II lineage was generally 
more virulent than the Type III lineage (Khan et al. 2009). Based on these early genotyping 
studies of global T. gondii isolates, it appeared that the overall population structure of the 
parasite was dominated by these three lineages that appeared to have expanded clonally 
throughout the world, with minimal sexual recombination (Howe and Sibley 1995).  Upon 
identification of these major clonal lineages, intensive research was carried out with the intention 
of determining the genetic basis for the observed differences in virulence.  
 
 
Genetic basis for mouse virulence differences among archetypal lineages 
 
The key findings relating to virulence differences of the clonal lineages mainly stem from 
research involving quantitative trait locus (QTL) mapping of progeny from sexual crosses among 
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Type I, II and III strains (Saeij et al. 2006, Taylor et al. 2006, Behnke et al. 2011). Using this 
forward genetics approach, a few distinct loci were identified as key determinants of mouse 
virulence. The first of these to be extensively studied, though not the locus most highly 
correlated with virulence phenotype, was determined to encode the rhoptry-secreted kinase 
ROP18 (Taylor et al. 2006). In the crosses described above, the Type I and II alleles of ROP18 
were found to segregate with virulence, while the Type III allele segregated with nonvirulence. 
This was determined to be the result of an insertion sequence in the Type III promoter that 
attenuates expression of the gene (Boyle et al. 2008). In Type I and II strains, the protein is 
expressed, and is secreted into host cells upon invasion.  
 
The chief function of ROP18 appears to involve the phosphorylation and resultant inactivation of 
a family of host proteins known as the immunity-related p47 GTPases (IRGs) and p65 guanylate-
binding proteins (GBPs) which normally bind to the parasitophorous vacuole membrane (PVM) 
and cause its disruption either directly (in the case of IRGs) by mechanical constriction of the 
membrane or indirectly (in the case of GBPs) by recruitment of other immunity-related proteins 
and complexes (Fentress et al. 2010, Steinfeldt et al. 2010, Howard et al. 2011, Winter et al. 
2011).  Expression of functional ROP18 is thus necessary for tachyzoites to evade these immune 
responses and thereby prevent clearance by the host.  
 
ROP18 alone is insufficient for parasite resistance to the host response. A second locus was 
identified via the same forward genetics approach that correlated much more strongly with 
virulence than even ROP18 (Taylor et al. 2006). This locus was found to contain a tandem array 
of paralogous genes encoding variants of the ROP5 rhoptry-secreted pseudokinase (Reese et al. 
2011). Despite being nonfunctional as a kinase due to mutations of the catalytic site,  ROP5 
plays an important role in suppression of the host immune response, in part through regulation of 
ROP18 activity. ROP5 has been shown to form a complex with ROP18 and with murine IRGs, 
facilitating their phosphorylation and inactivation by ROP18 (Etheridge et al. 2014, Reese et al. 
2014). The fact that it is primarily the most highly polymorphic regions of ROP5 proteins that 
interact with mouse IRGs appears to indicate a sort of evolutionary arms race between the two 
classes of proteins, in which mouse IRGs have diversified under the pressure to escape 
recognition by ROP5, while ROP5 proteins have likewise diversified in order to enhance binding 
to IRGs (Reese et al 2014). ROP5 was also found to interact with another rhoptry kinase, 
ROP17, which likely contributes to the stronger influence of ROP5 on parasite virulence 
compared to ROP18, though other interactions may be identified as well (Etheridge et al. 2014). 
Like ROP18, the functionality of ROP5 varies with strain genotype. In this case, the ROP5 
alleles expressed by Types I and III are sufficient to produce a virulent strain in combination 
with expression of functional ROP18, while the Type II ROP5 alleles are associated with 
avirulence regardless of the ROP18 genotype (Reese et al. 2011, Behnke et al. 2011).  
 
In addition to ROP5 and ROP18, two additional polymorphic loci have been identified as 
playing roles in determining virulence differences between the archetypal strains. These are the 
rhoptry kinase ROP16 and the dense granule protein GRA15 (Saeij et al. 2006, Rosowski et al. 
2011). In the case of ROP16, virulence is associated with a loss-of-function mutation in the 
catalytic site of the Type II allele. The functional Type I and III versions of the protein act as 
transcriptional regulators, phosphorylating and inactivating the pro-inflammatory transcription 
factors STAT3 and 6, thereby suppressing the host inflammatory immune response. In Type II 
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strains, expression of nonfunctional ROP16 results in increased production of pro-inflammatory 
cytokines by the host and a hyperactive inflammatory response, which appear to contribute to 
host mortality (Saeij et al. 2007, Yamamoto et al. 2009, Ong et al. 2010). The Type II allele of 
GRA15 appears to exacerbate this condition through suppression of the anti-inflammatory NF-
kB signaling pathway, whereas the Type I and III alleles are nonfunctional in this case and 
therefore NF-kB signaling is not suppressed (Rosowski et al. 2011, Jensen et al. 2011). The 
contributions of ROP16 and GRA15 to strain virulence appear to be much less significant than 
those of ROP5 and ROP18, however.  
 
As noted previously, the vast majority of host species for T. gondii are resistant to infection 
except in special cases. The virulence differences described above appear to be largely specific 
to house mice and some closely related species. For other host species such as rats or humans, 
infection with any of the three archetypal lineages typically results in progression to an 
asymptomatic, chronic infection (Dubey 2010). Mouse resistance to T. gondii infection appears 
to be heavily dependent on the IRG defensive response, as evidenced by the presence of 22 
different IRG genes in the mouse genome, located in two chromosomal clusters (Howard et al. 
2011, Gazzinelli et al. 2014). By contrast, humans possess only one functional IRG gene, and 
this is expressed only in the testes. Furthermore, the apparent paralogous expansion of the IRG 
genes appears likely to have evolved specifically as a defense mechanism against T. gondii.  
While resistance to several other intracellular pathogens including Chlamydia trachomatis has 
been shown to be dependent on certain IRGs, only resistance to T. gondii has been found to 
require the full complement of these genes (Howard et al. 2011). Thus, the importance of ROP5 
and ROP18 in strain virulence are emphasized in mice compared to other host species. It seems 
likely that mice are deficient in innate immune responses that confer resistance in other host 
species, such as caspase-mediated apoptosis of infected macrophages, as identified in rats 





The Th1, cell-mediated immune response appears to be of primary importance in the control of 
T. gondii in both mice and humans. This response is characterized in part by upregulation of the 
cytokine IL-12, which stimulates the production of IFNg by T cells and Natural Killer (NK) cells 
(Gazzinelli et al. 1993, Hunter et al. 1994). IFNg in turn serves as the primary mediator of T. 
gondii control mechanisms (Suzuki et al. 1998). Detection of T. gondii is known to involve 
specific Toll-Like Receptors (TLRs) as well as the TLR-associated adapter molecule MyD88, 
though it also appears that other methods of detection are involved as well (Scanga et al. 2002). 
Monocytes, neutrophils and dendritic cells (DCs) are recruited early to the site of infection in 
mice and all three cell types appear to be important producers of IL-12 (Dupont et al. 2012). In 
addition to IL-12 production, neutrophils are also implicated in several direct killing 
mechanisms, including phagocytosis, production of reactive chemical species, and formation of 
extracellular DNA nets (Bliss et al. 1999, 2000). Inflammatory monocytes also produce IL-12, 
though for this cell type a more essential role appears to involve the generation of nitric oxide 
(NO) via expresson of inducible NO synthase (iNOS), which has an inhibitory effect on parasite 
replication (Mordue and Sibley 2003, Borges and Johnson 1975). Monocytes also produce IL-1, 
which may act synergistically with IL-12 to induce IFNg production from both innate and 
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adaptive sources, and may mature into DCs and macrophages (Shibuya et al. 1998, Dupont et al. 
2012). DCs are possibly the most important producers of IL-12, and are essential antigen-
presenting cells (APCs), necessary for activating a number of adaptive immune processes (Liu et 
al. 2006). NK cells are of primary importance during the acute phase of infection and are 
essential producers of IFNg following stimulation with IL-12, as well as exhibiting cytotoxicity 
towards infected cells (Sher et al. 1993, Denkers et al. 1993).  
 
The adaptive immune response, including both T and B cell mediated pathways, is also 
important in resistance to T. gondii for both humans and mice, particularly during the chronic 
phase of infection. CD4+ T cells are essential for mediation of B and CD8+ T cell responses, and 
also are primary producers of IFNg and CD40L during chronic infection (Lutgen et al. 2006, 
Reichmann et al. 2000). As mentioned, DCs are considered to be the most important group of 
APCs involved in CD4+ T cell activation in response to T. gondii infection, though B cells and 
macrophages are also capable of performing this function (Jenkins et al. 2001). CD8+ T cells are 
also critical for protection, through production of IFNg and CD40L like CD4+ T cells, and also 
via perforin-mediated lysis of infected cells (Denkers et al. 1997, Gazzinelli 1992). T. gondii 
antigens known to stimulate CD8+ T cell activity include Surface Antigen 1 (SAG1), dense 
granule proteins GRA4 and GRA6, and the rhoptry protein ROP7 (Dupont et al. 2012). 
Expression of the stimulatory GRA6 epitope is restricted to Type II strains (Blanchard et al. 
2008). Humoral immunity has also been shown to be important for control in both humans and 
mice. In mice, antibodies are known to provide resistance through opsonization of parasites for 
phagocytosis, blockage of invasion, and activation of the classical complement pathway (Erbe et 
al. 1991, Vercammen et al. 1999, Schieber et al. 1980). As noted, CD4+ T cell activity is 
essential for effective B-cell stimulation and subsequent antibody production.  
 
IFNg appears to be the primary mediator of control of acute infection (Dupont et al. 2014). The 
main function of this cytokine with regard to mouse resistance seems to be the upregulation of 
the p47 immunity-related GTPases (IRGs) and p65 guanylate binding proteins GBPs discussed 
above (Howard et al. 2011, Virreira et al 2011). Numerous IRGs and several GBPs have been 
implicated in resistance. IRGs may be grouped into effector (GKS) proteins, which bind 
sequentially to the PVM and effect mechanical disruption, and regulatory (GMS) proteins that 
bind to host intracellular membranes (golgi, ER etc.) and protect these from colonization and 
disruption by GKS proteins (Howard et al. 2011, Khaminets et al. 2010). GBPs also bind to the 
PVM, but appear to facilitate clearance through less direct mechanisms, including recruitment of 
IRGs and other immunity-related molecules (Yamamoto et al. 2012). Following disruption of the 
PV, exposed parasites may egress, be killed through permeabilization, or may be disposed of via 
the host’s autophagic apparatus (Dupont et al. 2012). In addition to activating IRG-dependent  
parasite clearance,  IFNg also performs several other known immunity-related functions. One of 
these is the promotion of tryptophan degradation in infected cells through the upregulation of the 
genes IDO1 and IDO2, which catalyze this process (Murray et al. 1989). Being auxotrophic for 
tryptophan, T. gondii cannot replicate if this amino acid is not provided by the host (Sibley et al. 
1994). Additionally, expression of iNOS is increased in IFNg-stimulated macrophages, resulting 
in increased production of NO and inhibition of parasite replication in these and other cell types. 
However, upregulation of iNOS also requires additional signaling molecules, including TNFa 
and CD40L (Reichmann et al. 2000, Yap et al. 1998). These and other members of the TNF 
family of cytokines, including Lymphotoxin alpha (LTa), are required for protection during the 
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chronic stage of infection (Schluter et al. 2003). The primary contribution of TNFa to immunity 
appears to be through iNOS upregulation, but evidence suggests other functions may also be 
important (Yap et al 1998). CD40L acts in conjunction with IFNg in ways described above, but 
also has an IFNg-independent function relating to xenophagic parasite clearance in a manner 
dependent on the autophagy-associated protein Beclin-1 (Reichmann et al. 2000). LTa has also 
been shown to be essential for resistance in mice, though the precise role of this cytokine in 





Since the original genotyping work in which the three clonal lineages were identified in Europe 
and North America, subsequent genotyping studies using a variety of techniques including PCR-
RFLP, microsatellite DNA analysis, intron sequencing and whole genome sequencing have 
revealed that the true global T. gondii population structure contains more complexity than 
described by the clonal model (Su et al. 2012). The European population appears to most closely 
resemble this model, being largely dominated by Type II and III strains, and with Type I strains 
making up a significant percentage as well (Howe and Sibley 1995). Even in this case, other so-
called atypical strains also are quite prevalent, however (Herrmann et al. 2012). In North 
America, Type II and III strains are also most prominent, but several atypical strains closely 
related to the archetypal Type II lineage are also major components of the population (Dubey et 
al. 2011, Khan et al. 2011). In addition, many diverse atypical strain types have also been 
identified in small proportions. Furthermore, the Type I lineage makes up only a small 
percentage of the total population, with isolates of this genotype being outnumbered by 
numerous atypical genotypes (Darde et al. 2008, Dubey and Su 2009). In China and southeast 
Asia, the archetypal lineages are relatively small contributors to the regional population, which is 
instead dominated by a small set of atypical lineages (Dubey et al. 2007,  Zhou et al. 2009, Qian 
et al. 2012) . It should be noted that while the populations of Europe, North America and 
southeast Asia are more complex than was originally thought and contain some highly dominant 
atypical lineages, they do still appear to embody largely clonal structures (Shwab et al. 2014). 
That is to say that a relatively small number of strain types compose a vast majority of the 
overall populations, suggesting that asexual or clonal reproduction has been the primary mode of 
expansion in these regions, with little sexual recombination between strains of different types. 
Genotyping studies of limited T. gondii isolates from South America, by contrast, have revealed 
completely different population structures. In these cases, a large diversity of atypical strains 
have been identified, most of these being common only in specific localities, with no single 
genotype approaching the dominance observed in the populations of the northern hemisphere 
(Pena et al. 2008, In South America, it thus appears that recombination among strains has been 
much more prominent, and a clonal model is therefore not appropriate for describing the 
population structures of this region (Dubey and Su 2009).  The differences between the 
mechanisms of strain propagation in Northern continents and South America may reflect the 
endemic vs. epidemic nature of the parasite in these regions. The parasite is more abundant in 
South America than elsewhere on Earth, and thus coinfection of individual feline hosts with 
multiple strain types would be expected to be more common, increasing the likelihood of sexual 
recombination between strains.  
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Observations leading to current research 
 
While numerous genotyping studies of T. gondii have been carried out, no formal attempt has 
previously been made to standardize the methodology to genotype T. gondii, so all available data 
reported from different researchers are fragmented and could not collectively establish a 
cohesive big picture of genetic diversity and population structure.  This made it difficult to use 
available data in conjunction with knowledge of other aspects of parasite biology, specifically 
the host-specific molecular mechanisms of pathogenesis, to understand the principles that have 
shaped the present T. gondii population structure. Previous genotyping studies have for the most 
part been limited to small localities and particular host species. For example, a typical study 
might focus on isolates from chickens living on farms in a small region of Colombia. By itself, 
this information does not provide us with much new insight beyond the limited scope of the 
particular study. However, when hundreds of such studies are carried out, examining numerous 
host species in localities around the world, these can potentially contribute significantly to a 
larger understanding of T. gondii population genetics. For such comparisons between studies to 
be meaningful, however, it is necessary for the format of the data collected in each to be 
compatible. As such, we have focused first on developing and presenting a standardized method 
for T. gondii genotyping using PCR-RFLP targeting a specific set of ten genetic markers, 
presented in chapter two of this thesis. The standardized PCR-RFLP method has been applied to 
genotype over a thousand T. gondii samples worldwide, generated invaluable data within several 
years by many researchers. We have then proceeded to compile all of the data collected and 
published using this method through the end of the year 2012. This data is presented and 
analyzed as a whole in chapter three.  
 
As noted, the diversity observed within the South American T. gondii population seems to 
correlate with more widespread  and severe human disease in general, and the strain types 
associated with more serious symptoms of toxoplasmosis in humans also appear to have a greater 
tendency towards mouse virulence. Given these correlations, and the current rapid expansion of 
human populations in many South American countries, exacerbating the potential for exposure to 
new parasite strains and resultant disease outbreaks, it is important to understand the mechanisms 
governing the virulence of atypical T. gondii strains and to have a means of predicting the 
virulence phenotypes of uncharacterized isolates in order to assess their potential as threats to 
human health.  Though a number of previously published genotyping studies have included 
mouse virulence assays of isolated strains, this is not the case for the majority of isolates and 
many strains therefore remain uncharacterized with regards to virulence. As noted above, 
molecular studies have identified the genes ROP5 and ROP18 as the key determinants of 
virulence differences among the archetypal T. gondii lineages. However, the extent to which 
these genes determine virulence in the large number of atypical strains identified has only been 
studied in a limited capacity. We were interested in determining the extent to which these two 
loci determine virulence in atypical strains, both because this knowledge would be useful in and 
of itself in helping to understand the mechanisms of T. gondii pathogenesis, and because 
genotyping at these loci could potentially provide a convenient method of predicting the mouse 
virulence of new isolates without requiring mouse mortality assays to be carried out. This would 
be particularly useful in cases where parasite DNA from infected animal tissue is obtainable but 
viable isolated parasites are not. To this end, we developed PCR-RFLP-based genotyping 
methods for ROP5 and ROP18, and proceeded to genotype a library of global T. gondii isolates 
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with both known and unknown mouse virulence phenotypes. In this way, we were able to both 
determine that, taken together, the ROP5 and ROP18 genotypes are highly predictive of mouse 
virulence, and to infer the probable mouse virulence phenotypes of a myriad of global isolates. 
These findings are presented in detail in chapter four of this dissertation. Additionally, we have 
genotyped this same set of isolates at ten additional loci for which we have developed novel 
PCR-RFLP genotyping protocols. When combined with the ten standardized markers discussed 
in chapter two, we were able to generate the most comprehensive picture of the global T. gondii 
population structure to date. This data is presented in Appendix A.  
 
After obtaining as precise and complete an understanding of the global patterns of T. gondii 
diversity as possible, we sought to better determine the principles involved in shaping this 
population structure. It was clear from our own findings and those of other researchers that the 
archetypal Type II lineage and some closely related variants were consistently dominant in 
populations presenting  clonal structures, such as those of Europe, North America and southeast 
Asia. We hypothesized, therefore, that such strains possessed some sort of competitive advantage 
over other strain types in these regions. As the primary phenotypic difference between T. gondii 
strains involves virulence to mice, we focused on this trait as the source of variable fitness 
between strain types. It has been well documented that Type II strains generally have mouse 
virulence levels intermediate to those of the highly virulent Type I and much less virulent Type 
III lineages. In this case, it is easy to understand why evolution towards lower virulence in this 
host species would be advantageous, as in the example of myxomatosis in Australian rabbits 
(Kerr 2012). In contrast to highly virulent strains which typically kill their hosts during the acute 
phase of infection, less virulent strains may progress to the chronic stage of infection, thus 
persisting within the host indefinitely and prolonging the time period in which passage to other 
hosts may occur. The answer to the question of why intermediately virulent Type II strains 
would have a fitness advantage over less virulent Type III strains seems less obvious. For a 
potential answer, we looked to studies involving direct competition between T. gondii strains for 
infection of murine hosts. A number of such studies have been published, typically involving the 
challenge of mice already chronically infected by one parasite strain with a second strain. A 
detailed summary of the findings of a number of relevant studies of this type is provided in 
chapter four of this work. A common finding of these studies is that, while prior chronic T. 
gondii infection in mice usually is protective against subsequent infections, strains with higher 
virulence are more likely to be able to overcome this protection and establish a secondary 
chronic infection. Therefore, in our current work we hypothesize that strains of intermediate 
virulence may have a competitive advantage over those of high and low virulence. Such strains 
may both be able to establish chronic infections in mice unlike highly virulent strains, and have a 
greater probability of reinfecting previously infected mice than strains with low virulence. In 
order to determine if such advantages could drive the expansion of intermediately virulent strains 
within populations over long periods of time, we employed an in silico modeling approach, the 
results of which are presented and discussed in chapter five. In short, the simulation results 
indicated that the two variables of mouse virulence and probability of successful sequential 
infection are both potentially influential to a strain’s prevalence within a parasite population, and 
that strains which possess an optimal balance between these variables (most closely resembling 
the phenotypes of natural Type II strains) will be consistently dominant.  
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In addition to examining the relationship between mouse virulence and population genetics of T. 
gondii, we were interested in discovering more about the variations in host response to different 
parasite strains. While the differences between the three archetypal lineages and the ways in 
which these differences contribute to variable disease outcomes in mice have been studied 
extensively, the host side of these interactions is not as well understood. Previous studies have 
shown variations in macrophage cytokine production during in vitro infection with Type I and 
Type II parasite strains, and variations in macrophage activation pathways between Type II 
strains and Type I and III strains. Other cell types, including human foreskin fibroblasts, chicken 
embryonic fibroblasts, and human neuroepithelial cells also have been shown to produce 
different responses to infection with different strain types in vitro. Furthermore, overall transcript 
levels have been shown to be markedly different in mice during infection with Type I and II 
strains compared to Type III strains. These studies and others indicate the existence of strain-
specific responses of mice to infection with different T. gondii strains, but little is currently 
known about the specific ways in which these responses differ. For this reason, we were 
interested in performing experiments focused on identifying strain-specific immune responses of 
mice. Specifically, we performed a time-course microarray study in which we analyzed total 
gene expression profiles of mice on a daily basis for seven days following infection with a Type 
I, II or III strain of T. gondii. In this way, we were able to identify unique host response profiles 
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Toxoplasma gondii is an obligate intracellular, apicomplexan parasite that infects all warm-
blooded vertebrates, including mammals and birds. It is the only known species in the genus 
Toxoplasma and is considered to be one of themost successful eukaryotic pathogens in terms of 
the number of host species and percentage of animals infected worldwide. Up to one-third of the 
human population in the world is chronically infected (Dubey and Beattie, 1988; Tenter et al. 
2000). Human infections are primarily caused by ingesting undercooked meat containing viable 
tissue cysts or by ingesting food or water contaminated with oocysts shed in the faeces from 
infected cats (Dubey, 2004). Primary infections in adults are mostly asymptomatic but 
lymphadenopathy or ocular toxoplasmosis can occur in some patients. Severe acute, 
disseminated toxoplasmosis can occur in immunocompetent human patients when infected with 
some isolates (Bossi and Bricaire, 2004). Infection acquired during pregnancy may spread and 
cause severe damage to the foetus. In immunocompromised patients, the reactivation of a latent 
infection can cause life-threatening encephalitis (Montoya and Liesenfeld, 2004). T. gondii has 
subpopulation structures in different geographical regions. It has what appears to be a clonal 
population structure in North America and Europe, with 3 predominant lineages (named types I, 
II and III) defined by multi-locus enzyme electrophoresis (MLEE), polymerase chain 
reactionrestriction fragment length polymorphism (PCRRFLP) or microsatellite analysis (Darde 
et al. 1992; Howe and Sibley, 1995; Ajzenberg et al. 2002a). A recent report suggests the same 
clonal structure in Africa (Velmurugan et al. 2008). However, T. gondii isolates from animals 
and human patients in South America are diverse and largely distinct from those in North 
America and Europe (Ajzenberg et al. 2004; Khan et al. 2006; Lehmann et al. 2006; Pena et al. 
2008; Dubey et al. 2008d). Historically, these distinct and non-type I, II or III parasites were 
designated as the ‘atypical ’ or ‘exotic’ isolates. The low linkage disequilibrium among genetic 
loci of these isolates suggests that the parasites have undergone frequent sexual recombination 
(Ajzenberg et al. 2004; Lehmann et al. 2004; Su et al. 2006). The consequences of infection with 
T. gondii depend on the host species and parasite genotypes. In mice, type I lineages are 
uniformly lethal (LD100=1); by contrast, the type II and III lineages are significantly less virulent 
(LD100>=103) (Sibley and Boothroyd, 1992). In humans, disease manifestations vary widely, 
ranging from asymptomatic to severe acute toxoplasmosis (Bossi and Bricaire, 2004; Montoya 
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and Liesenfeld, 2004). Type II is the predominant lineage causing human toxoplasmosis. 
However, there are biases between disease presentations and parasite genotypes. For examples, 
type I or type I-like atypical isolates are more likely to be involved in severe toxoplasmic 
retinochoroiditis in human patients (Grigg et al. 2001) and the atypical isolates often cause 
severe acute, disseminated toxoplasmosis in immunocompetent patients (Bossi and Bricaire, 
2004). Clinical symptoms of T. gondii infection are non-specific and unreliable for diagnosis. 
The conventional diagnosis of T. gondii infection usually employs serological tests, bioassays in 
cats and/or mice, or a combination of the 2 approaches (Dubey and Beattie, 1988). In the past 2 
decades, the diagnosis of T. gondii infection by direct detection of parasite-specific DNA in 
biological samples using PCR-based molecular methods has gained popularity. The molecular 
diagnosis is more sensitive and cost-effective than the conventional methods (Schoondermark-
Van De Ven et al. 1994; Bessie`res et al. 2009). There are hundreds of papers in current 
literature databases (such as PubMed) describing the use of these molecular methods. However, 
in this review article, rather than conduct an exhaustive review of all of the literature, we focus 
on key, representative articles to provide a perspective on establishing an integrated approach for 
the detection and characterization of T. gondii. 
 
 
Molecular methods for detection and identification 
 
Molecular methods rely on PCR for the specific detection or analysis of T. gondii DNA. These 
methods have proved to be simple, sensitive, reproducible and cost-effective, and have been 
applied to a variety of clinical samples from animals and humans (Bell and Ranford-Cartwright, 
2002; Contini et al. 2005; Calderaro et al. 2006; Bastien et al. 2007). Molecular methods can be 
divided into 2 groups. The first group focuses on specific detection of T. gondii DNA in 
biological samples. The conventional PCR, nested PCR (n-PCR) and quantitative real-time PCR 
(qPCR) of repetitive DNA sequences belong to this group. The second group of molecular 
methods focuses on a high resolution identification of T. gondii isolates. The multilocus PCR-
RFLP, microsatellite, and multilocus sequence typing (MLST) of singlecopy DNA sequences 
belong to this group. In the following sections, we discuss the above methods in detail. 
Molecular detection by conventional PCR, nested PCR (n-PCR) or quantitative real-time PCR 
(qPCR) of repetitive DNA sequences To achieve high sensitivity, PCR of a small, repetitive 
DNA sequence is preferred, because the efficiency of amplifying a small DNA fragment is 
higher than that of a large one. In addition, there are more template copies in a repetitive 
sequence per organism. Three repetitive DNA sequences are often used for the detection of T. 
gondii in biological samples, including the 35-copy B1 gene, the 300- copy 529 bp repeat 
element and the 110-copy internal transcribed spacer (ITS-1) or 18S rDNA gene sequences. A 
molecular detection method (conventional PCR) for T. gondii, targeting the B1 gene, was first 
developed by Burg et al. (1989). This method has since been modified and adapted in different 
laboratories (Khalifa et al. 1994; Liesenfeld et al. 1994; Bretagne et al. 1995; Pelloux et al. 
1998; Contini et al. 2002, 2005; Reischl et al. 2003; Switaj et al. 2005; Bastien et al. 2007). The 
529 bp repeat element was identified by Homan et al. (2000), and it was reported to be 10- to 
100-times more sensitive than the B1 gene (Homan et al. 2000; Reischl et al. 2003; Calderaro et 
al. 2006). The 110-copy ITS-1 or 18S rDNA has been used as the target in a few studies 
(Hurtado et al. 2001; Jauregui et al. 2001; Calderaro et al. 2006) and showed similar sensitivity 
to the B1 gene. To achieve higher sensitivity, n-PCR of B1 gene and ITS-1 sequences has been 
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applied in some studies (Pelloux et al. 1998; Hurtado et al. 2001; Jauregui et al. 2001; Contini et 
al. 2002, 2005; Bastien et al. 2007), both markers showed high sensitivity, with the detection 
level being as low as 1 parasite (Hurtado et al. 2001; Jauregui et al. 2001; Calderaro et al. 2006). 
For a given repetitive sequence, n-PCR is more sensitive than conventional PCR. A case in point 
is that the n-PCR of the B1 gene is more sensitive than the conventional PCR for the detection of 
T. gondii in amniotic fluid samples from congenital toxoplasmosis of human (Okay et al. 2009). 
Recently, we employed a set of primers for n-PCR of T. gondii 18S rDNA, and found that it was 
more sensitive than the B1 gene (data not shown). The 18S rDNA marker is of particular interest, 
as it can distinguish several protozoan parasites which are closely related to T. gondii. There is 
further discussion of this marker in a later section (Toward an integrated approach for molecular 
detection and identification) of this article. In recent years, qPCR that targets the repetitive DNA 
sequences, has shown high sensitivity (detecting y1 parasite genome equivalent) (Jauregui et al. 
2001; Reischl et al. 2003; Contini et al. 2005; Calderaro et al. 2006; Edvinsson et al. 2006). The 
qPCR approach has gained popularity for not only detecting but also quantifying T. gondii in 
biological samples (Bell and Ranford-Cartwright, 2002; Contini et al. 2005). Its sensitivity is 
superior to n-PCR assays (Contini et al. 2005) and can detect T. gondii over a range of 6–7 
orders of magnitude (Lin et al. 2000; Jauregui et al. 2001; Contini et al. 2005). Quantification of 
T. gondii by qPCR has been applied to the detection of the parasite in animal tissues and whole 
blood or amniotic fluids of human clinical samples (Lin et al. 2000; Jauregui et al. 2001; 
Kupferschmidt et al. 2001; Contini et al. 2005). Since it can estimate the intensity of T. gondii 
infection in the patients following drug treatment, qPCR is extremely useful to monitor the 
progression of infections under treatment and to diagnose lowlevel infections or carrier states 
(Contini et al. 2005). The 529 bp element is a preferred target for qPCR, as it provides a 
sensitivity of 6 repeat equivalents, or 1/50 of a genome equivalent (Kasper et al. 2009), currently 
representing the most sensitive assay for the detection of T. gondii. Rapid and accurate detection 
of T. gondii infection is pivotal for prompt treatment of clinical toxoplasmosis. However, the 
above-mentioned detection methods (conventional PCR, n-PCR and qPCR of repetitive DNA 
sequences) provide no information beyond a positive diagnosis. To better understand the 
epidemiology of the parasite, there is an increasing interest and need in the genetic classification 
of T. gondii. In the following section, we discuss the methods used for the genetic identification 
and characterization of this parasite. Molecular characterization by multilocus PCR-RFLP, 
microsatellite or multilocus sequence typing (MLST) analysis For epidemiological studies, it is 
important to identify individual T. gondii isolates and to track the source of contamination. The 
commonly used methods for these purposes are multilocus PCR-RFLP, microsatellite or MLST 
typing. The PCR-RFLP is based on the ability of restriction endonucleases to recognize single 
nucleotide polymorphisms (SNPs), digest PCR products and subsequently display distinct DNA 
banding patterns on agarose gels by electrophoresis (Sibley and Boothroyd, 1992; Howe and 
Sibley, 1995). Microsatellite analysis is based on the DNA sequence length polymorphisms of 
short nucleotide tandem repeats. The tandem repeats in T. gondii are often simple, consisting of 
as few as 2 nucleotides (di-nucleotide repeats), and occur 2–20 times (Blackston et al. 2001; 
Ajzenberg et al. 2002a, 2004). The MLST is based on DNA sequence polymorphisms including 
the SNPs, insertion and deletion of nucleotides in the sequence. SNPs and microsatellites are 
predicted to mutate at different evolutionary rates. For eukaryotes in general, the mutation rate 
for SNPs is estimated at 10x9–10x10 per nucleotide position per replication, whereas the rate for 
microsatellites is 10x2–10x5 per locus per replication (Goldstein and Schlotterer, 1999). 
Although the exact mutation rates of SNPs and microsatellites are not known in T. gondii, it is 
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clear that the latter have a higher mutation rate and can provide enhanced resolution in typing 
(Ajzenberg et al. 2002a). The microsatellites are useful in distinguishing genetically closely 
related T. gondii isolates. Since multilocus PCR-RFLP and microsatellite typing are simple and 
cost effective compared with MLST typing, they are preferred tools for characterization of T. 
gondii in epidemiological studies. A hallmark study of the epidemiology and population 
structure of T. gondii was conducted more than a decade ago on 106 isolates collected from 
humans and animals in North America and Europe (Howe and Sibley, 1995). In this study, 6 
PCR-RFLP markers were used and 3 predominant lineages (types I, II and III) were identified. It 
was concluded that T. gondii had a clonal population structure (Howe and Sibley, 1995). Since 
then, different sets of multilocus PCR-RFLP or microsatellite markers have been applied to 
epidemiological and population studies (Blackston et al. 2001; Ajzenberg et al. 2002a, b, 2004, 
2005; Lehmann et al. 2004, 2006; Khan et al. 2005a, b; Ferreira et al. 2006, 2008; Su et al. 
2006). A key finding of these studies was that T. gondii isolates from South America were highly 
diverse and distinct from those of North America and Europe. It was concluded that, in South 
America, T. gondii has an epidemic population structure (Ajzenberg et al. 2004; Lehmann et al. 
2004, 2006; Pena et al. 2008). However, the comparing of genotypes among different studies has 
been difficult or impossible, as different markers have been employed in different laboratories. 
The disadvantage of using a single-copy gene or genomic sequence is that the sensitivity is 
compromised compared with a highly repetitive sequence. A technical challenge to multilocus 
typing is that often samples are limited both in volume and in DNA amount, particularly from 
tissues from clinical cases or the mouse bioassay. To alleviate this problem, we have developed a 
multiplex multilocus nested PCR-RFLP (Mn-PCR-RFLP) method employing 10 genetic 
markers, including SAG1, SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico 
(Dubey et al. 2007e). The sensitivity of this method is estimated at 10 or more T. gondii genome 
equivalents, based on a previous study with 4 (SAG2, SAG3, BTUB and GRA6) of these 10 
markers (Khan et al. 2005a). In contrast, the sensitivity of conventional PCR-RFLP is estimated 
at 100 T. gondii genome equivalents (unpublished data). In Mn-PCR-RFLP typing, all markers 
are preamplified by multiplex PCR using external primers in a single reaction, and the pre-
amplified PCR products are used as templates to amplify each individual marker by n-PCR 
(Figure II-1). The advantage of this approach is that only a limited amount of individual sample 
is needed, which is particularly useful when only small amounts of ‘precious’ samples are 
available. Mn-PCR-RFLP analysis has been applied to the genetic typing of a large number of 
animal isolates bioassayed in mice, generating a substantial amount of data regarding genetic 
diversity and population structure of the parasite (Dubey et al. 2007a-g, 2008a-e; Pena et al. 
2008; Sundar et al. 2008; Velmurugan et al. 2008; Dubey and Su, 2009). This method has also 
been used for the genetic characterization of T. gondii DNA extracted from the brains of sea 
otters (Sundar et al. 2008) and arctic foxes (Prestrud et al. 2008). Application of this method to a 
broad range of samples will greatly facilitate our understanding of molecular epidemiology and 
population diversity of T. gondii in the near future. When the amount of DNA for T. gondii 
isolates is not limited, the MLST typing is the method of choice because it has the highest 
resolution among all typing methods. Recent studies of T. gondii using this approach have 
revealed alleles unique to parasite isolates in Brazil (Khan et al. 2006, 2007), emphasizing the 
importance of a sequencing approach for studying the population genetics and molecular 
phylogeny of T. gondii. 
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Figure II-1. Multiplex multilocus nested PCR-RFLP (Mn-PCR-RFLP) typing. Several genetic loci are pre-amplified by multiplex 
PCR with external primers. Then each individual locus is amplified by nested PCR using internal primers. The nested PCR products 
are treated with restriction enzymes and resolved in agarose gel to reveal strain-specific DNA banding patterns (RFLP typing). 
Horizontal lines represent DNA sequences and the horizontal arrows represent PCR primers. 
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Table II-1. Comparison of the methods for molecular detection and characterization of T. gondii 
Method Sensitivity (no. of parasites per PCR) Advantages and Limitations Suitable applications References 
qPCR of repetitive 
sequences 
0.02 to 1 genome 
equivalents at 529-bp 
locus ~1 genome 
equivalent at B1 locus 
Highly sensitive in detection. 
Isolation of parasite not needed. 
Not suitable for typing. 
Diagnosis 
(Edvinsson et al. 2006; Kasper 
et al. 2009; Reischl et al. 2003; 
Calderaro et al. 2006; Contini 
et al. 2002) 
n-PCR of repetitive 
sequences 
1 to 5 genome 
equivalents at B1 locus 
Sensitive. Isolation of parasite 
not needed. Not suitable for 
typing. 
Diagnosis (Calderaro et al. 2006; Contini et al. 2002) 
Mn-PCR-RFLP ~10 genome equivalents 
Less sensitive. High resolution 
in typing. Isolation of parasite 
may not be needed. 
Epidemiology and population 





Less sensitive. High resolution 
in typing. Isolation of parasite 
may not be needed. 
Epidemiology, population 





Insensitive, high resolution in 
typing. Isolation of parasite 
needed. 
Epidemiology, population 
genetics and phylogenetics This study 
Multiplex PCR of 
microsatellite 
markers 





Table II-2. Summary of primers for multiplex multilocus nested PCR-RFLP (Mn-PCR-RFLP) 
Markers 
Multiplex PCR primers (external 









and time Reference 
SAG1 F: GTTCTAACCACGCACCCTGAG R: AAGAGTGGGAGGCTCTGTGA 
F: CAATGTGCACCTGTAGGAAGC 











Not needed. The DNA fragment for 5'-
SAG2 is covered by the external 
primers of alt. SAG2. 
F: ATTCTCATGCCTCCGCTTC  
R: GCAAGAGCGAACTTGAACAC 242 
MboI, NEB4, 
BSA, 37C 
1h. 2.5% gel 
(Howe et 
al. 1997; Su 
et al. 2006) 
3'-SAG2 F: TCTGTTCTCCGAAGTGACTCC R: TCAAAGCGTGCATTATCGC 
F: ATTCTCATGCCTCCGCTTC  
R: AACGTTTCACGAAGGCACAC 222 
HhaI, NEB4, 
BSA, 37C 
1h. 2.5% gel. 
(Howe et 
al. 1997) 
alt. SAG2 F: GGAACGCGAACAATGAGTTT R: GCACTGTTGTCCAGGGTTTT 
F: ACCCATCTGCGAAGAAAACG 
R: ATTTCGACCAGCGGGAGCAC 546 
HinfI + TaqI, 
NEB3, BSA, 
37C 30 min, 
65C 30 min. 
2.5% gel 
(Khan et al. 
2005b; Su 









Table II-2 continued 
 
Markers Multiplex PCR primers (external primers)* 












BTUB F: TCCAAAATGAGAGAAATCGT R: AAATTGAAATGACGGAAGAA 
F: GAGGTCATCTCGGACGAACA 
R: TTGTAGGAACACCCGGACGC 411 




60C 1h, 2.5% 
gel 
(Khan et al. 
2005b; Su et 
al. 2006) 
GRA6 F: ATTTGTGTTTCCGAGCAGGT R: GCACCTTCGCTTGTGGTT 
F: TTTCCGAGCAGGTGACCT 
R: TCGCCGAAGAGTTGACATAG 344 
MseI, NEB2, 
BSA, 37C 1h, 
2.5% gel. 
(Khan et al. 
2005b; Su et 
al. 2006) 
C22-8 F: TGATGCATCCATGCGTTTAT R: CCTCCACTTCTTCGGTCTCA 
F: TCTCTCTACGTGGACGCC 






37C 30 min, 
5C, 30 min, 
2.5% gel 
(Khan et al. 


















Multiplex PCR primers (external 












C29-2 F: ACCCACTGAGCGAAAGAAA R: AGGGTCTCTTGCGCATACAT 
F: AGTTCTGCAGAGTGTCGC 




BSA, 37C 1h, 
2.5% gel 
(Khan et al. 
2005b; Su 
et al. 2006) 
L358 F: TCTCTCGACTTCGCCTCTTC R: GCAATTTCCTCGAAGACAGG 
F: AGGAGGCGTAGCGCAAGT 
R: CCCTCTGGCTGCAGTGCT 418 
HaeIII + NlaIII 
(double digest), 
NEB1, BSA, 
37C 1h, 2.5% 
gel 
(Khan et al. 
2005b; Su 
et al. 2006) 
PK1 F: GAAAGCTGTCCACCCTGAAA R: AGAAAGCTCCGTGCAGTGAT 
F: CGCAAAGGGAGACAATCAGT 
R: TCATCGCTGAATCTCATTGC 903 
AvaI + RsaI 
(double digest), 
NEB4, BSA, 
37C 1h, 2.5% 
gel. 
(Khan et al. 
2005b; Su 






R: GGGATTCGAACCCTTGATA 640 
AflII + DdeI 
(double digest), 
NEB4, BSA, 
37C 1h, 3% gel 
(Su et al. 
2006) 
 
*F, forward primer. R, reverse primer
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Toward a molecular approach to identification and detection 
 
Each of the detection and identification methods discussed above has its advantages and/or 
limitations, depending on application. A comparison of these methods is presented in Table II-1. 
At present, most clinical studies have focused on detecting the presence of T. gondii DNA in 
biological samples using the highly sensitive nested or qPCR of repetitive DNA sequences, but 
little has been done to further characterize the parasites. This is because each of these markers 
(B1 gene, 529 bp repetitive element, or ITS-1) has identical or near-identical repetitive 
sequences, therefore they are not adequate for genetic typing. The conventional multilocus PCR-
RFLP analysis method relies on single-copy polymorphic DNA sequences, and usually a 
relatively large amount of starting templates from the parasite is required. Therefore, it has been 
difficult to genetically identify T. gondii in clinical samples, due to the extremely small amounts 
of parasite DNA available. The recent development of the Mn-PCR-RFLP method makes it 
possible to genetically characterize or classify T. gondii from clinical samples with high 
resolution. Here, we propose an integrated approach for the detection and genetic 
characterization of T. gondii. This approach should include detection of T. gondii infection in 
biological samples by n-PCR or qPCR of repetitive DNA sequences (employing the B1 gene or 
the 529-bp repeat element), followed by Mn-PCR-RFLP for the subsequent identification of T. 
gondii. There are a number of protocols developed in several laboratories for the detection of T. 
gondii by qPCR or n-PCR (Costa et al. 2000; Reischl et al. 2003; Edvinsson et al. 2006; 
Calderaro et al. 2006; Kasper et al. 2009). Although the sensitivity of these protocols varies 
among different laboratories, all studies demonstrate that the 529 bp repeat element is the most 
sensitive target, with a detection limit of 1/50 of a genome equivalent (Kasper et al. 2009).  
 
Regardless of the protocol employed, all positive-testing samples should be further characterized 
genetically by the Mn-PCR-RFLP typing method. The PCR primer sequences and experimental 
conditions for this typing method are listed in Table II-2. This integrated approach will provide 
maximum information for epidemiological studies in order to address questions regarding the 
association of disease manifestations with parasite genotypes and virulence. For phylogenetic 
studies, MLST is preferred for its high resolution. Conventional PCR based MLST requires the 
samples to have a relatively high concentration of genomic DNA (100 genome equivalents per 
PCR). Taking the Mn-PCR approach, we have been able to generate quality DNA sequence data 
from samples containing as low as 10 genome equivalent (data not published). The major 
precaution for this approach is that, if errors occur in the early cycles of PCR, erroneous 
sequences may be generated. This problem can be solved by sequencing at least 2 independent 
PCR products from the same sample.To standardize studies and facilitate comparison among 
different laboratories, it is strongly recommended that all sequencing efforts include a few 
commonly used introns such as UPRT-1, UPRT-7, EF1 and HP (Khan et al. 2006, 2007) and the 
GRA6 gene (Fazaeli et al. 2000). For genomic DNA samples extracted directly from animal 
tissues, we suggest screening all samples using n-PCR targeting the 18S rDNA sequence prior to 
Mn-PCR-RFLP typing for T. gondii. By sequence analysis of the 18S rDNA for a number of 
closely related apicomplexan parasites, we identified SNPs that can distinguish T. gondii, 
Hammondia hammondi, Neospora caninum and Sarcocystis neurona by RFLP analysis (Fig. II-
2). For n-PCR of 18S rDNA, the external primers are: Tg18s48F, CCA 
TGCATGTCTAAGTATAAGC and Tg18s359R, GTTACCCGTCACTGCCAC, which amplify 
a 312bp DNA fragment from T. gondii. The nested PCR primers are: Tg18s58F, 
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CTAAGTATAAGC TTTTATACGGC and Tg18s348R, TGCCACG GTAGTCCAATAC, which 
amplify a 291bp DNA fragment from T. gondii. These primers were designed based on 
sequences conserved for the above 4 parasites. The GenBank Accession numbers of these 
sequences are M97703 (T. gondii), AF096498 (H. hammondi), U17346 (N. caninum) and 
U07812 (S. neurona). Using this marker, we recently detected a mixed infection of Sarcocystis 
tenella and T. gondii from sheep brain tissues (data not published). The 18S rDNA marker 
provides an excellent tool for detecting apicomplexans that are closely related to T. gondii in 
animal samples, which will add additional value to the studies on T. gondii infection in animal 
populations. To monitor contamination of PCR amplification in Mn-PCR-RFLP genotyping, 
negative controls without DNA template should be included in each batch of experiments. In 
addition, a set of reference T. gondii isolates should be included to monitor the efficiency of PCR 
amplification and restriction enzyme digestion. This is very important, because for each batch of 
experiments there can be variation in efficiency of restriction digestion and sometimes 
incomplete digestion, and the concentration of electrophoretic gel can also vary slightly among 
experiments. Including T. gondii reference isolates in every experiment and on every 
electrophoretic gel will ensure the accuracy of results. The suggested references include RH88, 
GT1, PTG, CTG, TgCgCa1 (a.k.a. Cougar, COUG),MAS, TgCatBr5, TgCatBr64 and TgRsCr1 
(Su et al. 2006; Dubey et al. 2009). The genetic data for these reference strains are summarized 
in Table II-3. A set of gel images is presented in Figure II-3.  
 
Currently, there is a lack of standard nomenclature for T. gondii genetic typing. Historically, 
genetic markers were selected based on polymorphisms in DNA or protein sequences among the 
clonal type I, II, and III lineages, and the corresponding alleles were designated either as I, II, III, 
or 1, 2, 3, respectively (Darde et al. 1992; Sibley and Boothroyd, 1992; Ajzenberg et al. 2004; 
Ferreira et al. 2006; Khan et al. 2006; Su et al. 2006; Pena et al. 2008). Alleles which are distinct 
from those of types I, II or III were designated as either unique-1 (u-1), unique-2 (u-2), unique-3 
(u-3) etc., or 4, 5, 6, etc. In Table II-3 and Figure II-3, we use the former scheme to describe new 
alleles. In summary, the application of an integrated approach, combining molecular detection 
and high resolution genetic characterization, should assist in enhancing our understanding of the 
molecular epidemiology, population genetics and phylogeny of T. gondii, which will be 
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Figure II-2.  PCR-RFLP gel image for T. gondii, Hammondia hammondi, Neospora caninum and Sarcocystis neurona based on 
the 18S rDNA marker. PCR products from each parasite species were separated in 3% agarose gels. Samples GT1, PTG, and CTG 
represent T. gondii. All 4 apicomplexan species have unique banding patterns and can be clearly distinguished (mouse and human 
DNA were used as negative controls and no PCR products were amplified, not shown). MK: Low molecular weight DNA ladder (New 
England Biolabs Inc.).  
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Table II-3 Summary of multilocus PCR-RFLP typing for T. gondii reference isolates 
 Genetic markers 





SAG23 SAG3 BTUB GRA6 C22-8 C29-2 L358 PK1 Apico 
GT1, RH88 (Type I) I I I I I I I I I I I 
PTG (Type II) II/III II II II II II II II II II II 
CTG (Type III) II/III III III III III III III III III III III 
TgCgCa1 (cougar, 
COUG) I II II III II II u-1 u-1 I u-2 I 
MAS u-1 II III III III III I I I III I 
TgCatBr5 I III III III III III I I I u-1 I 
TgCatBr64 I u-1 III III III III I I III III I 
TgRsCr1 u-1 II I III I III I I I III I 
1 At SAG1 locus, Type II and III are indistinguishable. 
2 SAG2 marker based on 5’ and 3’ ends of the gene sequence (Howe et al. 1997). 
3 A SAG2 marker based on the 5’ end of the gene sequence but different from 5’ SAG2 (Su et al. 2006). 















Figure II-3. Multiplex multilocus nested PCR-RFLP (Mn-PCR-RFLP) analysis of T. gondii samples using 10 different genetic 
markers. T. gondii reference strains are GT1 (or RH88), PTG, CTG, TgCgCa1 (a.k.a. Cougar, COUG), MAS, TgCatBr5, TgCatBr64 
and TgRsCr1. Nested PCR products from each marker were digested with selected restriction enzymes (Table II-2), and DNA 
fragments were separated in agarose. All markers were resolved in 2.5% gels, except that Apico was resovled in 3% gels. MK, low 
molecular weight DNA ladder (New England Biolabs Inc.) 
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Chapter III. Geographical patterns of Toxoplasma gondii genetic diversity 
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Toxoplasma gondii is a parasitic protozoan parasite belonging to the phylum Apicomplexa. It 
parasitizes mammals and birds, and one third of the world’s human population is infected 
(Dubey, 2010). T. gondii generally forms chronic infections in its hosts, embedding in muscle 
and brain tissue (Tenter et al. 2000). In immunocompromised hosts such as AIDS patients, 
infection with T. gondii may result in encephalitis, and in developing fetuses acute toxoplasmosis 
may result in blindness, deformation, mental retardation, or even death (Montoya and Liesenfeld, 
2004). In veterinary medicine, toxoplasmosis is a major contributor to abortion in a number of 
economically important livestock animals such as sheep and goats (Buxton et al. 2007). 
Recently, chronic toxoplasmosis has been shown to cause behavioral changes in mice, making 
them attracted rather than repelled by the scent of cat urine, attributable to inhibition of neuronal 
function and alteration of neurotransmitter levels (Haroon et al. 2012; Gatkowska et al. 2012). In 
humans, the condition has also been shown to correlate with schizophrenia (Yolken et al. 2001; 
Torrey et al. 2007) and bipolar disorder (Pearce et al. 2012; Hamdani et al. 2013).  
       
Unlike many other parasites in the apicomplexan phylum, which exhibit stronger host specificity, 
T. gondii possesses an extremely broad host range, infecting both mammals and birds (Dubey, 
2010). The parasite has been isolated from a wide range of hosts, including both terrestrial and 
marine animals. In addition to having this expansive host range, T. gondii also seems to be nearly 
ubiquitous geographically, having been isolated from a variety of climatic regions on every 
continent surveyed (Dubey, 2010). It seems that this expansion of the parasite occurred relatively 
recently in its evolutionary history (Khan et al. 2007). Because of the remarkable evolutionary 
success of T. gondii that has resulted in such broad expansion, it is important to understand 
transmission patterns and the factors that influence such patterns. In 1995, Howe and Sibley 
published a landmark article showing evidence for a clonal population structure in Europe and 
North America, in which the vast majority of T. gondii strains could be grouped into three 
lineages, namely Types I, II and III (Howe and Sibley, 1995). There appeared to be very limited 
sexual recombination between strains belonging to each of the lineages. While this model of the 
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T. gondii population structure is still upheld to a large extent, it later became clear that the actual 
structure was more complex than was originally thought. This was found to be particularly true 
in Central and South America, where an abundance of atypical (non-clonal) strain types have 
been found (Lehmann et al. 2006; Ferreira et al. 2006; Khan et al. 2007; Pena et al. 2008; Su et 
al. 2012). Moreover, improvements in genotyping techniques have revealed greater complexity 
not only in Central and South America, but also in North America (Rajendran et al. 2012; Su et 
al. 2012). 
 
Several molecular techniques including polymerase chain reaction - restriction fragment length 
polymorphism analysis (PCR-RFLP) (Howe and Sibley, 1995; Su et al. 2006, 2010), 
microsatellite DNA analysis (Ajzenberg et al. 2002, 2010) and multilocus DNA sequence typing 
of introns (Khan et al. 2011; Khan et al. 2007) have been used to study the genetic makeup of T. 
gondii strains. A comprehensive review of these methods and their contribution to the state of 
molecular epidemiology and population genetics of T. gondii can be found in a recent 
publication (Dardé et al. 2014). Among these methods, PCR-RFLP analysis of ten markers (Su 
et al. 2006, 2010) was applied to more than a thousand T. gondii isolates worldwide, generating a 
significant amount of data and revealing the genetic diversity of the parasite. Here, we 
summarize the data generated to the end of 2012 using this approach. This data comes from 
numerous publications originating from studies performed on every continent except Antarctica, 
and provides information for 1457 isolates representing 189 different genotypes. A number of T. 
gondii isolates previously typed by other methods were genotyped by the ten PCR-RFLP 
markers in our laboratory and the results were integrated into this review article. Together, this 
information makes up the most comprehensive and cohesive picture of the global T. gondii 





Geographical patterns of genetic diversity 
 
At present, there is no standard nomenclature in designating genotypes for T. gondii. 
Conventional designation defined the clonal Type I, II and III lineages, and lumped up all others 
as atypical or exotic genotypes (Howe and Sibley, 1995; Grigg et al. 2001; Su et al. 2003). The 
subsequently identified major genotypes were added to the list including Type BrI, BrII, BrIII 
and BrIV, Type 12, Africa 1, and Chinese 1 (Chen et al. 2011; Khan et al. 2011; Mercier et al. 
2010; Pena et al. 2008). However, this scheme of genotype designation is too cumbersome to 
define hundreds of genotypes identified by the multilocus PCR-RFLP method. To overcome this 
problem, a scheme has been adopted in which each genotype is designated as a “ToxoDB PCR-
RFLP genotype” followed by a specific numeral. A comparison of conventional nomenclature 
and ToxoDB PCR-RFLP designations for major genotypes is provided in Table III-1. To find a 
more comprehensive comparison of genotype designation schemes, see the recent publication by 
Dardé et al. (2014).  
 
 A total of 189 ToxoDB PCR-RFLP genotypes identified from 1457 samples are summarized in 
Table E-1 (Appendix E) . The compiled data were based on published results reported up to the 
end of 2012. The vast majority of T. gondii isolates were obtained from domestic and wild 
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animals with chronic infection.  For these samples, infection of T. gondii was first determined by 
the presence of anti-Toxoplasma antibodies in their sera, followed by bioassay of seropositive 
animal tissues (brain and/or muscle) in mice or cats. T. gondii isolates obtained from 
experimentally infected mice or cats were further processed for genotyping. The global 
distribution of the 189 genotypes is illustrated in Figure III-1. The ten most frequently identified 
genotypes are genotype #2, #3, #1, #5, #4, #9, #6, #7, #8 and #10, accounted for 13.8, 12.6, 12.2, 
5.0, 4.5 3.8, 3.3, 2.6, 2.3 and 2.1% of the samples, respectively. Genotypes #1 and #3, which 
differ only at the Apico locus, together compose the conventional Type II lineage, accounted for 
24.8% (362/1457) of the population. Genotype #1 is also referred to as Type II clonal, whereas 
#3 as Type II variant (Table III-1). As noted, genotype #2, also known as Type III, accounted for 
13.8% (201/1457) of the samples. Genotypes #4 and #5, which differ only at the SAG1 locus and 
are collectively known as Type 12, accounted for 9.5% (139/1457) of the population. The results 
showed that genotypes #1, #2 and #3 (Type II clonal, Type III and Type II variant) are identified 
worldwide. These three genotypes are highly prevalent in Europe. Genotypes #1, #2, #3, #4 and 
#5 dominate in North America. Genotypes #2 and #3 (Types III and II variant) dominate in 
Africa, and genotypes #9 and #10 (Chinese 1 and Type I) are prevalent in east Asia. In the 
paragraphs below, we have summarized the genotyping results by major geographical regions. 
Due to small sample size (only 3 isolates), Australia is not discussed further. 
 
North America  
 
In North America, including the USA and Canada, a total of 501 isolates (including 2 samples 
from Hawaii) have been typed to 40 genotypes. The majority of the samples (86.4%, 433/501) 
fall into genotypes #1, #2, #3, #4 and #5 (Figure. III-1). Genotypes #1 (29.7%, 149/501) and #3 
(14.2%, 71/501), which are the conventional Type II lineage, accounted for 43.9% (220/501) of 
the population. Genotype #2 (Type III), accounted for 18.2% (91/501) of the samples. Genotypes 
#4 (10.0%, 50/501) and #5 (14.4%, 72/501) (together as Type 12) accounted for 24.4% 
(122/501) of the population. Type 12 is now recognized as the fourth clonal lineage in North 
America (Khan et al. 2011). It was shown that Type 12 is a dominant lineage in wildlife in North 
America (Dubey et al. 2011). Toxoplasma gondii strains belonging to this lineage, also 
designated as Type X, were associated with high mortality in sea otters along the coast of 
California (Miller et al. 2008). Genotype #10 (Type I), previously considered as one of several 
dominant types in North America, accounted only for 0.8% (4/501) of the population.  
 
Europe 
Of the 64 samples obtained from European countries, 9 genotypes were identified (Figure III-1). 
Nearly three quarters (64.1%, 41/64) belong to the genotypes #1 (25.0%, 16/64) and #3 (39.1%, 
25/64), which are recognized as the Type II lineage. Genotype #2 (Type III) makes up 12.5%, 
(8/64) of the samples. Genotype #10 (Type I) and genotype #6 (a.k.a Type BrI, Africa 1), both 
have relatively high frequencies, accounted for 9.4% (6/64) and 4.7% (3/64), respectively. This 
genetic uniformity gives Europe the closest resemblance to the three-lineage model proposed by 
Howe and Sibley (Howe and Sibley, 1995). The prevalence of genotypes #4 and #5 (also 
collectively designated as Type 12) in North America provides contrast with Europe,where 
genotype #4 has not been found and genotype #5 makes up only a minor part of the population. 
More sampling from a greater diversity of hosts is needed from European countries for better 
understanding of the region’s T. gondii population structure.  
 31 





RFLP Genotypes Representative isolates References 
Type I, type 1 #10 GT1 Su et al. (2012) 
Type II, type 2 
(type 2 clonal) #1 PTG Su et al. (2012) 
Type II, type 2 
(type 2 variant) #3 PRU Su et al. (2012) 
Type III, type 3 #2 VEG Su et al. (2012) 
Type 12, atypical, 
exotic #4 B41 Khan et al. (2011); Su et al. (2012) 
Type 12, atypical, 
exotic, includes 
Type X and Type 
A #5 ARI Khan et al. (2011); Su et al. (2012) 
Type BrI, atypical, 
exotic, Africa 1 #6 FOU, TgCatBr2 
Pena et al. (2008); Mercier et al. 
(2010); Su et al. (2012) 
Type BrII, atypical, 
exotic #11 TgCatBr1 Pena et al. (2008); Su et al. (2012) 
Type BrIII, 
atypical, exotic #8 P89 (TgPgUs15), TgCatBr3 Pena et al. (2008); Su et al. (2012) 
Type BrIV, 
atypical, exotic #17 MAS, TgCkBr147 Pena et al. (2008); Su et al. (2012) 
Chinese 1, atypical, 
exotic #9 TgCtPRC4 
Dubey et al. (2007b); Chen et al. 








Figure III-1. Geographical distribution of T. gondii genotypes.  Black dots indicate locations from which T. gondii isolates were 
obtained and genotyped using the PCR-RFLP method. The numbers around pie chart edges indicate ToxoDB PCR-RFLP genotypes. 
In some cases, alternative strain type designations are overlaid on pie charts in bold lettering (also see Table III-1 for correlations 
between nomenclatures). Sizes of pie charts correlate with total number of isolates (n), and colors indicate different genotypes. Two 
strains (GANGI and WIK) reported from Africa without specific countries of origin were listed in Supplemental Table S1, but not 





Figure III-1 continued  
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Asia   
 
In Asia, there also appears to be a high degree of genetic uniformity. From 102 samples, 10 
genotypes were identified. Genotype #9 (Chinese 1) is by far the most commonly found, 
accounting for 48.0% (49/102) of samples. It is present in China, Vietnam and Sri Lanka, 
indicating a widespread distribution in Eastern Asia. Genotype #10 is also common in China, 
unlike in most other countries (13.7%, 14/102 in Asia). Genotypes #4, #18 and #20 have 
relatively high frequencies among the samples in Asia. Genotype #20 has been identified in a 
wide range of areas, from Sri Lanka in south Asia to Egypt in north Africa. Thus far, most of the 
sampling from Asia has been from the more populous eastern regions. More sampling is thus 
needed from the western areas where the climate and geography, as well as the distribution of 




A total of 141 samples were typed and 13 genotypes identified in Africa. Most samples 
(118/141) in Africa were from Egypt. Overall, genotype #3 (45.4%, 64/141) and #2 (39.0%, 
55/141) are the two dominant types, accounting for 84.4% of the samples. Genotype #6 was 
identified for several samples. The limited data that are available from sampling in Western 
Africa seem to suggest a high level of diversity, with a relatively low frequency of common 
genotypes. However, more sampling is required in Africa before strong conclusions can be 
drawn regarding the makeup of the T. gondii population of that continent. It would be of special 
interest to have more information regarding T. gondii in the tropical regions of Africa.  
 
Central and South America 
 
A total of 646 samples were typed and 156 genotypes identified in Central and South America. 
Unlike in the northern hemispheric countries discussed above, T. gondii in this region displays a 
highly diverse population structure, in which no genotype appears to be clearly dominant. The 
top ten genotypes are #2, #6, #7, #8, #11, #3, #65, #13, #19 and #146, with frequencies of 6.8, 
6.2, 5.0, 3.7, 3.3, 3.1, 3.1, 2.5, 2.5 and 2.3%, respectively. The genotypes #1, #2, #3 and #10 are 
at low frequencies and have not taken over the genetic landscape as in the north. Of these 
genotypes, the #2 (Type III) is the most frequently occurring (6.8%, 44/646) and is found in 
many of the countries in this region, even those for which the sample size is low, such as 
Panama, Peru and Grenada. Even in these regions however, genotype #2 is often less frequent 
than many other genotypes. An exception to this trend is found in Chile, where we see a genetic 
makeup more similar to that found in North America and Europe, in which genotypes #1, #2 and 
#3 predominate. Chile is located on the west side of the Andes Mountains which separate it from 
most of the countries in South America. On its west side is the Pacific Ocean, which provides 
ports for maritime transportation to other continents. Trading with countries on different 
continents might bring genotypes #1, #2 and #3 to Chile, eventually allowing them to become 






Quantitative comparison of genetic diversity 
 
To quantify differences of genetic diversity among T. gondii populations from major 
geographical areas, we analyzed the typing data based on different continents. Within- and 
between-population diversity and shared genotypes were analyzed by Arlequin v3.5 as described 
in previous reports (Rajendran et al. 2012; Excoffier and Lischer, 2010). The results are 
summarized in Table III-2, Figure III-2 and Table III-3. Among the five major regions including 
Africa, Asia, Europe, North America, and Central/South America, the genotype diversity (gene 
diversity) indices are 0.6433, 0.7280, 0.7679, 0.8285 and 0.9792, respectively, indicating high 
diversity in Central/South America, followed by North America (Table III-2). Pairwise 
comparison revealed that there are significant differences among populations in Africa, Asia, 
Europe, North America, and Central/South America, with only the populations of Europe and 
North America exhibiting similar genetic composition to each other (Figure III-2). Furthermore, 
the difference between Central/South America and other areas is more prominent (Figure III-2). 
Analysis of shared genotypes revealed the distribution of common genotypes (Table III-3). 
Genotypes #1, #2 and #3 exist in all five continents. Genotype #6 (BrI, Africa 1) has been 
identified in all but North America, genotype #10 (Type I)  has been identified in all but Africa, 
and genotype #15 identified in all but Asia. The North and Central/South Americas shared 17 





The compiled PCR-RFLP typing results of 1457 T. gondii samples revealed 189 genotypes. 
Overall, geographical differences are readily recognized. Only a few genotypes dominate in the 
northern hemisphere, whereas hundreds of genotypes coexist with a few having a relatively 
higher frequency in the southern hemisphere. These results suggest a clonal population structure 
in the north and an epidemic population structure in the south. This finding is in strong 
agreement with the conclusion from a smaller sample size that was analyzed by combined typing 
methods (Dardé et al. 2014). Though the frequencies of genotypes may change with more 
intensive sampling, we expect that the compiled results of 1457 samples have captured the big 
picture of global T. gondii diversity. 
 
Understanding T. gondii population structure is of great interest, as it may provide us with 
essential information regarding the transmission and evolution of this widespread zoonotic 
parasite. Several major factors may have been involved in shaping the modern-day T. gondii 
population structure. First, the rise of human agriculture about 11,000 years ago in Mesopotamia 
and its expansion to the New World in the last few hundred years may have significantly 
transformed our biological environment and reduced genetic diversity of animal parasites 
(Rosenthal, 2009). In North America, Europe and east Asia, large-scale farming and the erection 
of cities have largely transformed the landscape throughout much of these regions, and likewise 
many of the ancestral wild animal species have been replaced with genetically uniform domestic 
animals. Such transformation of geography and reduced animal diversity may have led to 
expansion of a few T. gondii genotypes that adapted to the new environment. The limited data 
lend support to the idea that the clonal T. gondii lineages may have become dominant in a 
manner that was concomitant with the beginnings of human agriculture in the region of 
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Mesopotamia, whereupon these lineages then spread outward alongside the flow of human 
migration. However, more data is certainly required from the Middle East and other regions 
before more definitive conclusions can be drawn regarding this matter.  
 
Second, the low genetic diversity of T. gondii observed in the northern hemisphere may be a 
result of the founder effect. The high genetic diversity observed in South and Central America 
suggests that T. gondii originated in this region (Lehmann et al., 2006).  It is possible that a small 
number of founding strains were introduced from South America to other continents by maritime 
trading of goods, transportation of pet animals such as cats, or accidental transport of infected 
rodents within the last five centuries (Lehmann et al., 2006). These founder populations could 
then have expanded throughout their respective geographic regions with little competition or 
recombination between strains, leading to the observed clonal population structures. 
 
Another possible explanation for the high genetic diversity found in South and Central America, 
in contrast to the low diversity of the northern hemisphere, is that the tropical and subtropical 
zones in the former region support a greater diversity and number of animal hosts, each of which 
might favor the selection of different T. gondii genotypes, enabling a wider variety of strains to 
proliferate. Additionally, the warmer climate may allow a greater number of oocysts to survive in 
nature for a longer period of time, resulting in more infection of hosts overall as well as 
decreased selective pressure compared to the northern hemisphere. Thus far, sampling in tropical 
regions other than those of South and Central America has been sparse and so understanding of 
the T. gondii population structures in these areas remains limited. If additional sampling were to 
reveal that regions with similar climate and host species diversity such as those found in Africa 
and southeast Asia also supported highly diverse T. gondii populations, such a finding would 




The existing genotyping studies have revealed essential information regarding the global 
diversity of T. gondii and its population structure, providing us preliminary data for further study 
on the origin, transmission, ecology and evolution of this highly successful protozoan parasite. 
To start tackling these topics, more in-depth sampling of T. gondii is necessary for several 
aspects. First, sampling of T. gondii in wildlife from remote areas that are not disturbed by 
human civilization is needed to better assess the effect of human settlement on the diversity of T. 
gondii. A recent study in French Guiana showed that a human environment may favor clonal 
expansion and reduce T. gondii diversity (Mercier et al. 2011). Given that human agriculture 
arose in the Fertile Crescent about 11,000 years ago in Mesopotamia (Diamond and Bellwood, 
2003), it might have led to expansion of genotypes #1, #2 and #3 and significantly reduced T. 
gondii diversity in Europe and Southwest Asia. However, we would expect that high genetic 
diversity may still be maintained in wildlife from remote geographical regions that have not been 
disturbed by human settlement in Europe and Southwest Asia. Similar studies are also necessary 
in tropical Africa, the Amazon rainforest, South Asia and Australia to better understand the 
effect of human societies on T. gondii genetic diversity. Availability of these data will allow us 
to understand the global transmission patterns of T. gondii. 
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Second, potential long distance transmission of T. gondii by migratory marine mammals and 
birds is poorly understood. It was shown that striped and bottlenosed dolphins, as well as a 
variety of Antarctic pinnipeds were seropositive for T. gondii infection (Dubey et al. 2007a, 
2008; Rengifo-Herrera et al. 2012). Dolphins may migrate over relatively large distances and 
thus may be important vectors for the long distance spread of T. gondii. Several studies have 
focused on the prevalence of T. gondii in marine mammals such as sea otters along the coastlines 
of California, Washington and Alaska. A genotype designated as ‘Type X’ (genotype #5) was 
dominant in these sea otters (Conrad et al. 2005; Sundar et al. 2008). The same genotype seemed 
to be the major cause of high mortality in otters in California (Conrad et al. 2005). Though sea 
otters are not migratory themselves, they may be sentinels of a route by which T. gondii might be 
introduced into the marine ecosystem (or at least an indicator of the types of strains present in 
such ecosystems), through which it seems likely that intercontinental transmission may occur. 
Migratory birds may also be an important contributor to the transmission of T. gondii between 
continents. However, few studies have been performed targeting such species. A recent study 
reported genotyping of a single isolate from a wild pigeon in Mexico (Alvarado-Esquivel et al. 
2011). Other studies have found sporadic cases of T.  gondii infection in wild bird species 
(Dubey et al. 2011a,b). Given the potential role of migrating marine mammals and birds in long 
distance transmission of T. gondii, more studies on these animals are needed to better understand 
their contribution to the evolution of T. gondii on a global scale. 
 
Third, most T. gondii samples studied so far have been from nonhuman animal origin. Only a 
limited number of samples have been isolated from human infections. A total of only 84 human 
samples have been analyzed by the 10 PCR-RFLP markers that are the focus of this review 
article. These samples have revealed a variety of genotypes with no clear pattern emerging. 
Atypical genotype #65 was found to occur in human patients in Sao Paulo, Brazil in a single 
study (Ferreira et al. 2011). Another feature of note seems to be that genotype #10 (Type I), the 
highly mouse-virulent lineage, appears to be more prevalent in human infections than is seen in 
other hosts. A larger sample size is necessary to determine the significance of this feature, and 
human toxoplasmosis patients need to be sampled from a greater variety of geographic regions in 
order to determine whether this is a global phenomenon. It would also be of interest to determine 
the mouse-virulence of the atypical strains found in human hosts in order to investigate the 
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Table III-2. Basic statistics of T. gondii populations from different geographical regions 
 Africa Asia Europe North America 
Central/South 
America 
Number of isolates 141 102 64 501 646 
Number of genotypes 
13 10 9 40 156 
Gene diversity 
0.6433+/-0.0256 0.7280+/-0.0391 0.7679+/-0.0351 
0.8285+/-
0.0086 0.9792+/-0.0017 
Mean no. of pairwise 
differences over loci 
5.5687+/-2.6895 4.9293+/-2.4182 5.0968+/-2.6495 
5.0968+/-
2.4762 6.1121+/-2.9118 
Due to the small sample size of only 3 isolates, Australia was not included for analysis in this table 
 
 
Table III-3. Shared genotypes among geographical regions 
 Africa Asia Europe North America 
Africa     
Asia 1,2,3,6,20    
Europe 1,2,3,6,15 1,2,3,6,10   
North America 1,2,3,15 1,2,3,4,9,10 1,2,3,5,10,15  
Central/South 
America 1,2,3,6,15 1,2,3,4,6,9,10,18 1,2,3,6,10,17 1,2,3,4,7,8,9,10,11,14,15,28,32,73,74,118,157 






Figure III-2. Pairwise Fst of five T. gondii populations from different geographical regions. Comparison of populations were 
conducted using Arlequin ver 3.5. Statistical significance is determined at P=0.001. The “+” sign indicates significant difference 
between two populations, whereas “-“ indicates insignificance. N. am = North America, C.S. Am = Central and South America. The 
heat map indicates the Fst value. 
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Chapter IV. The ROP5 and ROP18 genotypes are highly predictive of 





Toxoplasma gondii is among the most widespread eukaryotic parasites known. It is thought to 
chronically infect approximately one third of the world’s human population and has been 
isolated from an extremely diverse array of mammals and birds from every continent besides 
Antarctica. Toxoplasmosis is a leading cause of death among AIDS patients and can also cause 
birth defects and mortality in infants when transmitted vertically during pregnancy (Dubey, 
2010). In immunocompetent adults, asymptomatic chronic infections generally develop 
following a brief and mild symptomatic period, though more severe symptoms may also occur. 
Ocular infections are associated with approximately 2 percent of T. gondii infections, and these 
may result in visual impairment or blindness if improperly treated.  Additionally, in some cases 
severe and potentially deadly systemic toxoplasmosis, sometimes referred to as Amazonian 
toxoplasmosis, may occur in otherwise healthy adults. This form of the disease often requires 
intensive medical care and has resulted in deaths due to multiple organ failure (Demar et al. 
2007, 2012).  
 
Though a link between parasite genotype and the severity of human disease has not been 
definitively established, an increasing abundance of circumstantial evidence lends support to this 
probability. We have recently compiled all of the PCR-RFLP genotyping data that had been 
published as of the end of 2012 using a widely-employed set of ten genetic markers, which 
included a total of 1,475 isolates comprising 189 distinct genotypes (Shwab et al. 2014). These 
isolates were collected from all continents with the exception of Antarctica, and from a variety of 
mammalian and avian species, both wild and domesticated. Our analysis revealed distinct 
population structures for each major geographic region examined, with striking contrast between 
the largely clonal populations found in North America, Europe and Asia, wherein only a few 
dominant genotypes account for the overwhelming majority of isolates and highly diverse, 
endemic structure of the South/Central American region wherein many genotypes coexist with 
none being notably dominant. In addition to being more genetically diverse, South American 
strains are also more highly mouse-virulent on average than strains identified on other 
continents. In mouse bioassays described in the studies referenced in Shwab et al. (2014), 61 
percent of South and Central American strains caused mortality following ingestion of infected 
tissue by mice, compared to only 7 percent of North American strains. North American and 
European populations are dominated by the archetypal Type II and III clonal types (toxoDB 
genotypes #1, 2 and 3) which exhibit low to intermediate mouse virulence, while the Asian 
population is dominated by the Type II-related genotype #9.  
 
Evidence indicates a correlation between the extreme diversity of atypical parasite genotypes 
found in South America and the manifestation of more dangerous forms of human disease. In 
Brazil for example, severe symptoms were found to be associated with congenital ocular 
toxoplasmosis at a rate five times higher than that recorded in Europe (Gilbert et al. 2008), and 
when 20 tissue samples from a diverse assortment of toxoplasmosis patients from multiple 
hospitals and clinics in Sao Paulo state were genotyped, 18 were determined to be infected with 
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the atypical mouse-virulent ToxoDB genotype #65, which makes up only a small fraction of 
Brazilian T. gondii isolates, suggesting a possible association of this genotype with human 
disease (Ferriera et al. 2011). In French Guiana, more than 50 cases of Amazonian 
toxoplasmosis have been recorded since 1998. This form of the disease appears to be associated 
with a sylvatic cycle of parasite transmission, through wild felids and intermediate hosts as 
opposed to domesticated animals, as patients generally reported recent rainforest-related 
activities such as consumption of undercooked wild game or surface water. In cases where 
parasites have been isolated from patient tissues, isolates were found to possess atypical 
genotypes that were highly virulent in mice (Darde et al. 1998, Demar et al. 2007, Carme et al. 
2002, 2009). Though not yet identified outside of French Guiana, it is expected that the strain 
types responsible may be present in adjacent areas inhabited by wild felids (Carme et al. 2009). 
Even among cases of toxoplasmosis in regions with predominantly clonal population structures, 
bias appears to exist towards infection by mouse virulent or atypical genotypes. In a study 
performed in the United States, two thirds of genotyped isolates from patients with ocular 
toxoplasmosis were found to belong to the virulent archetypal Type I or Type I-related atypical 
genotypes despite the overwhelming dominance of less virulent Type II and III strains in North 
America (Grigg et al. 2001). Disproportionate association of atypical genotypes with severe 
clinical symptoms has also been observed in Europe (Bossi and Bricaire 2004, Delhaes 2010). 
   
If mouse virulence of T. gondii strains correlates with human disease, as suggested by the 
aforementioned observations, it is of great interest to have a means of predicting the potential 
virulence of newly identified genotypes, as well as to understand the mechanisms governing 
pathogenesis in these strains. The rhoptry-secreted proteins ROP18 and ROP5, have been 
identified as the key determinants of virulence in murine hosts among the archetypal parasite 
lineages (Taylor et al. 2006, Saeij et el. 2006, Reese et al. 2011). A third polymorphic rhoptry 
protein, ROP16 has also been shown to be important in modulating the host response to parasite 
invasion in mice (Saeij et al. 2006, Yamamoto et al. 2009, Ong et al. 2010). It appears to be 
variations in the assortment of alleles of these genes that constitute the functional differences 
between the three archetypal lineages with regard to pathogenesis in mice. Type I strains possess 
functional ROP5 and ROP18 alleles, which work in tandem to inactivate host immunity-related 
GTPases that would otherwise target and disrupt the parasitophorous vacuole membrane, thus 
allowing these strains to propagate in a rapid and unchecked manner, resulting in a high degree 
of mortality (Refer to chapter I of this work and Niedelman et al. 2012, Etheridge et al. 2014, 
Reese et al. 2014). Type III strains, by contrast, do not express ROP18 and thus are easily 
overcome by the host’s defenses, making these strains largely avirulent to mice (Boyle et al. 
2008, Niedelman et al. 2012). Type II strains are the most distantly related of the three lineages, 
and appear to employ a somewhat different pathogenic strategy in mice, determined by their 
particular set of virulence gene alleles. They express a functional version of ROP18, but a 
deficient version of ROP5, making them vulnerable to host defenses (Saeij et al. 2006, Behnke et 
al. 2011). However, they also express a different ROP16 allele from those of Type I and III 
strains, resulting in altered host gene expression and a more severe inflammatory response 
compared to that associated with Type III invasion, which is sufficient to cause mortality in some 
cases (Saeij et al. 2006, Yamamoto et al. 2009, Ong et al. 2010). The key role played by 
configurations of these polymorphic virulence genes in the murine virulence of T. gondii has 
been demonstrated conclusively in representatives of the three archetypal lineages, using both 
forward and reverse genetic approaches, and for a subset of atypical strains as well (Taylor et al. 
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2006, Saeij et al. 2006, Reese et al. 2011, Etheridge et al. 2014, Niedelman et al. 2012). These 
data suggest that this may be a general phenomenon across all strains of T. gondii. If this is the 
case, then identification of strain genotypes at these loci would presumably be an excellent 
indicator of strain virulence, and an important means of classifying strains based on biologically 
relevant genetic variation.  
 
Though ROP5, ROP18, and to a lesser extent ROP16, have been shown in molecular studies to 
play key roles in determining the virulence of laboratory T. gondii strains, the distribution of 
their alleles in natural populations and the broad influence of these allele combinations on T. 
gondii virulence have not been examined in depth. Dubey et al. (2014) identified a correlation 
between ROP18 and ROP5 genotypes for a set of 23 strains, comprising isolates from North 
American wildlife along with several reference strains. Here, we have sought to expand upon 
these findings by genotyping a broader assortment of strain types, focusing on diverse atypical 
South American strains as well as Asian isolates.  We have employed a PCR-RFLP-based 
genotyping strategy for these three polymorphic, pathogenesis-associated loci similar to that of 
Dubey et al. (2104), though with a higher resolution protocol for the ROP5 locus. In this manner, 
we demonstrate through correlation of identified PCR-RFLP genotypes of 308 T. gondii strains 
with published mouse virulence data that the combination of ROP5 and ROP18 (but not ROP16) 




Materials and methods 
 
PCR-RFLP Protocols  
 
PCR-RFLP protocols for ROP16 and ROP18 were identical to those employed by Dubey et al. 
2014, except that restriction enzyme digestion was deemed unnecessary in the case of ROP18 as 
different alelles produced nested PCR products of distinguishably different lengths. In the case of 
ROP5, a protocol was developed based on the ROP5 sequences identified by Niedelman et al. 
(2012) in order to differentiate the major identified ROP5 allele complements. For each locus, 
PCR was performed on parasite genomic DNA using external primers, followed by a second 
round of PCR with nested primers using external primer products as template, based on the 
strategy described by Su et al. (2010). Restriction enzymes targeting single nucleotide 
polymorphisms identified between strain types were then used to differentially digest PCR 
amplified DNA. For ROP18, two sets of internal primers were used, one to amplify the upstream 
promoter insertion sequence (UPS) of the archetypal Type III allele, and one to amplify a 
repetitive sequence (DEL) in the promoters of the archetypal Type I and II alleles. No restriction 
enzyme digestion was required to distinguish ROP18 genotypes as different genotypes produce 
nested PCR products of different lengths, as noted. For ROP16, nested PCR products were 
digested with NlaIII and TaqaI enzymes. For ROP5, nested PCR products were digested with 
FspBI and HaeII enzymes. Samples with ROP5 genotype 5 RFLP pattern were further digested 
with BstUI to distinguish genotypes 5 and 8. Primers and restriction enzymes for each marker are 
shown in Table IV-1. All DNA samples from T. gondii isolates were amplified in 96-well PCR 
plates via multiplex PCR using all external primers simultaneously according to Su et al. (2010). 
Amplification for multiplex PCR used FastStart DNA Polymerase (Roche). The thermocyler 
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program was as follows: 4 minutes at 95C, 30 cycles of 30 seconds at 95C, 1 minute at 55C, and 
2 minutes at 74C. This was followed by nested PCR amplification using PAQ5000 DNA 
polymerase (Stratagene) with individual marker primers and a thermocycler program of 4 
minutes at 95C, 35 cycles of 30 seconds at 95C, 1 minute at 58C, and two minutes at 72C. 
Restriction enzyme digestions were carried out using PCR amplified DNA in 96-well plates. 
Digested products were separated via electrophoresis in 2.5% agarose gels stained with ethidium 
bromide and visualized under UV light. Each gel contained a set of standard T. gondii reference 
strains including GT1, PTG, CTG. MAS, COUG, TgCtBr5, TgCtBr64 and TOUCAN which 
aided in genotype identification. Each plate also contained multiple no-template negative 
controls.  
 
T. gondii isolate DNA 
 
Genomic DNA samples from T. gondii strains were provided by numerous laboratories from 
around the world. Specific information regarding isolate origins is provided in Shwab et al. 
(2014). Genomic DNA stocks were stored at -20C prior to analysis.  
 
Strain virulence assessement 
 
Strain virulence information was based on published mouse bioassay data. References for each 
strain are provided in Shwab et al. (2014). Bioassays typically consisted of oral inoculation of 
mice with tissue from chronically infected animals.  Each strain was categorized as lethal or 
nonlethal based on virulence in lab mice. Strains were categorized as lethal if death was caused 
in all infected mice within 30 days post infection, while strains were cateforized as nonlethal if 
all or some infected (seropositive) mice survived for at least 30 days and produced tissue cysts. 
Statistical analysis of the correlation between genotype (ROP5, ROP16 and ROP18) and mouse 
mortality was performed using the non-parametric Kruskal-Wallis (group analysis) and Mann 
Whitney U (individual comparisons) tests.  
 
Network Analysis  
 
Allelic data from multilocus analysis of PCR-RFLP markers were used to generate a network 
of T. gondii strain polymorphisms from 308 samples. Multilocus PCR-RFLP typing data were 
coded for ROP18 and ROP5 loci. For a given locus, presence or absence of DNA restriction 
fragments was coded as either 1 or 0, respectively. SplitsTree v4.4 was used to generate an 





Identification of PCR-RFLP genotypes at ROP18, ROP5 and ROP16 loci   
 
PCR-RFLP protocols were developed in order to identify SNPs present at the ROP18, ROP5 and 
ROP16 loci. Figure IV-1 depicts the RFLP patterns at each of these loci for a set of eight diverse 
reference strains representing a number of major distinct phylogenetic clusters of T. gondii  
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Table IV-1. Primer sequences and restriction enzymes for PCR-RFLP genotyping of ROP16, ROP18 and ROP5 loci. 
Marker External Primers (5' to 3') Internal Primers (5' to 3') Restriction 
Enzymes 
ROP16 ROP16F-ext: ATCTGCTTATCCGGCGACTA 
ROP16R-ext: TCCGTTGGCATTTATCATCA 





UPSRext: GAGTGCTTTCTGTCGCTCCT   
ROP18-DelFint: 
AGTTCCCTTCCCTGGTGTCT  ROP18-











FspBI+HaeII              
BstUI 
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isolates identified previously (Su et al. 2010). These reference strains include GT1 (archetypal 
Type I), PTG (archetypal Type II), CTG (archetypal Type III), MAS, COUG (TgCgCa1), 
TgCatBr5, TgCatBr64 and TOUC (TgRsCr1). These reference strains capture the majority of the 
genetic diversity identified at each locus, however in some instances additional alleles were 
identified that were not present in any of these reference strains. Three alleles were identified for 
ROP16 markers, four alleles were identified for ROP18 and eight separate alleles were identified 
for ROP5.  In some cases, alleles were very rare and were limited to a few or even only a single 
strain out of the 308 analyzed.  
 
Genotyping of 308 T. gondii isolates at ROP18, ROP5 and ROP16 loci  
 
As the ROP18 and ROP5 (and to a lesser extent ROP16) genes have been shown to heavily 
influence mouse virulence phenotype in archetypal T. gondii lineages, PCR-RFLP markers were 
developed for these loci and the genotypes of 308 isolates, representing 143 ToxoDB genotypes, 
were determined. Table E-2 (Appendix E) shows the complete genotypic data at all 3 loci for 
each isolate. A total of 28 combinations of these genotypes were identified. Also indicated are 
the mouse mortality data from bioassays of each strain, where available (for strain references see 
Shwab et al. 2014, except where noted in Table E-2). The ROP16, ROP18 and ROP5 genotypes 
and the combined ROP18/5 haplotype were plotted against this published mouse mortality data 
for 239 strains with virulence data (representing 121 ToxoDB genotypes) in order to determine 
whether a correlation exists between mouse virulence and genotype at these loci. Of these, 
strains belonging to ToxoDB genotypes #6, 10, 11, 14, 15, 17, 21, 28, 34, 46, and 70 
demonstrated both lethal and nonlethal phenotypes. In the case of genotype #6, strain BOF 
possesses an alternate ROP5 genotype (6 as opposed to 3 for other #6 strains) which may 
account for the nonlethal phenotype of this strain. TgCatBr54 also displays a nonlethal 
phenotype despite having ROP5 genotype 3 (though mortality was fairly high at 75 percent). For 
genotype #17, the three nonlethal strains were found to possess ROP18 genotype 3, while the 
five lethal strains were found to possess ROP18 genotype 4. This was also the case for genotype 
#28, wherein the one nonlethal strain showed ROP18 genotype 3 while the two lethal strains 
showed ROP18 genotype 4. In ToxoDB genotypes #10, 11, 14, 15, 21, 34, 46 and 70, differences 
in lethality were not associated with variations in ROP18, 5 or 16 genotypes. Though all strains 
of the ToxoDB genotype #9 (Chinese I) displayed nonlethal phenotypes, 5 of these 21 strains 
were found to possess ROP18 genotype 3 (generally associated with avirulence) while the others 




As noted, three ROP16 alleles were identified. ROP16 genotype 1 identifies the similar 
archetypal Type I and Type III alleles, while genotype 2 identifies the archetypal Type II allele. 
ROP16 genotype 3 represents an atypical allele. ROP16 genotype 1 was identified in 168 of the 
strains examined, while genotype 2 was identified in 76 strains, and genotype 3 in only 4 strains. 
When the average mouse mortality during bioassay associated with each ROP16 genotype was 
determined (Figure IV-2A), strains with genotype I were found to have produced an average of 
about 63 percent mortality, genotype 2 about 33 percent average mortality and the four strains 




Figure IV-1. Reference strain RFLP patterns for 3 PCR-RFLP markers. Restriction fragments of reference strains GT1, PTG, 
CTG, MAS, COUG, TgCatBr5, TgCatBr64 and TOUCAN for the 3 described PCR-RFLP markers using primers and restriction 
enzymes as given Materials and Methods. Strain IDs are presented above each column of gels and identified genotypes are indicated 




genotype 1 and 2 strains were relatively high, and no statistically significant difference was 
observed between the mortality caused by each of these two groups. Genotype 3 correlated with 
high virulence and was significantly different from genotype 2, but due to the small sample size 




Four ROP18 genotypes were identified,  with genotypes 1, 2 and 3 indicating similiarity to the 
archetypal Type I , II and III alleles respectively, and genotype 4 identifying alleles with 
similarity to the ToxoDB #17 reference strain MAS. 47 isolates with mouse virulence data were 
found to be of ROP18 genotype 1, 29 of genotype 2, 68 of genotype 3, and 93 of genotype 4. 
Association of each of the four ROP18 genotypes with mouse virulence are shown in Figure IV-
2B. Strains with genotypes 1 and 4 produced averages of 85 and 89 percent mortality, 
respectively, and were highly significantly different in this regard from strains with genotypes 2 
and 3, which produced averages of approximately 4 and 15 percent mortality, respectively. Thus, 
ROP18 genotypes 1 and 4 appear to be heavily associated with a highly mouse virulent 
phenotype within this sample set, whereas genotypes 2 and 3 are associated with low mouse 
virulence. Genotype 3 includes the archetypal Type III allele of the gene as mentioned, found to 
associate with low virulence in QTL mapping studies, while the archetypal Type II allele 
(represented by ROP18 genotype 2) has been found to associate with a highly virulent phenotype 
(Taylor et al. 2006). It therefore seems likely that the correlation between ROP18 genotype and 
avirulence observed here may be the indirect result of co-segregation of this allele with avirulent 




Eight distinct ROP5 genotypes were identified among the 330 isolates examined. Genotype 3 
(associated with the archetypal Type III allele) was the most commonly identified with 138 
occurrences out of 248 strains with mouse virulence data. This was followed by genotype 4 
(associated with reference strain MAS) with 31 strains, genotype 5 (associated with reference 
strain COUG) with 30 strains, genotype 1 (associated with archetypal Type I) with 25 strains, 
genotype II (associated with archetypal Type II) with 16 strains, genotype 8 (associated with 
VAND and related virulent Guyana strains) with 6 strains, and genotypes 6 and 7 with only one 
occurrence each (BOF and TgCkGh1, respectively). Figure IV-2C shows the mouse mortality 
associated with the six genotypes with more than one occurrence. The majority of these groups 
could be distinguished from one another statistically though standard deviations were high for 
genotypes 1, 3, 4 and 5, presumably due mainly to the presence of different ROP18 alleles within 
these groups. Genotypes 2 and 6 are more uniform and were found to be tightly associated with 




Because ROP18 and ROP5 were found to be by far the strongest indicators of virulence among 
the archetypal T. gondii strains, analysis of the correlation between mouse virulence and the 
combined ROP18/5 haplotype for the 308 strains examined was performed. 17 different 
haplotypes were identified, 4 of which had only one occurrence. The mouse mortalities 
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Figure IV-2. Mouse virulence of strains categorized by ROP16, ROP18 and ROP5 genotypes. Average mouse mortality for 239 
T. gondii strains with published bioassay results were categorized by ROP16 (A), ROP18 (B) and ROP5 (C) genotypes and ROP18/5 
haplotypes (D). Average percent mouse mortality is plotted against genotype and error bars indicate plus or minus one standard 
deviation. Number of strains representing each genotype are given in parentheses below genotype IDs. Different letters above data 
points indicate statistical differences as determined by Mann-Whitney U test. Data are significant at maximum P-values of 0.05, 0.01, 
5x10-5 and 0.001 for A, B, C and D, respectively.  
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 Figure IV-2 continued 
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associated with the other 13 haplotypes are presented in Figure IV-2D. clear and statistically 
significant segregation with either high or low mouse virulence was observed for each haplotype 
with the exception of haplotype 3/4, which includes several strains with intermediate to high 
virulence, despite possession of the avirulence-associated Type III ROP18 allele, including the 
virulent CASTELLS strain.  
 
Network analysis of ROP18/5 haplotypes was also performed in order to visualize the 
relationships between groups. Qualitative mouse virulence of each network node/haplotype, 
grouped into lethal (100 percent mortality) and nonlethal (no or partial mortality) categories is 
presented in Figure IV-3. The majority of haplotypes were observed to associate mainly with 
high or low virulence in most cases, though a range of phenotypes, including both lethal and 
nonlethal strains, was observed for all but a few. This would seem to indicate that the ROP18 
and ROP5 genotypes are strong predictors of strain virulence but that other factors also 
contribute to this phenotype. Some of the observed variation is likely due to the fact that the data 
presented were collected from many different sources with inevitable differences in inoculation 
technique, parasite dosage and other factors, but it may also be the case that some strains utilize 
alternative pathogenic mechanisms that allow them to be highly mouse virulent despite 
possession of canonically avirulent ROP18 and/or ROP5 alleles (as in the case of CASTELLS) 





In the current study, we have shown that, as in the archetypal lineages which have been 
intensively studied on a molecular level, the ROP5 and ROP18 genes are strong determinants of 
virulence even among highly diverse atypical T. gondii strains.  This was evidenced by the 
strong overall correlation of the ROP18/5 haplotype with mouse virulence. Using our PCR-
RFLP approach, we were able to distinguish 4  ROP18 genotypes. In a previous study (Khan et 
al. 2009), ROP18 loci from a number  of strains were sequenced, leading to the identification of 
three major alleles, termed I*, II* and III*, and the I* allele was further subdivided into alleles 
I*a, I*b and I*c.. Based on the strains sequenced, our ROP18 genotypes 2 and 3 appear to 
correlate with the II* and III* alleles from this previous study, while genotype 4 seems to 
correlate with the I*c allele, and genotype 1 appears to combine both alleles I*a and I*b. As 
alleles I*a, b and c were all found to confer virulence in transgenic strains, this grouping is 
consistent with the lethality found herein to be associated with ROP18 genotypes 1 and 4. For 
ROP5, 8 distinct RFLP genotypes were identified. As strains generally possess multiple copies 
of ROP5, alleles of this locus have been more difficult to characterize than for ROP18 
(Niedelman et al. 2012). ROP5 genotypes 1, 2 and 3 appear to correlate with the archetypeal 
Type I, II and III ROP5 allele complements, based on their association with reference strains 
GT1 (Type I), PTG (Type II) and CTG(Type III), respectively. The Type I and III allele 
complements have been shown to be very similar in sequence and to confer virulence in 
transgenic strains, while the Type II complement is more divergent and was associated with 
avirulence in transgenic strains (Benkhe et al. 2011, Fleckenstein et al. 2011). ROP18 genotype 
4 was associated with the highly virulent reference strain MAS in this study, suggesting that this 
genotype represents another virulent ROP5 allele complement. Niedelman et al. (2012) found 
ROP5 alleles to be highly expressed in the MAS strain, and for this strain to be resistant to IFNγ- 
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Figure IV-3. Network analysis of ROP18/5 haplotypes and associated lethality in mice . A neighbor-joining network was 
generated for 330 strains using Splitstree v.2.2.based on the ROP18/5 haplotypes. Haplotype IDs are indicated at each node in bold 
lettering, as well as a pie chart indicating mouse mortality for haplotypes with such data available. Number of strains representing 
each haplotype are given in parentheses beside corresponding pie charts. Strains in each haplotype are divided into lethal (complete 
mortality during mouse bioassay) and nonlethal (no or partial mortality during mouse bioassay) categories and these categories are 





dependent host immune responses in cell culture experiments. ROP5 genotype 5 was associated 
with the nonlethal COUGAR strain. Since this strain has been found to highly express ROP18 
(Niedelman et al 2012), it may be that this ROP5 genotype is the cause of avirulence in this case, 
though this would need to be tested experimentally. If this is the case, it would potentially 
explain the nonlethal phenotypes observed for the ToxoDB genotype #9 (Chinese I) strains 
analyzed in this study, all of which possessed the virulence-associated ROP18 genotype 2 in 
combination with ROP5 genotype 5. However, another Chinese isolate with this same ROP5 
genotype, TgCatPR5 (ToxoDB genotype #49), was found to have a lethal phenotype. This latter 
result may be a reflection of higher intermediate level of virulence, however, as a closely related 
strain (TgCatPR6, genotype #112) with the same ROP18/5 complement produced 92 percent 
mortality in mouse bioassay. ROP5 genotype 6 was only identified in the nonlethal strain BOF, 
which has been previously shown to have very low ROP5 expression, and thus is likely to 
represent an avirulent form of this locus (Niedelman et al. 2012). ROP5 genotype 7 was only 
identified in strain TgCkGh1, which has not been characterized with regard to virulence 
phenotype. ROP5 genotype 8 was associated with a clade of highly virulent strains, members of 
which were isolated from human patients with severe acquired toxoplasmosis in French Guiana 
(Carme et al. 2002), suggesting association of this allele with a virulent phenotype. 
 
 Statistically, the ROP18 genotype alone was found here to be the strongest predictor of mouse 
virulence, moreso than the combined ROP18/5 haplotype; however, this is likely due in part to 
the fact that fewer ROP18 genotypes were identified compared to ROP18/5 haplotypes, meaning 
that each ROP18 group comprised a higher number of strains, contributing to statistical 
significance, and also due to the apparent relative lack of recombination between archetypal 
Type II-related strains, associated with the avirulent Type II form of the ROP5 locus, and other 
strains with virulent forms of ROP5. Thus, although the Type II ROP18 allele has been linked to 
mouse virulence in molecular studies, in nature this allele is generally associated with an 
avirulent form of ROP5, resulting in an indirect correlation with avirulence in strains possessing  
the Type II ROP18 allele. For this reason, to use the ROP18 genotype alone as a predictor of 
mouse virulence is to run the risk of overlooking potentially virulent strains possessing a Type 
II-related ROP18 allele in combination with a virulent form of the ROP5 locus. In the current 
study, no strains were identified which possessed ROP18 genotype 2 in combination with either 
of the known virulent forms of the ROP5 locus (represented by ROP5 genotypes 1 and 3), but 
association of ROP18 genotype 2 with ROP5 genotype 5 was observed in the ToxoDB #9 strains 
discussed above. While this haplotype was associated with low virulence, this same ROP5 
genotype was associated with high virulence in combination with ROP18  genotype 4 
(TgCatPr5). Thus, it is not entirely clear to what extent the ROP5 genotype may be contributing 
to mouse virulence phenotype in these cases. Regardless of the overall correlation with 
virulence, within the majority of ROP18/5 haplotypes, both lethal and nonlethal strains were 
identified. In some cases this is likely due to variations in dosage administered, as bioassays 
were primarily done through the feeding of infected tissue to mice, without precise measurement 
of parasite load in these tissues. However, in other cases counterpredicted phenotypes may be 
indicative of alternative pathogenic mechanisms in these strains. That appears to be the case for 
the strain CASTELLS, which has previously been demonstrated to have a highly virulent 
phenotype despite possessing the unexpressed Type III ROP18 allele (Khan et al. 2009). Further 
analysis of strains with unexpected virulence phenotypes identified here using more standardized 
virulence assays may thus aid in the discovery of alternative mechanisms leading to parasite 
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virulence. Of particular interest are strains of the predominantly avirulent 3/3 ROP18/5 
haplotype that produced high mouse mortality, including TgDgCo8, TgCkNi4, and the reference 
strain TgCatBr64.   Overall, the ROP18/5 haplotype provides a strong prediction of strain 
virulence that should be useful for future characterization of new T. gondii strains, particularly in 
cases where parasite genomic DNA is accessible but viable parasites cannot be successfully 
isolated for determination of parasite virulence via bioassay.  
 
Interestingly, the dominant Asian strain type, ToxoDB genotype #9 (Chinese I) was in this study 
separated into two subtypes, differing only at the ROP18 locus (Table E-2). The first subtype 
(genotype combination 10) possesses ROP18 genotype 2, associated with the virulent Type II 
allele,  while the second subtype (genotype combination 16) possesses ROP18 genotype 3, 
associated with the avirulent Type III allele. It has been previously noted that genotype #9 strains 
include both virulent and avirulent forms (Li et al. 2014), and the identification here of two 
subgroups differing at the ROP18 locus seems likely to be relevant to this observation. While the 
genotype #9 strains used in this study for which virulence data was available all displayed 
nonlethal phenotypes in mice, it seems plausible that virulent genotype #9 strains may also 
possess ROP18 genotype 2, possibly in combination with an alternate ROP5 genotype. It is 
necessary to perform ROP18 and ROP5 genotyping on virulent genotype #9 isolates in order to 
elucidate the genetic basis for the observed variation of genotype #9 strains with regard to 
virulence.  
 
The work described herein indicates a high degree of universality in the principles governing 
virulence of T. gondii strains. The high proportion of mouse-virulent strain types observed in 
South America compared to elsewhere in the world appears to be largely a result of virulent 
combinations of ROP18 and ROP5 alleles in these strains. Though it is clear that the South 
American T. gondii population differs dramatically with regard to strain virulence as compared 
to elsewhere in the world, the evolutionary reasons for this discrepancy are not well understood. 
It may be considered that the high degree of strain variability found in South America provides 
evidence that the parasite originated in this region, and thus has resided there longer than in other 
regions of the world and has therefore had more time to evolve a diversity of forms. By contrast, 
T. gondii populations found on other continents would likely then be the result of  more recent 
founding events, seeded by limited numbers of strains carried either by wild migratory animals, 
or by intercontinental transport of domesticated host animals by humans. This scenario would 
thus explain the reduced diversity observed outside of South and Central America. Another, not-
mutually-exclusive possibility is that the inordinately high host species diversity found in the 
tropical regions of South and Central America has also promoted the diversification of parasite 
strains exposed to varying selective pressures within different host organisms. While the 
domestic cat is by far the most abundant definitive host for T. gondii worldwide, making it and 
its primary prey species the house mouse essential for parasite transmission and thus key sources 
of selective pressure, in many regions of South America wild felid hosts are still prevalent, as are 
a diverse assortment of wild prey species. Thus, parasite transmission via the sylvatic cycle is 
likely prominent, allowing the propagation and persistence of highly mouse virulent strains 
which would be poorly adapted to domestic cycle transmission (Carme et al. 2009). Genotyping 
information from other geographic regions with high species diversity, such as the tropical 
rainforests of Africa and southeast Asia, could provide valuable insight as to the influence of 
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host species variability on the T. gondii population structure and the distribution of virulent strain 
types. However, such data is unfortunately quite scarce. 
 
Given the correlation that has been observed between the severity of human disease and mouse 
virulence of infecting T. gondii strains, the results of this study may also help researchers to 
better evaluate the medical risks posed to humans by parasite strains identified in a given 
geographic region. Our results lend additional interest to the findings of Sanchez et al. (2013) in 
which the researchers used a PCR-based genotyping approach to determine that a higher 
proportion of strains isolated from human patients in Colombia with symptomatic ocular 
toxoplasmosis were negative for an upstream promoter sequence (UPS) responsible for the 
suppression of the Type III ROP18 allele (and thus presumably expressing functional ROP18) 
than those isolated from asymptomatic patients. The findings of our study support the notion that 
these UPS-negative strains are likely to be mouse virulent, providing further evidence for a 
correlation between mouse virulence and human disease. As many South American countries 
(Brazil in particular) are among the fastest developing in the world today, the geographic 
expansion of these societies as sparsely inhabited areas become more populous may lead to 
human contact with previously unidentified strains of T. gondii, generating a possible risk of 
exposure to more dangerous genotypes such as those responsible for the numerous cases of 
Amazonian toxoplasmosis recorded in French Guiana (Carme et al. 2009). This work should 
provide researchers with an enhanced set of tools for future studies, and a means of quickly 
identifying potentially virulent strain types without the requirement of parasite isolation, thus 
facilitating a higher degree of preparedness for disease outbreaks.  
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Among eukaryotic pathogens, the protozoan parasite Toxoplasma gondii is perhaps the most 
ubiquitous, having been identified in the tissues of myriad animal hosts, including both 
mammalian and avian species. Moreover, T. gondii is estimated to chronically infect 
approximately one third of the world’s human population, causing ocular toxoplasmosis in 
immunocompetent individuals and often-fatal encephalitis in the immunocompromised, as well 
as birth defects and mortality following vertical transmission to developing fetuses (Dubey, 
2010; Montoya and Liesenfeld, 2004). In a recent study, genotypic data from more than 1,400 
globally distributed T. gondii samples were compiled, providing the most comprehensive picture 
of the global T. gondii population structure yet assembled (Shwab et al. 2014). This analysis 
revealed distinct population structures for each major geographic region examined, with striking 
contrast between the highly diverse, endemic structure of the Central/South American region and 
the more clonal populations found in all other areas, wherein only a few genotypes account for 
the overwhelming majority of isolates. In particular, PCR-RFLP genotypes #1 and #3 
(collectively known as Type II),  #2 (a.k.a. Type III),  #4 and #5 (collectively known as Type 12) 
dominate in North America, genotypes #1, #2 and #3 dominate in Europe and northern Africa, 
and genotype #9 (Chinese 1) dominates in east Asia (Shwab et al. 2014).  
 
The prevalence of a few dominant T. gondii genotypes in much of the world could be the result 
of the founder effect. Alternatively, it could be the consequence of natural selection. The most 
notable phenotype among T. gondii strains that might potentially be under natural selection 
pertains to murine virulence. Due to polymorphisms in several key effector proteins secreted into 
host cells during infection, different genotypes of T. gondii produce markedly different disease 
outcomes in the house mouse Mus musculus  (Taylor et al. 2006; Saeij et al. 2006; Reese et al. 
2011). This variability provides the primary systematic contrast between the three archetypal 
lineages including the PCR-RFLP genotypes #1, #2, #3 and #10. The PCR-RFLP genotype #10 
(Type I) strains are known to be lethal  to house mice, causing rapid death within two to three 
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weeks after infection with only 1 viable parasite, whereas genotypes #1 and #3 (Type II) and 
genotype #2 (Type III) infections are non-lethal to mice and can generally establish an 
asymptomatic chronic infection (Sibley and Boothroyd, 1992). However, while genotype #2 
strains are essentially non-virulent to mice except at very high dosages (LD50 > 105 parasites) , 
genotype #1 and #3 strains display a wider and intermediate range of virulence , causing 
mortality in infected mice at lower dosages than #2 strains (Khan et al. 2009).  
 
Prior studies have shown that more virulent parasite strains have an advantage in the context of 
reinfection of mice already chronically infected with a less virulent T. gondii strain (Krahenbuhl 
et al. 1971; Reikvam et al. 1976; Araujo et al. 1997; Dao et al. 2001; Brandao et al. 2009; Silva 
et al. 2012). While a previous T. gondii infection is often protective against subsequent 
infections, it appears that strains with higher virulence are frequently able to overcome this 
protective immunity and establish a secondary infection. Under these circumstances, a greater 
number of murine hosts should be susceptible to infection by more virulent strains as compared 
to strains with low virulence, giving the former group a distinct advantage.  For highly virulent 
strains, this advantage would presumably be offset by the high mortality rate (often 100%) 
associated with infection of naïve mice, which reduces the likelihood of transmission to new 
hosts. This dichotomy provides selective pressure which may favor or against T. gondii virulence 
depends on host sensibility to infection in the transmission cycle of the parasite.  
 
We hypothesize that agricultural development and urbanization in the past 11,000 years has 
enhanced T. gondii transmission through the domestic life cycle, within which the virulence of T. 
gondii in house mice has a significant impact on parasite fitness and the global T. gondii 
population structure.  To test this hypothesis, we used an in silico modeling approach that 
simulates the life cycle of the parasite, monitoring transmission of lethal (highly virulent) and 
non-lethal (intermediately virulent and non-virulent) strains of T. gondii between intermingled 
populations of domestic cats and mice.  Under a variety of simulation conditions, we found that 
the advantage conferred to strains of intermediate virulence during sequential infection was 
sufficient to allow this strain type to dominate in populations, at the expense of the lethal and 




Materials and Methods 
 
Collection and analysis of mouse virulence data from South, Central and North America, and 
determination of virulence of dominant PCR-RFLP genotype #9 from East Asia 
 
Data regarding mouse virulence of South, Central and North American T. gondii isolates were 
obtained from references in a recent review paper (Shwab et al., 2014). Specific information 
regarding methods for virulence determination may be found in the original publications. The 
majority of data were obtained via bioassay, in which mice were orally inoculated with tissue 
from infected host animals and observed for disease presentation and mortality. Some studies 
also included inoculation via IP injection of tachyzoites from cell cultured strains, or via oral 
inoculation with oocysts. 
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Collection of previously published data on sequential infection of mice with different T. gondii 
strains 
 
Available data on competition of different T. gondii strains in sequential infection of mice were 
collect by reviewing published research papers. Details regarding methodology for previously 
published studies may be found in the original articles.  
 
Simulation of sequential infection of T. gondii strains with different virulence phenotypes in 
house mice. 
 
To assess the potential impact an advantage for more virulent strains during reinfection of 
previously infected mice could have on the evolution of the T. gondii population structure, a 
model was developed to simulate transmission dynamics of T. gondii in domestic and sylvatic 
life cycles (Figure V-1). The simulation was run using the software NetLogo version 10.1.0 
(https://ccl.northwestern.edu/netlogo/). Because many of the parameters involved in this model 
are not clearly defined by experimental data, we carried out simulations under a variety of 
conditions relating to mouse mortality rate and probability of reinfection for each parasite 
virulence type, as well as host and parasite starting population sizes and duration of the 
simulation. Simulated environments consisted of variables including cats, mice, the environment 
and the parasites. The parasites comprise three categories: non-virulent (NV), intermediately 
virulent (IV) and highly virulent (HV). The cats and mice were programmed to move randomly 
within the area of a spatial grid, interacting when a cat and a mouse occupied the same point on 
the grid. Such an interaction resulted in the cat consuming the mouse. If the mouse were a carrier 
of T. gondii, the cat would then become infected. If the consumed mouse were infected with two 
different parasite strains, the cat would randomly become infected by one or the other strain. 
Following infection, cats shed oocysts into the environment, which persisted for a specified 
period of time. Encounter of oocysts by mice or other cats resulted in those animals becoming 
infected. If mice were to become infected by T. gondii, they would have a specified percentage 
chance of dying between 7 and 14 days later that was specifically indicated for each parasite 
virulence category.  Mice that did not die would remain chronic carriers of the parasite for the 
remainders of their life spans. If a chronically infected mouse were to encounter an oocyst of a 
different virulence category, the strain would have a certain percentage chance of reinfecting that 
mouse based on a probability value specified for each virulence category. Birth and natural death 
rates of cats and mice were also separately specified. Simulations were run for specified numbers 
of days, with one event occurring for each organism per day. That is, each organism would move 
to one new location each day and process any developments that the new location and/or 





Virulence of T. gondii in house mice 
 
For the analysis of mouse virulence, we obtained data from previously published papers on T. 
gondii population genetic studies (Shwab et al. 2014)  Toxoplasma gondii isolates that caused 
mortality in mice within a month post infection,  with any surviving mice being seronegative or  
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Figure V-1. Flow chart of possible cat and mouse actions within the simulated environment
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free of tissue cysts, were considered lethal (highly virulent, HV), while those that could establish 
chronic infection and produced less than 100% mortality in mice were considered non-lethal 
(intermediately virulent, IV or non-virulent, NV). The results showed that overall 61% of  427 
isolates characterized from South/Central America have been determined to be lethal to mice, 
compared to only 7% of 193 isolates from North America. This difference is quite striking and 
underscores the evolutionary divergence of T. gondii in Central/South America compared to 
North America.  
 
For the dominant T. gondii genotypes (genotypes #1, #2, #3, #4, #5, #9) in the north hemisphere, 
and the genotype #6, which has a relatively higher frequency in South America and Africa, we 
examined parasite virulence in greater detail by compiling cumulative mortality rates published 
in literature (Table V-1). Reliable data for genotype #9 was not available at the time of this 
study, so we tested 3 isolates for this genotype. At the time of writing this paper, a new study on 
mouse virulence of genotype #9 became available (Li et al., 2014) and we compiled those results 
in Table V-1 as well. For this comparison, isolates were roughly grouped into three categories 
based on the cumulative percentage of mortality caused in mice. The first group comprised 
strains that produced less than 20% mouse mortality (non- virulent), the second included strains 
producing between 20 and 95% mouse mortality (intermediately virulent), and the third group 
consisted of strains producing 95 to 100% mortality (highly virulent, lethal).  We found that the 
dominant strain types including genotypes #1, #4, #5 and #9 are intermediately virulent, whereas 
genotypes #2 and #3 were non-virulent to mice. However, genotype #6 was highly virulent 
(Table V-1). It is worth noticing that, though mouse mortality may vary among isolates 
belonging to the same genotypes and the grouping of mouse virulence is subjective, it does 
reflect the overall levels of virulence among these genotype groups.  Together, these data 
demonstrate that, in addition to markedly different patterns of parasite diversity, the northern 
hemisphere and South America also differ greatly with regard to the mouse virulence of 
evolutionarily successful strains from each region.  
 
Strains of higher virulence demonstrate a greater frequency of successful reinfection of 
chronically infected mice than strains of lower virulence 
 
To determine how  the virulence level  of a T. gondii strain affects the strain’s ability to super 
infect mice already infected with a non-lethal strain of the parasite, we identified a number of 
published studies in which sequential T. gondii infections had been performed (Table V-2). 
Araujo et al. (1997) orally challenged Swiss-Webster mice chronically infected with ME49 with 
tissue cysts of the relatively virulent strain C56 and its highly virulent variant R-C56, and 
identified successful infection of mouse brain tissue with both challenge strains. Dao et al. 
(2001) orally challenged OF1 mice chronically infected by the low virulence strain 76K with 
another strain of low virulence, PRU, and mice chronically infected by PRU with the  more 
highly virulent NED strain. In this study, no reinfection was detected in the brains of mice 
challenged by PRU, while 44% of the NED-challenged mice did show successful reinfection. 
Brandao et al. (2009) challenged BALB/c mice chronically infected by the low virulence strain 
D8 with either the intermediately virulent strain CH3 or the highly virulent strain EGS. These 
researchers identified a reinfection rate of 38% for CH3 and 88% for EGS. Silva et al. (2012) 
challenged BALB/c mice chronically infected by either ME49 or D8 with either CH3 or EGS, 
and found that CH3 had 20% and 44% success rates for reinfecting mice chronically infected by 
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Table V-1. Mouse virulence (based on accumulative mortality) of dominant T. gondii strains from different geographic regions 
ToxoDB PCR-
RFLP genotype 







#1 (Type II) ME49, PIH, PE N. America, Europe 24 0-40 Intermediate Khan et al. 2009 
#2 (Type III) CTG, VEG, STRL, C56 N. America, Europe 3 0-13 Low Khan et al. 2009 
#3 (Type II) DEG, PRU N. America, Europe 3 0-6 Low Khan et al. 2009;       Li et al. 2014 
#4 (Type 12) B41 N. America 71 71 Intermediate Khan et al. 2011 
#5 (Type 12) ARI, T61, WTD3 N. America 37 10-80 Intermediate Khan et al. 2009; Khan et al. 2011 
#6 (BrI) FOU, TgCatBr2, TgCatBr9 S. America 100 100 High Khan et al. 2009 
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ND ≥53 Reikvam et al. 1976 
Swiss-
Webster Oral ME49 ≤500 0 C56 5 100 100 
Araujo et al. 
1997 
Swiss-
Webster Oral ME49 ≤500 0 RC56 5 100 100 
Araujo et al. 
1997 
OF1 Oral 76K 10 0 PRU 10 0 0 Dao et al. 2001 
OF1 Oral PRU 10 0 NED 10 ND 44 Dao et al. 2001 
BALB/c Oral D8 20 0 CH3 20 100 38 Brandao et al. 2009 
BALB/c Oral D8 20 0 EGS 20 100 88 Brandao et al. 2009 
BALB/c Oral D8 20 0 CH3 20 100 20 Silva et al. 2012 
BALB/c Oral D8 20 0 EGS 20 100 71 Silva et al. 2012 
BALB/c Oral ME49 20 0 CH3 20 100 44 Silva et al. 2012 
BALB/c Oral ME49 20 0 EGS 20 100 100 Silva et al. 2012 
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D8 and ME49, respectively, while EGS had success rates of 71% and 100% in reinfecting mice 
chronically infected by these same strains. The results of these studies indicate a positive 
correlation between the relative virulence of the primary and secondary infecting strains and the 
frequency of successful reinfection of chronically infected mice. Krahenbuhl et al. (1971) and 
Reikvam et al. (1976) reported that, when mice chronically infected with the low virulence C37 
and BEV strains were challenged with the highly virulent RH strain, partial mortality in mice 
was observed. The full extent of reinfection was not determined in these studies, and was only 
inferred through mortality. However, it is likely that mice that did not succumb to secondary 
infection may still have been reinfected. In all cases where the challenging strain showed higher 
virulence than the chronically infecting strain, a reinfection was found to develop in at least some 
percentage of the mice. Moreover, in the studies by Brandao et al. (2009) and Silva et al. (2012), 
the highly virulent EGS strain showed a higher rate of reinfection in mice chronically infected 
with D8 and ME49 than did the intermediately virulent challenge strain CH3, suggesting that 
higher virulence may correlate with a higher rate of reinfection. Only in the case of challenge of 
76K-infected mice with PRU, a strain of approximately equal virulence, was no reinfection 
observed. Though no data on the virulence of the RH and NED strains were provided in the 
studies cited, these strains have previously been established as having high and intermediate 
virulence, respectively (Khan et al. 2009, Li et al. 2014; Sahm et al. 1998).  
 
Simulation of parasite transmission in silico. 
 
Transmission of T. gondii was simulated using the program NetLogo version 10.1.0. There are 
three major components in the transmission cycle: the definitive host, the intermediate host and 
the environment. Simulations were carried out in two scenarios including the domestic and 
sylvatic cycles. For the domestic cycle, the three components are the domestic cat definitive host, 
the house mouse intermediate host, and the environment.  Given that most mice may become 
infected by ingesting a small amount of T. gondii oocysts in the environment, the mortality rates 
in mice infected with non-lethal types are expected to be low. We set the mortality rate to be at 
0.1% for the non-virulent type (NV), 1% for the intermediately virulent type (IV), and 90% for 
the highly virulent type (HV). For reinfection, the HV parasites were able to infect NV infected 
mice at a rate of 70%, and the IV parasites could infect NV infected mice at a rate of 25%. The 
simulations were run for 100 years with and without allowing reinfection of the second T. gondii 
strains. Figure V-2 shows the results of representative simulations.  When reinfection of 
chronically infected mice with a more virulent genotype was enabled, the outcome of 
transmission changed (Figure V-2A-C,).  Under this condition, the HV genotype circulated in the 
cats, mice and the patches a little longer than without reinfection, though it still quickly 
disappeared. The NV genotype circulated in the animal population and the environment for 
several decades, but was subsequently cleared. However, the IV genotype was able to maintain 
transmission for 100 years. Running the simulation for 500 years did not change the outcome 
(data not shown).  When no reinfection was allowed, the HV T. gondii type rapidly disappeared 
from cats, mice and the patches in the environment (Figure V-2D-F). Though the IV genotype 
could circulate in the cats, mice and the patches for some time (about a decade or two), its 
transmission was not sustainable and disappeared eventually. However, the NV genotype was 
maintained in the population.  The results did not change even when the simulation was run for 
500 years (data not shown).   
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For the sylvatic cycle, the three components are the definitive host (wild cats), the intermediate 
host (wildlife that are resistant to T. gondii), and the environment.  Given that most wildlife are 
resistant to T. gondii, and the infection is generally chronic, we assumed that there is no 
significant difference and set the mortality rates at 0.1% for all three groups (HV, IV and NV) of 
T. gondii.  For reinfection rate, the HV type was programmed to infect NV-infected wildlife at a 
rate of 10%, and the IV type was programmed to infect NV infected wildlife at a rate of 5%. The 
simulations were run for 100 years with and without allowing reinfection of the second T. gondii 
strains. Figure V-3 shows the results of representative simulations.  When reinfection of 
chronically infected wildlife with a more mouse-virulent genotype was activated, the outcome of 
transmission changed dramatically (Figure V-3A-C).  Under this condition, the HV quickly 
dominated over both the IV and NV genotypes and became fixed within a period of 25 years, 
whereas the IV and NV genotypes became extinct. When no reinfection was allowed, all 
categories of T. gondii types (HV, IV and NV) randomly circulated in the population, each with 
the same probability of becoming fixed or distinct (Figure V-3D-F). 
 
The effects of increasing virulence of the IV genotype on transmission dynamics in the domestic 
cycle were evaluated and are shown in Figure V-4. Here, the NV and HV types were set at 
mortality rates of 0.1 and 90 percent, respectively. Probability of sequential infection was set at 
zero percent for the NV type and 100 percent for the IV and HV types. As the virulence of the IV 
type was increased from 0.1 to 2 percent, the dominance of this type in the population was found 
to decrease correspondingly with regard to infected cats, mice and patches with shed oocysts 
(Figure V-4A). Prevalence in mouse hosts decreased more precipitously than prevalence in cats 
or shed oocysts. At 2 percent mortality, the prevalence of the IV type in mice fell below 50 
percent, though it remained over 50 percent in cats and oocysts. Figures V-4B, C and D show 
representative graphs of population structure evolution at different IV mouse mortality rates. 
Figure S1E illustrates the effect of increasing probability of sequential infection for the IV strain 
type. Here, mouse mortality rates caused by the NV, IV and HV types were set at 0.1, 1 and 90 
percent, respectively, and probabilities of sequential infection for the NV and HV types were set 
at 0 and 100 percent. As the probability of sequential infection for the IV type was increased 
from 0 to 100 percent, it was observed that the prevalence of this type in cats, mice and oocysts 
all increased as well. Increases between reinfection probabilities of zero and 20 percent were the 
most dramatic, though notable differences were observed between probabilities of 25 and 50 
percent as well as 75 and 100 percent. Below a reinfection probability of 10 percent, the IV type 
became dominated by the NV type, and at 0 probability, the IV type was found to be consistently 
eliminated from all three populations within about 40 years. Figures V-4F, G and H provide 
representative examples of population structure fluctuation at different IV probabilities of 
sequential infection. If the possibility of co-infection was removed from the simulation, all 
dominance of IV strains was eliminated, and NV parasites consistently became the most 
prevalent type, with the IV lineage decreasing to low levels and eventually disappearing from the 
population when mortality rates were set to 1% and 0.1% for IV and NV (Figure V-4F). In all the 
aforementioned cases, the mouse mortality rate of the highly virulent (HV) type was set to 90%. 
Under this condition, HV rapidly declined and was consistently eliminated from the simulated 
environment, as the hosts carrying it were killed off (Figure V-4C,D,G,H). In cases where the 
NV and IV strain types were assigned equal mortality rates (Figure V-4B), eliminating any 
advantage for the NV strain type, in addition to the IV type becoming dominant in the population 
the HV type also persisted in higher proportion than the  
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Figure V-2. Transmission dynamics in susceptible intermediate hosts.  The lines show frequency of NV (blue), IV (green) and HV 
(red) T. gondii genotypes in the form of oocysts contaminating patches (C,F) of environment and bradyzoites in infected cats (A,D) 
and mice (B,E) over the indicated time courses. (A, B, C) With reinfection of mice enabled or (D, E, F) without reinfection of mice 























Figure V-3. Transmission dynamics in resistant intermediate hosts. The lines show fluctuations in frequency of NV (blue), IV 
(green) and HV (red) T. gondii lineages in the form of oocysts contaminating patches (C,F) of environment  and bradyzoites in 









Figure V-4. Dominance of intermediately virulent T. gondii lineage is dependent on mouse mortality and sequential infection 
rates. (A and E) Graph showing average proportion of IV strain type in simulated populations over 100,000 days (~275 years) at 
various levels of mouse virulence (A) and probability of sequential infection (E). For (A), NV and HV mouse mortality set at 0.1 and 
90%, respectively, and sequential infection probabilities set at 0,100 and 100% for NV, IV and HV strains, respectively. For (E), NV, 
IV and HV mouse mortality set at 0.1, 1 and 90%, respectively, and sequential infection probabilities set at 0, and 100% for NV and 
HV strains, respectively. (B,C,D,F,G,H) Histograms showing fluctuations in frequency of NV (blue), IV (green) and HV (red) T. 
gondii lineages in the form of oocysts contaminating patches of environment and tachyzoites and bradyzoites in infected cats and mice 
over the indicated time courses. (B,C,D) NV and HV mouse mortality set at 0.1 and 90%, respectively, and sequential infection 
probabilities set at 0,100 and 100% for NV, IV and HV strains, respectively. IV mouse mortality indicated to the right of each set of 
graphs. (F,G,H) NV, IV and HV mouse mortality set at 0.1, 1 and 90%, respectively, and sequential infection probabilities set at 0, 










Figure V-4 continued 
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NV type in cat infection and patch contamination, though not in mice infection. Likewise, if the 
probability of reinfection was reduced to zero for the IV type, eliminating any advantage over 
NV for this type, the HV type became dominant over IV in cat and patch populations though 





The strikingly different population structures and distribution of mouse-virulence for T. gondii 
strains observed in Europe, Africa, Asia and North America versus in South America is of great 
interest for understanding the transmission and evolution of this ubiquitous protozoan parasite. 
Of the most common lineages, PCR-RFLP genotypes #1, #2 and #3 dominate in Europe and 
northeast Africa, genotypes #1, #2, #3, #4 and #5 dominate in North America, and genotype #9 
dominates in eastern Asia. However, a highly diverse population is observed in South America 
with genotype #6 having the highest relative frequency (Shwab et al., 2014). Phenotypically, all 
dominant genotypes in Europe, northeast Africa, Asia and North America are non-lethal to house 
mice whereas the most common South American genotype, #6, is virulent (Table V-1).  In 
addition, comparing the populations of North and South America (with larger sample sizes), it is 
obvious that more T. gondii genotypes in South America are virulent than in North America. 
There are two likely explanations for this geographical partition of genotypes and mouse 
virulence, including: 1) the founder effect of a few T. gondii genotypes which originally existed 
in the northern hemisphere; and 2) the consequence of natural selection of strains with discrete 
virulence phenotypes. Here, we have investigated the life cycle of T. gondii and integrated 
information regarding population structure, mouse-virulence, sequential infection of mice with 
different genotypes and variations in environmental  conditions to gain a better understanding of 
the factors that may have shaped the modern day population structure and virulence distribution 
patterns of T. gondii.  
 
T. gondii has a complex life cycle in which felines serve as the definitive hosts, while 
intermediate hosts include a wide variety of mammals and birds  
 
Figure V-5 illustrates the sykvatic and domestic life cycles of the parasite. Sexual reproduction 
of the parasite occurs only within the small intestines of feline hosts, following ingestion of 
infected intermediate hosts, which results in the production of large numbers of oocysts which 
are shed into the environment. Intermediate hosts become infected by ingesting oocysts from 
contaminated food or water, or tissue cysts in infected prey animals. The life cycle is completed 
by predation of infected intermediate hosts by felids (Dubey, 2010). It is notable that whereas 
house mice are highly sensitive and may succumb to infection depending on the infecting 
parasite genotype, most other mammals and birds are resistant and infection generally results in 
the establishment of asymptomatic chronic infections regardless of strain genotype (Dubey, 
2010). The high degree of variability in mouse virulence observed in T. gondii underscores the 
evolutionary significance of house mice (M. musculus) as an intermediate host for the parasite. 
Prior to the rise of human agrarian societies approximately 11,000 years ago, transmission of T. 
gondii would have presumably occurred through a variety of wild felines and intermediate host 
species, in what is termed the sylvatic life cycle. However, the more simplified domestic cycle, 
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involving only transmission between domestic cats and house mice, may be more important in 
association with human settlements (Figure V-5).  
 
Cats play a central role in T. gondii transmission 
 
Modern felid species originated in Asia about 10 million years ago and subsequently radiated to 
all continents during the next 3 million years (Johnson et al., 2006). Genetic assessment of 
domestic cats and their wild progenitors has revealed that cats were domesticated in the Near 
East, coincident with agricultural village development in the Fertile Crescent, where they 
probably began their association with humans as a commensal, feeding on the rodent pests such 
as house mice that infested the grain stores of the first farmers (Driscoll et al. 2007).  The earliest 
evidence of feline domestication by humans dates back to approximately 9500 years ago in 
Cyprus (Vigne et al. 2004).   
 
The house mouse, Mus musculus, is considered an important host within the domestic cycle of T. 
gondii. It has an exceptionally widespread geographical range and is the most successful and 
ubiquitous invasive mammal other than humans (Cucchi et al. 2012). Mus musculus arose and 
diverged in the vicinity of the Indo-Pak subcontinent between 1.7 and 0.7 million years ago, and 
its three major subspecies M. m. musculus, M. m. domesticus, and M. m. castaneus became 
adapted to life in woodland, shrub land, and grassland steppe, and radiated to different regions of 
the Eurasian continent and north Africa within the past 100,000 years (Figure V-6A) (Suzuki and 
Aplin, 2012). The house mouse is remarkable in its propensity for commensalism with humans 
in the context of a settled agricultural environment. Though the house mouse species arose an 
order of magnitude earlier than any form of settled human existence, it began developing its 
commensal relationship with humans starting with the very beginnings of agriculture and the 
creation of the first grain stores in the Fertile Crescent about 11,000 years ago (Bonhomme and 
Searle, 2012). The association of house mice with human settlements led to a period of rapid 
geographical expansion and allowed them to expand their range well beyond their natural limits 
of tolerance. Therefore, human agriculture is considered to be the key factor in the evolution of 
house mice (Cucchi et al. 2012). Today, the three major subspecies of M. musculus have 
different geographical distributions: M. m. castaneus has colonized southeastern Asia, M. m. 
musculus has colonized eastern and central Asia and northern Europe, whereas M. m. domesticus 
has colonized southwestern Asia, the Mediterranean, western Europe and northern Africa.  
Furthermore, M. m. domesticus eventually spread to regions other than Eurasia and northern 
Africa through long-distance colonization by the European expansion to the New World and 
Australia during the past 500 years (Figure V-6A)(Bonhomme and Searle, 2012).  
 
Human agricultural societies independently arose from several locations worldwide between 
about 11,000 and 4,000 years ago.  Among these locations, southwestern Asia, central China, 
Mexico and western Africa are the cradles for the domestication and cultivation of grain crops. 
Wheat was first cultivated about 11,000 years ago in the Fertile Crescent in southwest Asia, the 
rice 9,000 years ago in central China, corn 5,000 years ago in Mexico, and legumes 5,000 years 
ago possibly in western Africa (Figure V-6B) (Bellwood, 2005). Agriculture in the Fertile 
Crescent and central China originated much earlier than in Mexico and western Africa, and 
development occurred on a much larger scale and had a broader impact on human societies in 
these regions. Within a few millennia, the farming system developed in Fertile Crescent had
 76 
Figure V-5. The life cycle of T. gondii. Parasites are shed by definitive feline hosts in the form of oocysts, which may then be 
ingested by intermediate hosts. Transmission back to definitive hosts may then occur by ingestion of infected intermediate host tissue 
containing bradyzoites in tissue cysts. The sylvatic cycle (left) includes many definitive wild feline host species and varied 
mammalian and avian intermediate host species, whereas the domestic cycle (right) includes only the domestic cat as definitive host 
and the house mouse as intermediate host. Prehistorically, the sylvatic cycle was presumably the major means of T. gondii 
transmission, but as the world’s human population increased due to the expansion of agricultural communities (bottom), domestic cats 
came to far outdistance other definitive host species, with the house mouse serving as their major prey species. Thus the domestic life 
cycle became of primary evolutionary importance for transmission of the parasite. 
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Figure V-6. Relationships between global expansion and distribution of house mice, human agriculture and T. gondii. (A) 
Expansion patterns and current global distribution of the three major house mouse subspecies, Mus musculus domesticus (red), M. m. 
musculus (green), and M. m. castaneus (yellow) (Bonhomme and Searle 2012). Colored arrows indicate directions of mouse 
subspecies expansion over the indicated time frames. (B) Origins of agriculture and association with domestic cats and house mice 
(Bellwood 2005). Indicated are cultivation of wheat in the Middle East, rice in southeast Asia (both associated with domestic cats and 
house mice), corn in South and Central America and sorghum in Africa. Arrows indicate directions of outward agricultural expansion, 
including migration of European settlers to North America and concomitant exportation of domestic cats and house mice. (C) 
Distribution of T. gondii lineages by continent (Shwab et al. 2014).  Pie charts indicate proportions of color-coded T. gondii PCR-
RFLP genotypes present on corresponding continents. Populations in the northern hemisphere are largely clonal in structure, with 





Figure V-6 continued 
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spread over vast areas of the Old World: to Britain in the west, to central Asia in the east, to 
Egypt and north Africa in the south, and to Pakistan and India in the southeast.  Similarly, 
agriculture developed in central China also dispersed to a wide area, reaching southeastern Asia 
and eastern India rapidly. Following the initial domestication of plants, sedentary agricultural 
societies began to develop, enabling the production of reliable and more abundant food sources, 
and subsequently leading to rapid expansion of the human population (Bellwood, 2005). Such 
changes inevitably impacted the regional ecosystems in numerous ways, including facilitation of 
the expansion and dispersal of house mice. To this end, abundant data are available from the 
Fertile Crescent, the earliest origin of human agriculture. Zooarchaeological studies of Neolithic 
sites of Syria and Turkey revealed that the occurrence of house mice among small mammals was 
less than 5% in the vicinities of hunter-gatherer communities of 12,000 years ago, but this 
proportion jumped to an overwhelming 80% in association with the earliest human agricultural 
settlements of 11,000 years ago (Cucchi et al. 2012). House mice would likely have been a major 
prey animal for domestic cats throughout their history, and in fact control of such rodent species 
was likely a major incentive for the initial domestication of felines (Driscoll et al. 2007). Prior to 
the rise of human agrarian societies, transmission of T. gondii would have presumably occurred 
through a variety of wild definitive felid hosts and intermediate hosts within the sylvatic  cycle 
(Figure V-5). However, the human agricultural environment has unintentionally created a unique 
niche to transmit T. gondii among domestic cats and house mice by way of the domestic cycle 
(Figure V-5).  The impact of this contribution has been twofold: 1) cats and house mice have 
been brought together into a close proximity, and 2) higher densities of cats and mice have been 
sustained in the same environment.  Because of its high abundance worldwide and sympatry with 
the abundant domestic cats, M. musculus is probably the most evolutionarily important 
intermediate host for T. gondii (Lilue et al. 2013).  The shift in transmission from sylvatic life 
cycle to domestic life cycle in settled human agricultural environments would be expected to 
have altered the selective pressures on this parasite, requiring its adaptation for survival in and 
transmission by the highly susceptible house mouse host. Unlike most other mammals, house 
mice, particularly the variety of lab mice which are derived from M. m. domesticus, are sensitive 
to T. gondii infection. Their response to different lineages of T. gondii can be markedly different. 
The commonly used lab mice are highly sensitive to genotype #10 (Type I) T. gondii strains, and 
can quickly succumb to the parasites within 2 to 3 weeks post infection. However, they are 
resistant to genotypes #1 and #3 (Type II) and genotype #2 (Type III) and most infections 
become chronic if inoculated at low doses (Sibley and Boothroyd 1992; Howe and Sibley 1995). 
The difference in sensitivity of mice to different T. gondii genotypes may have affected the long-
term fitness of these parasites. Simultaneously, the virulence of certain genotypes of T. gondii 
may have placed a strong selective pressure on the evolution of defense mechanisms in the house 
mice.  One example is the family of IFNγ-inducible, 47 kDa immunity-related GTPases (IRGs). 
House mice (both laboratory and wild lineages) have two adjacent clusters of IRGs on 
chromosome 11 and one cluster on chromosome 18. These IRGs are highly polymorphic, 
particularly among wild mice (Lilue et al. 2013). The IRG proteins are essential for mouse 
immunity to T. gondii, defending mice against the non-lethal T. gondii strains (genotype #1 - 
Type II and genotype #2 - Type III) but not the lethal strain (genotype #10 - Type I).  This is due 
to expression by genotype #10 T. gondii of polymorphic rhoptry proteins 5 (ROP5) and 18 
(ROP18), which together confer resistance to the destruction by host IRG proteins of the parasite 
parasitophorous vacuole, the membrane protecting the parasite within host cells (Howard at al. 
2011). The existence of polymorphisms both in host IRG proteins and the parasite ROP proteins 
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suggest that the house mice and T. gondii have had a long-term association, and that house mice 
are an evolutionarily important intermediate host for the parasite.  
 
Recent studies in lab mice have provided evidence that though the highly virulent parasite strains 
cause high mortality in naïve mice, they have an advantage in the context of reinfection of mice 
already chronically infected with a less virulent T. gondii strain (Table V-2) (Krahenbuhl et al. 
1971; Reikvam et al. 1976; Araujo et al. 1997; Dao et al. 2001; Brandao et al. 2009; Silva et al. 
2012).  The preexisting chronic infection of a low virulence T. gondii strain likely provides 
sufficient immune protection for the mice to survive what would normally be a fatal infection by 
a highly virulent strain. This would lend an advantage to transmission of virulent parasites.  
However,  such an advantage would presumably be offset by the high mortality rate associated 
with infection of naïve mice, which would reduce the likelihood of transmission to new hosts.  
 
To assess the consequences of virulence phenotype on transmission of T. gondii strains within an 
agricultural environment, we performed analyses using a simulation of domestic cycle parasite 
transmission. The results showed that, when reinfection of chronically infected mice with more 
virulent genotypes is enabled, the IV genotype is able to maintain transmission and becomes 
clearly and consistently dominant over the NV genotype (Figure V-1A-C).  This is likely due to 
a favorable balance between strain lethality and the ability to reinfect intermediate hosts by the 
intermediately virulent T. gondii genotype, which invades more aggressively but still does not 
generally cause significant mortality. The ability to utilize previously infected mice as viable 
hosts may provide a significant competitive advantage. The consequence of such evolutionary 
selection would be expected to be reduced genetic diversity and dominance of a small number of 
clonal T, gondii genotypes. This outcome is in agreement with the fact that only a few 
intermediately virulent T. gondii genotypes have become dominant in Europe (#1, #2, and #3), 
northern Africa (#1, #2, and #3), North America (#1, #2, #3, #4 and #5), and China (#9) (Figure 
V-6C). Such a population structure superimposes nicely with human agriculture and domestic 
cat/house mice geographic distributions (Figure V-6A-B).  These dominant strains have all been 
shown to display intermediate virulence in mice, with the exception of genotype #3 which seems 
to have relatively lower virulence (Table 1). Within the simulated populations, when assuming a 
complete immunity upon initial chronic infection that prevents sequential reinfection of mice 
with a second T. gondii strain, only the non-virulent genotype was found to maintain infection in 
the population (Figure V-1D-F). The virulent T. gondii strains quickly disappeared, followed by 
the intermediately virulent genotype. The rate of disappearance was correlated with the level of 
virulence (mortality): the higher the virulence, the faster the parasite disappeared (Figure V-1D-
F). This result suggests that, under the situation of a clonal population structure, evolutionary 
selection reduces virulence in T . gondii. This principle may help explain the dominance of the 
less-virulent genotype #3 in Europe (Table V-1).  
 
To simulate the sylvatic cycle of T. gondii transmission, we set the mortality rate for all three 
strain types at a very low value (0.1%), equivalent to the mouse non-virulent genotype. This is 
based on the fact that most wildlife are resistant to T. gondii, and infections are generally 
chronic. When reinfection of chronically infected wildlife with more mouse-virulent genotypes 
(HV and IV) was enabled, HV quickly became dominant, but the mouse IV and NV populations 
diminished to extinction within a few decades (Figure V-3A-C).  When we examined the murine 
virulence data for globally isolated T. gondii strains, a far greater proportion of highly mouse-
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virulent strains were identified in South/Central America compared to elsewhere in the world. 
The outcome of the simulation is thus more or less in line with the modern-day population 
structure in Central/South America, suggesting mouse virulent T. gondii genotypes are 
evolutionarily favored in this tropical environment.  In contrast to the northern hemisphere, the 
highly diverse felids and intermediate hosts of Central/South America may differentially select 
heterologous T. gondii genotypes with varying virulence phenotypes, thereby maintaining a 
genetically diverse parasite population. When reinfection was disabled in simulated 
environments with sylvatic transmission, each of the three categories of T. gondii genotypes was 
observed to randomly circulate within the population with equal probability of becoming fixed or 
extinct (Figure V-3D-F). As this is a deviation from the observed populations of Central/South 
America wherein more virulent phenotypes appear to have an evolutionary advantage, this seems 
unlikely to be an important selective mechanism for the population. 
 
Because the exact parameters regarding mortality rates and sequential infection probabilities 
during mouse infections in nature are difficult to ascertain, we also examined the dynamics of 
simulated populations over a range of values for both of these variables (Figure v-4). We found 
that dominance of the IV strain type decreased as its virulence was increased and the rate of 
decreasing is higher in mice than in cats and in contaminated patches (Figure v-4A-D). At 5% 
mortality, dominance in all three categories was lost (Figure v-4A,D). In nature, we generally 
expect mortality rates of mice infected with intermediately virulent strains to be minimal, as only 
small doses of parasite are likely to be encountered and ingested. In bioassay studies such as 
those cited in Shwab et al. (2014), wherein potentially infected tissue is fed to laboratory mice 
for the purposes of detecting and isolating T. gondii, nonvirulent and intermediately virulent 
strains are rarely distinguishable from one another, in that the dosages are only sufficient to 
cause mortality from highly virulent strains, and higher concentrations of parasite are required to 
identify strains of intermediate and low virulence. In the case of reinfection probability, we 
found that dominance of IV strains increased rapidly up to about a 10% reinfection rate, and then 
more gradually above this threshold (Figure v-4E-H).  Taken together, virulence in terms of 
mouse mortality and the capability of invading existing chronic infection (reinfection) are two 
important aspects that likely under evolutionary selection in T. gondii.   
 
Aside from house mice, any intermediate hosts sensitive to T. gondii infection and which have 
differential susceptibility to distinct parasite genotypes may exert selective pressure on the 
parasite.  There are a few candidate intermediate hosts of possible of importance in this regard. 
Wild rabbits (lagomorphs) have been reported to be the major diet for domestic cats and bobcats 
(Liberg et al. 1984; Delibes et al. 1997). Experimental challenges of laboratory rabbits showed 
that they are highly sensitive to T. gondii infection (Dubey, 2010). Given the worldwide 
distribution and abundance of lagonorphs, more studies are needed to determine their role in T. 
gondii transmission. Another potentially important intermediate host of T. gondii is the deer 
mouse (Peromyscus maniculatus).  Among the small rodents in North America, the deer mouse 
is the most abundant species with a wide distribution from the Yukon Territory in Canada in the 
north to the Mexican Plateau in the south (Witmer and Moulton, 2012). It was found to be the 
most common rodent in a variety of crop fields (Kaufman and Kaufman, 1990). Experimentation 
has shown that deer mice can be easily infected withT. gondii and that infections may be 
transmitted vertically to offspring as in house mice (Rejmanek et al. 2010). Therefore, deer mice 
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may play an important role in T. gondii transmission in North America where the genotypes #4 
and #5 dominate in wildlife (Khan et al., 2011, Dubey et al, 2011).  
 
Our study has shown that the domestic and sylvatic transmission cycles of T. gondii are under 
different selective pressures, with the key factor under selection being parasite virulence. The 
domestic life cycle associated with human agricultural settlements is expected to promote an 
evolutionary trajectory favoring the development of the more clonal population structure 
dominated by less virulent T. gondii genotypes. While the virulent strains pay a high fitness costs 
during infection of naïve mice, they benefit from the ability to overcome host immunity and 
reinfect mice chronically infected with less virulent T. gondii genotypes.  In this situation, strains 
of intermediate virulence may strike a balance which provides them with an overall selective 
advantage. In contrast, within natural environments such as the tropical Amazon rainforest, the 
sylvatic cycle favors development of a diverse population supporting highly virulent T. gondii 
genotypes.  This is due to the high diversity of host species that are resistant to T. gondii, 
alleviating the selective pressure associated with strain virulence. Thus, it appears that the South 
American population structure likely resembles the primordial state of the parasite, while the 
genetic uniformity observed elsewhere represents a relatively recent, human influenced state. 
This makes sense as much of South America, particularly the Amazon rainforest region, remains 
undeveloped compared to countries in the northern hemisphere. In addition, a greater variety of 
animal species are present in this region than in any other part of the world, which would 
presumably contribute to a corresponding diversification of parasite strains (Dirzo and Raven, 
2003). More extensive sampling in other less developed regions of the world with a high 
diversity of wildlife, such as the tropical areas of Africa and southeast Asia, is necessary to 
further examine the extent to which these variables influence the population structure of T. 
gondii.  
 
Our findings suggest that, as human influence continues to expand and more of Earth’s 
ecosystems are altered, the global T. gondii population structure may continue to evolve towards 
uniformity and reduced mouse virulence. South American countries such as Brazil are currently 
among the most rapidly developing in the world. As the human populations of these countries 
grow and more land is transformed by agriculture and urbanization, we may see a decline in the 
prevalence of more highly mouse-virulent South American strains.  But in the meantime, 
encroachment into unexplored natural environments such as the tropical Amazon will potentially 
expose us to more virulent T. gondii strains in the wild, increasing the risk of contracting more 
severe forms of toxoplasmosis. While humans are more resistant to T. gondii infection than mice 
in general, some evidence suggests an increased association of highly mouse virulent strains with 
acute toxoplasmosis in immunocompetent humans (Ferreira et al. 2011; Dubey et al. 2012). 
Though the long term effect of human agricultural expansion has been to reduce the genetic 
diversity and virulence of T. gondii throughout much of the world, human-associated changes to 
ecosystems such dramatic increases in densities of house mouse and domestic cat populations 
(including feral cats) may lead to higher infection rates of T. gondii in these animals, resulting in 
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 Introduction  
 
Toxoplasma gondii is one of the most successful protozoan parasites infecting mammals and 
birds (Dubey, 2010). It is estimated that up to one-third of the world's human population is 
chronically infected with this parasite (Dubey 2010, Tenter et al. 2000). Genetic analyses 
showed that, in Europe and North Africa,  two T. gondii lineages, namely type II (ToxoDB PCR-
RFLP genotype #1 and #3) and type III (genotype #2) predominate. In North America type II, 
type III and type 12 (genotype #4 and #5) are the major lineages. A previously defined type I 
(genotype #10), was widely spread globally, but it was isolated with a low frequency. Though 
genetic variation between these major lineages is about 1-2 % (Khan et al. 2009), the type I, II 
and III strains differ widely in virulence, persistence, migratory capacity, attraction of different 
cell types, and induction of cytokine expression (Saeij et al. 2005). Type I strains are highly 
virulent in mice with an LD100 as low as a single parasite, while strains of type II and III are less 
virulent (LD100>1000), and as such are able to establish chronic infections in mice readily 
(Sibley and Boothroyd 1992, Sibley et al. 2009). The variability of disease outcome in human 
infections may also be linked to the type of strains that cause the infection. Type I strains are 
often found in severe acquired toxoplasmosis and congenital infection (Xiao et al. 2009, Melo et 
al. 2011, Khan et al. 2005). Type II strains cause the majority (70 to 80%) of human cases of 
toxoplasmosis in North America and Europe (Howe and Sibley 1995, Ajzenberg et al. 2009).  
 
To understand how these distinct T. gondii lineages lead to different outcomes in infected hosts, 
strain-specific host responses are of interest for investigation. A previous study of macrophage 
cytokine production after in vitro infection with parasites of virulent type I and intermediate type 
II genotypes showed that a type II strain induced nearly 200-fold higher level of IL-12 than a 
type I strain after 24-h of infection (Robben et al. 2004). Macrophages were activated through 
the classical (Th1 response-associated) pathway by type II infection, but the alternative (Th2 
response-associated) pathway by type I and III infections (Jensen et al. 2011). The Toxoplasma 
rhoptry kinase ROP16 (type I and III alleles) was reported to be responsible for alternative 
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activation through activating STAT6 (Butcher et al. 2011).  The type II dense granule protein 
GRA15 is able to promote classical activation of macrophages by activating the NF-kB pathway 
(Jensen et al. 2011). Strain-dependent host response was also found in human foreskin 
fibroblasts (Saeij et al. 2007, Rosowski et al. 2011), chicken embryonic fibroblasts (Ong et al. 
2011), and human neuroepithelial cells (Xiao et al. 2011). Our previous study also showed that 
overall transcription levels in mice were similar in type I and type II infections, and both had 
greater changes than the infection with type III on day 5 post-infection (Hill et al. 2012).  
 
Based on these studies, it is clear that there are significant differences in the host response to 
different T. gondii genotypes. However, the knowledge of host response to these different 
genotypes is confined to in vitro model and/or limited time points sampled. To provide a broad 
spectrum of host response to different T. gondii strains, we therefore conducted a time course 
study in mice to reveal dynamics of gene transcription, and expression networks in mice infected 
with different lineages of T. gondii. Through gene ontology and network analysis, major cause-
effect relationship among a number of transcripts of immune and inflammatory responses are 
proposed and discussed.   
 
 
Materials and Methods 
 
Parasite strains and infection in mice 
 
T. gondii Type I strain GT1 (high virulence), Type II strain PTG (intermediate virulence), and 
Type III strain CTG (non-virulence) were propagated in confluent human foreskin fibroblast 
(HFF) monolayers as described previously (Hill et al. 2012). The tachyzoites were harvested by 
filtering through 3-µm-pore-size polycarbonate filters (catalog # 420400; Fisher Scientific, 
Hanover Park, IL) and counted with a hemocytometer. Five hundred tachyzoites were inoculated 
into 6-8-week old female outbred CD-1 mice (ICR-Harlan Sprague) by intraperitoneal injection. 
Four mice were euthanized on day 1, 2, 3, 4, 5 and 7 post infection, respectively. To collect 
peritoneal cells, 5 ml of ice-cold phosphate-buffered saline (PBS) was injected into the peritoneal 
cavity, and then peritoneal lavage was collected. The cells were collected by centrifugation at 
1,000×g for 10 min at 4 °C, resuspended in 1 ml of RNAlater solution (Ambion, Austin, TX), 
incubated in 4°C for 1 h, and then stored at -70°C before RNA extraction. The mouse spleens 
were collected, weighed, homogenized, and homogenized in PBS to 0.1 g/ml for DNA extraction 
and subsequent determination of parasite burden. Four uninfected mice were used as negative 
controls. The use of mice for this study was approved by the Institutional Animal Care and Use 




Microarray analysis was performed by the method described previously (Hill et al. 2012). In 
brief, total RNA from peritoneal cells was extracted using Qiagen RNeasy Plus Mini Kit (catalog 
#74131; Qiagen,Valencia, CA) following the manufacturer’s instructions. The quality of RNA 
was tested by agarose gel electrophoresis, and the concentration of RNA was determined by 
reading the absorbance at 260/280 nm. Affymetrix Mouse Exon 1.0 ST array containing 35,556 
transcripts was used. RNA samples were processed according to the Affymetrix protocol for one-
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cycle DNA synthesis using a Message Amp II-Biotin Enhanced Kit (P/N AM1791; Ambion, 
Austin, TX). Five micrograms of fragmented cRNA was hybridized to the Affymetrix GeneChip. 
Arrays were processed using the Affymetrix Hyb/Stain kit PN900720. Arrays were immediately 
scanned using the Affymetrix 7G scanner. Array images were visually inspected for anomalies. 
The individual chip scans were quality checked for the presence of control genes and background 
signal values. All microarray procedures were done at the University of Tennessee Affymetrix 
Core Facility. 
 
Analysis of differential gene expression 
 
Gene expression analysis was performed using Affymetrix® Expression Console and 
Transcriptome Analysis Console (TAC) 2.0 Software (www.affymetrix.com). The raw data in 
the form of Affymetrix CEL files from the arrays were normalized with the robust multichip 
algorithm (RMA-Sketch).  The analysis was performed to detect genes with statistically 
significant expression levels between T. gondii-infected mice and the uninfected control mice. 
Gene transcripts were considered to be differentially expressed when there was at least a 2-fold 
change (up or down) from the uninfected controls with a false discovery rate (FDR) p value of 
≤0.05. The expression analysis was performed at gene level (not exon level). 
 
Analysis of biological pathways enriched during T. gondii infections.  
 
In order to identify enriched biological functions, the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) v.6.7 bioinformatics software was employed (Huang et al, Nature 
Protocols, 2009). This online software allows for analysis of large gene lists based on functional 
annotations from multiple databases. In our analysis, lists of Affymetrix exon gene IDs for 
significantly up- or downregulated genes (q≤0.05 based on FDR analysis) from each of the three 
infection types across all time points were uploaded into the DAVID functional annotation tool. 
The output of Functional Annotation Chart was obtained based on GO term - biologic process 
(GOTERM_BP). Functional Annotation Clustering analysis identified groups of functionally 
related genes that were enriched among the listed transcripts, meaning that genes belonging to 
these function were represented significantly more frequently than would be expected in a 
random set of M. musculus transcripts. An enrichment score was generated for each cluster, 
calculated by averaging the negative logarithms of the modified Fisher Exact P-values (EASE 
scores) of the individual pathways in the cluster. For clustering analysis, the stringency level was 
set as “high”. 
 
Microarray data validation by quantitative real-time RT-PCR (qRT-PCR)  
 
To validate the microarray data, a few up- and down-regulated transcripts at different time points 
were selected for qRT-PCR analyses using the High Capacity cDNA Reverse Transcription Kit 
with RNase Inhibitor (catalog #4374966; Applied Biosystems, Foster City, CA) according to the 
manufacturer's instructions. One microliter of RNA was transcribed into cDNA, and Quantitative 
PCR was performed using TaqMan Gene Expression Assays and Mouse ACTB Endogenous 
Control (Assay ID 4352341E; Applied Biosystems, Foster City, CA) in the iCycler thermal 
cycler (iQ5, Bio-Rad Laboratories, Inc. Hercules, CA). The TaqMan Gene Expression Assays 
consist of pre-formulated PCR primers and a FAM dye-labelled TaqMan probe for selected 
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target transcripts. The Mouse ACTB Endogenous Control contained pre-formulated PCR primers 
and a VIC dye-labelled TaqMan probe of β-actin. Multiplex PCR reaction mix had a volume of 
25 µl containing 9 µl of H2O, 12.5 µl of 2×TaqMan Fast Advanced Master Mix (catalog 
#4444964; Applied Biosystems, Foster City, CA), 1.25 µl of 20X TaqMan® Gene Expression 
Assay buffer, 1.25 µl of ACTB Endogenous Control, and 1 µl of cDNA. The reaction was 
carried out using the following cycling conditions: 50°C for 2 min, 94°C for 10 min, followed by 
40 cycles of 95°C for 15 sec, 60°C for 60 sec. The comparative CT method (△△CT) was chosen 
for the relative quantification of gene expression (Schmittgen and Livak 2008). 
 
Parasite load determination by quantitative PCR (qPCR) 
 
Parasite load in mouse spleen tissue was determined as described previously (Hill et al. 2012) 
with modifications. Briefly, 100 µl of homogenized spleen tissue at a concentration of 0.1 g/ml 
in PBS was diluted with 100 µl of PBS, then 50 µl of 10 mg/ml proteinase K was added, and the 
mixture was incubated at 55°C for 2 h. DNA was extracted using a Qiagen DNeasy Blood and 
Tissue Kit (catalog number 69504; Qiagen, Valencia, CA). For qPCR standard controls, the 
spleen of an uninfected mouse was homogenized and diluted in PBS, and T. gondii tachyzoites 
were spiked into the homogenized spleen to make a series of concentrations of 1×107 to 1×103 
tachyzoites/ml. All homogenized spleen samples were adjusted to a volume of 0.1 g/ml in PBS, 
and genomic DNA was purified using the same procedure as detailed above. The concentration 
of parasites in mouse spleen was estimated by qPCR using a TaqMan probe targeting the ITS1 
sequence (GenBank accession number AY143141). The primers for PCR amplification were 
ITS1-Fx (GAAGGGGCTCAATTTCTGG) and ITS1-Rx 
(TGTTCCTCAGATTTGTTGTTTGA), which amplify a 117-bp sequence. The ITS1 probe was 
5’-5-FAM-CGTGTCTCTGTTGGGATACTGATTTCCAGG- BHQ-1-3’, with the 5’ end labeled 
with 6-carboxyfluorescein (FAM) and the 3’ end labeled with Black Hole Quencher-1(BHQ-1) 
(Integrated DNA Technologies, Inc., Coralville, IA). The qPCR mixture had a total volume of 25 
µl containing 10.9 µl of H2O, 12.5 µl of 2×TaqMan Fast Advanced Master Mix(catalog number 
4444964; Applied Biosystems, Foster City, CA), 0.15 µl of 50 µM ITS1-Fx and ITS1-Rx 
primers, 0.3 µl of 50 µM ITS1 probe, and 1 µl of purified DNA. The reaction was carried out 
using the iCycler thermal cycler (iQ5, Bio-Rad Laboratories, Inc. Hercules, CA) under the 
following conditions: 94°C for 10 min, followed by 40 cycles of 95°C for 15 sec, 60°C for 60 
sec. The CT value of each sample was compared to values of the standard controls to estimate 







Two to four high-quality RNA samples from mice infected with each of the three T. gondii 
strains at each of the six time points were used for microarray experiments. A total of 45 mouse 
peritoneal cell samples were processed and analyzed including two samples for each strain at 
each time point with exception of three samples for Type III (CTG) on day 5 and day 7,  three 
for Type I (GT1) on day 7, four samples for Type I on day 5 and four for uninfected mice. 
Differentially expressed genes (DEGs) were identified based on signal intensity values and fold 
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changes compared to values from the uninfected mice. For Type I infected mice, 9, 75, 1830, and 
1307 genes were significantly changed on days 3, 4, 5, and 7, respectively. For Type II infected 
mice, 58, 71, 124 and 1029 genes were significantly changed on days 2, 3, 4 and 5, respectively. 
For Type III infected mice, 112, 52, 111, 64 and 158 genes were significantly changed on days 2, 
3, 4, 5 and 7, respectively. No significant differences in gene expression were observed for other 
days. Changes in DEG number for each strain type over the course of the experiment are shown 
in Figure VI-1A. In both Type II and Type III infected mice, the number of DEGs increased 
markedly on day 2. However, in the case of Type III, the number of DEGs then remained 
relatively constant through day 7, while in the case of Type II, DEGs increased again nearly ten-
fold on day 5, then had dropped completely by day 7. The pattern of gene expression observed 
for Type I infection was quite distinct, as no significant change was observed until day 3, 
followed by roughly ten-fold increases in DEGs on days 4 and 5. This peak number of DEGs 
was then approximately maintained through day 7. Thus, each of the three strain types elicited a 
unique response in terms of the temporal patterns of gene expression, with Type III and Type II 
eliciting an earlier response than Type I, which then remained constant for Type III while spiking 
on day 5 and then dropping on day 7 for Type II. Type I, on the other hand, elicited a delayed 
response which increased steadily to reach a peak level similar to that of Type II on day 5, but 
which unlike Type II was maintained through day 7. The change of up-regulated genes in all 
three infections followed the same trend of total number of DEGs (Figure VI-1B). On day 2 and 
day 3, clearly there are higher numbers of genes up-regulated in Type II and Type III infection 
than in that of Type I. Downregulated genes were considerably lower in all strains, but increased 
in Type I and to a lesser extent Type II on day 5, followed by decreases on day 7 (Figure VI-1C). 
 
Functional analysis of DEGs in mice infected with the three distinct T. gondii strains. 
 
Functional analysis of DEGs was performed by DAVID ver 6.7. GO TERM biological processes 
(GO TERM_BP) were evaluated by Functional Analysis Charting, and the enrichment of related 
biological function was evaluated by Functional Analysis Clustering. Statistical significance was 
set at FDR q<=0.5, the stringency for the latter analysis was set at “high”.  For all T. gondii 
infections, immune response was the top affected function (Table VI-1). The number of DEGs 
for this response is summarized in Figure VI-2. The trend of change among the three T. gondii 
strains follow the total number of DEGs and the up-regulated DEGs nicely. Overall, Type III 
infection caused least number of DEGs, whereas Type I caused the highest. For Type III infected 
mice, innate defense response is the main scheme of reaction, dictated by the up-regulation of 
GBPs. Inflammatory response is quite weak. For Type I infected mice, inflammatory responses 
dominate, particularly on days 4, 5 and 7, whereas Type II infected mice had intermediate levels 
of inflammatory response, particularly on day 5.  
 
Time course of DEGs 
 
Genes that had at least 2-fold change in expression, which were also statistically significant 
(FDR q<=0.05) for at least 4 time points among infection of the three genotypes of parasites, 
were selected for time course analysis. The results are summarized in Figure VI-3.  These genes 
include several immunity-related GTPases (IRGs), guanylate-binding proteins (GBPs), INF-γ, 
IL1b, TNF-α, CXCL9, CXCL10/IP-10, CCL12, chitinase 3-like 3 (Chi3l3/ECF-L/Ym1), serine  
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Figure VI-1. Temporal patterns of differentially expressed genes (DEGs).  (A) Total DEGs over seven days post-infection for 







Table VI-1. Immune response in mice infected with GT1, PTG and CTG strains. 
Type I day2 day3 (8, 8 w/ID) day4 (77, 64 w/IDs) day5 (1554, 1402 w/ IDs) day7 (1293, 1182 w/ IDs) 
 No significant changes Immune Response (6), 
genes include CCL12, 
CXCL13, complement 
factor properdin, (CFP), 
complement component 
1, s subcomponent (C1s), 
and  T-cell spedific 
GTPase (Tgtp1/Irgb6), 
GBP1.    
                                                             
Most enriched cluster 






(16), Regulation of T-
cell Proliferation (5), 
Defense Response (9). 
Genes for Immune 
Response include 
XCL1, CCL4, CXCL9, 
CXCL10, CXCL13, 
INF-g, IL12b, 





domain containing 2 
(RSAD2), Tgtp1/Irgb6, 
Irgm1, GBP1, GBP4, 
GBP8/GBP10.     
                                           
Most enriched cluster 




Immune Response (134), 
Defense response (89), 
Response to wounding (74), 
Inflammatory response (57),  
Positive regulation of 
immune system process (50), 
negative regulation of 
immune system process (19).  
                                                                     
Most enriched cluster (score: 




Immune Response (129), 
Positive regulation of immune 
system process (62), Cell cycle 
(99), Defense response (81), 
Cell cycle process (70), 
Response to wounding (64), 
Inflammatory response (55).  
Negative regulation of immune 
system process (25).  
                                                                                        
Most enriched cluster (score: 










Table VI-1 continued 
Type II day2 (59, 50 w/ ID) day3 (72, 63 w/ID) day4 (130, 108 wi/IDs) day5 (775, 662 w/ IDs) day7 
 Immune Response (11), 
including  Fc receptor, 
IgG, high affinity I 
(Fcgr1), IL18R, 
Iigp1/Irga6, Irgm1,  
Tgtp1/Irgb6, GBP1, 
GBP4, GBP8/GBP10, 
GBP9.   
                                            
Most enriched cluster 
(score: 5.92) -- GBP 
proteins. 
Immune Response (13), 
Inflammatory response 
(7), Positive regulation of 
response to stimulus (6). 
Genes for Immune 
response include Fcgr1, 




activation 2 like 
(Mpa2L), IDO1, 
Tgtp1/Irgb6, GBP1, 
GBP4, GBP8/GBP10.   
                                                       
Most enriched cluster 









(14), genes include 
Fcgr1, CXCL9, 
CXCL10, CXCL13, 
IL12b, myosin 1f, 
collectin sub-family 
member 12, 
Iigp1/Irga6,  Irgm1,  
Tgtp1/Irgb6,  GBP1, 
GBP4, GBP8/GBP10, 
GBP9.                 
                                                    
Most enriched cluster 
(score: 4.76) -- GBP 
proteins. 
Immune Response (72), 
Defense response (50), 
Inflammatory response (32), 
Response to wounding (36), 
Positive regulation of 
immune system process (25), 
negative regulation of 
immune system process (13).      
                                                     
Most enriched cluster (score: 
8.01) -- lectin/sugar 
binding/carbohydrate 
binding. At the medium level 
of stringency by DAVID 
clustering analysis, the most 
enriched cluster (score: 

















Table VI-1 continued 
Type III day2 (111, 94 w/ ID) day3 (51, 46 w/IDs) day4 (126, 104 w/IDs) day5 (68, 56 w/ID) day7 (147, 131 w/IDs) 
 Immune Response (21). 
Cell division (11), 
Mitosis (9). Genes for 
immune response include 
Fcgr1, C1s,  XCL1, 
CXCL9, CXCL10, INF-g 
(inflammatory response), 
interferon induced with 
helicase C domain 1 
(IFIH1), macrophage 
activation 2 like 
(Mpa2L), myxovirus 
(influenza virus) 
resistance 1 (mx1), serine 
(or cysteine) peptidase 
inhibitor, clade G, 
member 1 (SERPING1), 
toll-like receptor 2 
(TLR2), tumor necrosis 
factor (ligand) 
superfamily, member 10 
(TNFSF10), TNFSF14, 
IigP1/Irga6, Tgtp1/Irgb6, 
Irgb10, Irgm1, GBP1, 
GBP4, GBP8/10, GBP9.      
 
Most enriched cluster 
(enrichment score: 6.29) 
-- GBP proteins. 
Immune Response (9), 
Inflammatory Response 
(5), Positive Regulation 
of Apoptosis (5). Genes 
for Immune Response 
include Fcgr1, CXCL10, 
CXCL13, ,  Tgtp1/Irgb6, 
TNF-a, Iigp1/Irga6,  
GBP1, GBP4, GBP8/10.  
                                                                    
Most enriched cluster 
(enrichment score: 2.95) -





Response (9), Positive 
Regulation of 
Response to Stimulus 
(8). Genes for Immune 
Response include 
Fcgr1,  XCL1, 
CXCL9, CXCL10, 
CXCL13, CCL12, 





containing 2 (RSAD2), 
similar to T cell signal 
transduction molecule1 
SAP; SH2 domain 
protein 1A (Sh2d1a), 
Iigp1/Irga6, 
Tgtp1/Irgb6, Irgb10, 
Irgm1, GBP1, GBP4, 
GBP8/10, GBP9.     
                                                            
Most enriched cluster 
(score: 6.08) -- GBP 
proteins. 
Immune Response (17). 
Genes include 2'-5' 
oligoadenylate synthetase 3 
(Oas3), IL18RAP, IFIH1,  
interferon regulatory factor 7 
(IRF7), Mpa2L, SERPING1, 
XCL1, tumor necrosis factor 
(ligand) superfamily, 
member 13b (TNFSF13b), 
Tgtp1/Irgb6, Ligp1/Irga6, 
Irgb10, Irgm1, GBP1, GBP3, 
GBP4, GBP8/10, GBP9.  
                                    Most 
enriched cluster (score: 9.58) 
-- GBP proteins. 
Immune Response (25), 
Regulation of Immue Effector 
Process (8). Genes for Immune 
Response include Fcgr1, XCL, 
INF-g, Oasl2, growth arrest 
and DNA-damage-inducible 45 
gamma (Gadd45g), 
histocompatibility 2, Q region 
locus 1 (H2-Q1),  
histocompatibility 2, T region 
locus 9 (H2-T9),  interferon 
regulatory factor 7 (TRF7), 
IL18BP, Mpa2L, SERPING1, 
CCL12, CXCL10, RSAD2, 
interferon gamma inducible 
protein 47 (Ifi47), Iigp1/Irga6, 
Irgb10, Irgm1, Tgtp1/Irgb6, 
GBP1, GBP2, GBP3, GBP4, 
GBP5, GBP8/10, GBP9.        
 
Most enriched cluster (score: 
12.56) -- GBP proteins. 
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(or cysteine) peptidase inhibitor, clade G, member 1 (SerpinG1), serine (or cysteine) peptidase 
inhibitor, clade B, member 6b (SerpinB6b),  Z-DNA binding protein 1 (Zbp1), Fc receptor, IgG, 
high affinity I (Fcgr1), Fc receptor, IgG, low affinity IV (Fcgr4), lymphocyte antigen 6 complex, 
locus C1 (Ly6c1), lymphocyte antigen 6 complex, locus I (Ly6i), V-set and immunoglobulin 
domain containing 4 (Vsig4), CXCL13, arachidonate 15-lipoxygenase (Alox15), and 
apolipoprotein E (Apoe).  
 
Immunity-related GTPase (IRG) gene family upregulation 
 
Among the highly up-regulated genes, a number of IRG proteins were identified, including 
Irga6, Irgb6, Irgm1 and Irgm3. Irga6 was shown to be highly upregulated during Type III 
infection from day 2 through the end of the study, with a dramatic peak on day 2 followed by 
more moderate upregulation during subsequent time points. In the case of Type II infection, 
upregulation was maintained from days 2-4, followed by a peak on day 5 and a marked decline 
on day 7. For Type I infection, upregulation declined during days 2-4, then increased on days 5 
and 7. In the case of Irgb6, all three strains also caused early upregulation starting on day 2, 
though this was more marked in Type II and Type III infections than in Type I infection. 
Upregulation was maintained steadily during Type III infection, increased over time for Type I 
infection, and dropped to zero by day 7 for Type III infection. The regulatory IRGs Irgm1 and 
Irgm3 also displayed significant levels of upregulation. For both genes, this upregulation 
persisted from days 2 to 7 during Type III infection, though declining overall with time. Type II 
infection resulted in strong upregulation from day 2 to 5, followed by a drop to zero on day 7. 
Type I caused a relatively constant level of upregulation from days 2 through 7.  
 
In addition to the IRGs, numerous genes encoding members of the p65 guanylate-binding protein 
(GBP) family were found to be upregulated during infection with all three strain types including 
the chromosome 3 GBPs Gbp1, Gbp3, Gbp5 and Gbp7, and the chromosome 5 GBPs Gbp4, 
Gbp6, Gbp8, Gbp9 and Gbp11. The chromosome 3 BGP genes all followed similar patterns of 
upregulation, showing strong upregulation on day two for Type III and Type II infections with 
comparatively lower upregulation for Type I infection. Upregulation associated with Type II and 
Type III infections dropped on day 3 and then rose through day 5, while levels associated with 
Type I infection remained relatively constant during this period. Upregulation remained 
relatively high on day 7 of Type III and Type I infections, but dropped to zero for Type II 
infection. For chromosome 5, Gbp4, Gbp6, Gbp8, Gbp9 and Gbp11 also all showed similar 
temporal patterns of expression, with upregulation observable for all strains on day 2, highest 
during Type III infection and lowest during Type I infection. Upregulation then declined through 
day 4 for Type III infection, then increased gradually through day 7. In the case of Type II 
infection, upregulation was maintained relatively constantly until dropping completely or to a 
low level on day 7. Type I infection, by contrast, resulted in a gradual and somewhat steady 
increase in upregulation over the course of the experiment, ultimately reaching levels 
comparable to those generated by Type III infection.  
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Figure VI-3. Expression of specific immunity related genes. Expression of genes over seven days follwing infection with Type I 




Figure VI-3. Expression of specific immunity related genes (continued). 
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Figure VI-3. Expression of specific immunity related genes (continued). 
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Figure VI -3. Expression of specific immunity related genes (continued). 
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Figure VI-3. Expression of specific immunity related genes (continued). 
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Figure VI-3. Expression of specific immunity related genes (continued)
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Chemokine gene upregulation  
 
In addition to the IRG and GBP genes, other immunity-related genes also showed significant 
upregulation. The chemokine gene CXCL10 was strongly upregulated on day 2 of Type III 
infection, then declined steady through day 7. Type II and Type I resulted in lower level 
upregulation on day 2, fluctuating and dropping to a minimal level on day 7 for Type II, and 
increasing steadily during the course of the experiment for Type I. The CXCL11 gene showed a 
sharp rise in upregulation during Type II infecton between days 1 and 3, followed by an equally 
sharp decline to zero between days 5 and 7. For Type III infection, only a single sharp spike on 
day 3 was observed, followed by a decline to zero upregulation by day 5. Type I showed no 
upregulation until day 3, followed by maintenance of fairly constant upregulation for the 
duration of the experiment. CXCL9 showed an early spike in upregulation on day 2 of Type III 
infection, followed by a steady decline to a minimal level by day 5. Upregulation of this gene 
increased steadily from days 2 through 5 for both Type II and Type I infections, then dropped for 
both strain types on day 7, completely so for Type II and only moderately for Type I. CCL2, 
CCL3, CCL4 CCL7, CCL8, CCL12 and CCL22 all showed similar patterns of expression, with a 
sharp peak in expression on day 3 of Type III infection, followed by a decrease to near zero by 
day 7 (data not shown). Type II infection resulted in fairly strong upregulation between days 3 
and 5, followed by a sharp decline on day 7. Type I infection resulted in a sharp increase in 
upregulation from day 3 to 5 (with a moderate dip on day 4 in most cases), followed by a more 
gradual drop on day 7. In the case of CCL22, the increase from day 4 to 5 during Type I 
infection was especially dramatic relative to the expression levels associated with infection by 
other strain types (data not shown).  
 
Upregulation of other immunity-related signaling molecule genes and related effectors 
 
The IFNg displayed weak upregulation during Type III infection peaking at day 3, somewhat 
stronger upregulation during Type II infection peaking at day 5, and weak upregulation during 
Type I infection starting on either day 3 or 4, followed by a steady increase to high levels by day 
7. TNF-a also was moderately upregulated, with all three strains producing a similar increase in 
expression on day 3, which then dropped to zero by day 5 for Type III infection and fluctuated 
before dropping to zero by day 7 for Type II infection. Type I infection produced a similar 
pattern to Type II infection through day 5, but dropped only slightly on day 7, so that unlike in 
the cases of Type II and Type III infection, upregulation was still high at the end of the 
experiment during Type I infection.  
 
Other upregulated genes 
 
Other genes were also upregulated, including the chitinase-like gene Ym1, which spiked on day 
three during Type III infection, then declined rapidly, while spiking and gradually declining on 
day 5 for Type II and Type I infections, with a stronger spike in the latter than in the former case. 
The high-affinity IgG receptor gene Fcgr1 showed similar patterns of upregulation for all three 
strains in the earlier stages of infection, increasing on days 2 and 3, followed by a plateau or 
small decline on day 4. After this point, upregulation showed a consistent but slow decline for 
Type I infection, a sharp drop followed by a plateau for Type III infection, so that both Type I 
and Type III infections produced similar expression levels on day 7, and a continued increase 
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followed by a sharp decline to zero on day 7 for Type II infection. The IgG/IgE receptor gene 
Fcgr4 showed stronger upregulation on day 2 for Type III and Type II infections than for Type I 
infection, followed by declines associated with the former strains and an increase associated with 
the latter, so that all three strains produced similar expression on days 3 and 4. However, while 
Type I and Type II infections both showed declines from days 5 to 7, upregulation associated 
with Type III infection increased considerably on day 5, followed by a moderate decline that still 
resulted in relatively strong upregulation on day 7.  
Ly6c1 showed a dramatic increase in upregulation on day three during infections with all three 
strains types, followed by declines associated with Type II and Type III infections, while 
upregulation during Type I infection remained relatively constant. Ly6i showed a similar pattern 
of upregulation, except that upregulation was much higher overall, and during Type I infection it 
increased consistently from day 3 to day 7, rather than plateauing as in the case of Ly6c1 
expression. The peptidase inhibitor Serpinb6b displayed a similar pattern of upregulation to 
Ly6i, though like Ly6c1 this was also on a smaller scale. Upregulation of the IFNg-induced Z-
DNA-binding protein gene Zbp1 followed a pattern similar to that of Ly6c1, and on a similar 




In addition to upregulation, many genes were also found to be downregulated during T. gondii 
infection, examples are Vsig4,  CXCL13,  Alox15 andApoE. Expression of these genes showed a 
general trend of strong downregulation on day 3 of infection with each strain type, followed by a 
return to control or near-control levels of expression on day 5 for Type III infections and day 7 
for Type II infections. During Type I infections, downregulation of these genes generally 
fluctuated between days 4 and 7, though always ending up with significant downregulation on 
day 7.  
 
Annotated pathway enrichment analysis 
 
Bioinformatic analysis using the DAVID software revealed that sets of up- and downregulated 
genes associated with infection by each of the three T. gondii strains were enriched for genes 
associated with markedly different biological pathways, as shown in Tables VI-2-4. Type III 
infection was associated with enrichment of the smallest number of pathways annotated in the 
KEGG PATHWAY and BioCarta databases (Table VI-2). These comprised clusters of genes 
involved in cell-mediated immunity and inflammation (Including MHC Class I genes, perforin 1, 
IFNg, TNFa and IL-1) and cell cycle regulation (cyclins and cyclin kinase inhibitors).  
 
For Type II infection, 7 enriched clusters were identified (Table VI-3). All of these comprised 
cell-mediated immunity-related pathways such as those relating to CD4+ T Cell activation and 
Th1 differentiation (IL-12, IL-12 receptor, CD3, IFNg, IFNg receptor, TNFa), proinflammatory 
cytokine production and cytotoxicity (IFNg, TNFa, IL-10, CCL3, CCL4, IL-1, granzyme B, 
Nos2), T-Cell and other leukocyte signaling and surface molecules (selectins, ICAM-1, Lck, 
Zap70) and apoptosis (Fas, FasL, Caspase 7, IkBa).  
 
Type I infection was associated with enrichment of the largest number of identified clusters, 15 
in all (Table VI-4). These included many immunity-related gene clusters similar to those 
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enriched during Type II and Type III infection, but in general the number of DEGs per cluster 
was higher, and comprised a greater diversity of pathways. These included immune pathways 
relating to CD4+ T-Cell differentiation and proliferation (CD28, CD4, CD3, IL-2, IL-12, IL-12 
receptor, IL-18 receptor, IL-4 receptor, CXCR3, colony-stimulating factor 2), inflammation 
(CCL3, CCL4, CCR2, CCR5, IFNg, IFNg receptor, iNOS2), apoptotic pathways (fas, fasL, fas 
death domain associated protein (DAXX), MAPKAPK2, caspase 3, 7, cytochrome C, TNFa, 
TNFa receptor, mapk13, IkBa, PKC), the complement pathway (complement component 1, 6, 
C1, C3 prepropeptide, complement component factor H, factor B, complement receptor 2) and T 
Cell signaling (CD3, CD4, CD8, CD28, IL-6, fas, fasL, fyn proto oncogene, lymphocyte protein 
tyrosine kinase, zap kinase, ctl associated protein4, inducible T-cell co-stimulator). Pathway 
clusters not directly related to the immune response were also enriched, including those 
associated with DNA replication and damage response (dna primase p49 subunit, DNA 
replication helicase 2 homologue (yeast), ATP-dependent DNA ligase I, DNA polymerase 
subunits, replication factors, exonuclease I, checkpoint kinase 1 homologue (S. pombe), polo-
like kinase, Brca1), carbohydrate metabolism (galactose, starch, sucrose, amino sugar and 
nucleotide sugar metabolic enzymes), muscle functioning and Calcium channel regulation 
(voltage dependent calcium channel subunits, insulin-like growth factor 1, integrins, AAPK 
gamma2 subunit, cardiac ryanodine receptor, solute carrier family proteins, TGFb, actinin A1, 
gap junction protein alpha 1, junction plakoglobin, cardiac RyR2), cell-cycle regulation (cell 
division cycle protein homologues (S. pombe), cyclins, CDPK6, P21 CDPK inhibitor, 
dihyrofolate reductase, IkBa), transcriptional regulation and cellular signaling (calmodulin, jun 
oncogene, phospholipase C, PKC, vav1 oncogene, endothelin1, Fyn protooncogene, STAT1, 
Igf1, inositol monophosphatase , phosphoinositide-3-kinase, neuregulin 4, jun oncogene, 
MyD88). This latter category also included genes related to B-cell response and humoral 
immunity (B-Cell Linker protein, CD79B, high affinity Ige Fc receptor (alpha polypeptide), 
membrane spanning 4 domains subfamily A2).  
 
Microarray data validation by quantitative real-time RT-PCR (qRT-PCR)  
 
To validate the microarray data, four up-regulated transcripts (IFN-γ, iNOS, IL-12β and TNF) 
and one down-regulated gene (CXCL13) at five time points (days 1, 2, 3, 4, and 5) were used for 
qRT-PCR analysis. RNA samples from day 7 were accidently lost during storage and could not 
be included in analysis. TaqMan Gene Expression Assays (Applied Biosystems) were applied for 
IFN-γ (assay ID: Mm01168134_m1), iNOS (Mm00440502_m1), IL-12β (Mm00434174_m1), 
TNF (Mm00443260_g1), and CXCL13 (Mm04214185_s1). As shown in Figure VI-4, the qRT-
PCR expression data of five transcripts at five time points revealed overall agreement with the 
microarray data (R2=0.7964). There is some degree of variation between the microarray and 
qRT-PCR data, but magnitudes of expression changes measured by each method were similar.  
 
Determination of parasite load by qPCR 
 
Parasite loads in the spleens of mice infected with 500 tachyzoites on day 1, 2, 3, 4 and 5 post-
infection were quantified. Since the parasite was not detectable in some samples on day 1, the 
data generated from day 1 were excluded in the following analysis. Parasites load on day 2 
through day 5 in three infection groups are displayed in Figure VI-5. No significant differences 
in parasite loads were observed from day 2 to day 4 among the three groups; however, the  
 104 
















Pathway Type I diabetes mellitus 6 1.40E-03 7.10E+00 
KEGG 












Pathway Viral myocarditis 3 3.50E-01 2.40E+00 
KEGG 
Pathway Cell cycle 6 2.70E-02 3.50E+00 
KEGG 
Pathway p53 signaling pathway 4 6.30E-02 4.30E+00 2 1.16 Cell Cycle Regulation 
KEGG 
Pathway Oocyte meiosis 4 1.90E-01 2.60E+00 
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Pathway Graft-versus-host disease 13 3.10E-06 5.40E+00 
KEGG 
Pathway Allograft rejection 10 5.40E-04 4.20E+00 
KEGG 











disease 8 2.80E-02 2.70E+00 
BIOCART
A 
CTL mediated immune 
response against target 
cells 
7 3.20E-05 9.10E+00 
BIOCART
A 
T Cytotoxic Cell Surface 
Molecules 5 6.90E-03 6.00E+00 
BIOCART
A 
T Helper Cell Surface 











6 5.50E-01 1.20E+00 
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Table VI-3. Continued 
Cluster 
Enrichment 





Selective expression of 
chemokine receptors 
during T-cell polarization 
7 6.80E-03 3.80E+00 
BIOCART
A 
NO2-dependent IL 12 
Pathway in NK cells 5 9.40E-03 5.50E+00 
BIOCART
A 
IL12 and Stat4 
Dependent Signaling 
Pathway in Th1 
Development 








A Th1/Th2 Differentiation 5 3.10E-02 4.00E+00 
KEGG 
Pathway Allograft rejection 10 5.40E-04 4.20E+00 
BIOCART























Table VI-3. Continued 




Pathway Apoptosis 9 2.60E-02 2.50E+00 
BIOCART
A 
NFkB activation by 
Nontypeable 
Hemophilus influenzae 




through IL1R 5 8.80E-02 2.90E+00 




Pathway 4 1.70E-01 2.70E+00 
BIOCART
A 
Monocyte and its 
Surface Molecules 4 3.50E-02 5.20E+00 
BIOCART
A 
Neutrophil and Its 





Adhesion Molecules on 















Table VI-3. Continued 





T cell receptor signaling 
pathway 12 9.20E-03 2.50E+00 
BIOCART
A 
Lck and Fyn tyrosine 
kinases in initiation of 
TCR Activation 




Signal During T-cell 
Activation 
4 9.30E-02 3.60E+00 
BIOCART
A 
T Cell Receptor 
Signaling Pathway 6 9.70E-02 2.40E+00 
BIOCART
A 
Activation of Csk by 
cAMP-dependent 
Protein Kinase Inhibits 
Signaling through the T 
Cell Receptor 





















Table VI-4. Enrichment of functional gene clusters during GT1 infection 









15 1.70E-04 2.80E+00 
BIOCART
A 
NO2-dependent IL 12 
Pathway in NK cells 9 1.50E-03 3.30E+00 
BIOCART
A 
IL12 and Stat4 
Dependent Signaling 
Pathway in Th1 
Development 








A Th1/Th2 Differentiation 9 1.90E-02 2.40E+00 
KEGG 
Pathway DNA replication 17 6.20E-07 4.10E+00 
KEGG 




















Table VI-4. Continued 
Cluster Enrichment Score Function Database Pathway DEG Count P-Value 
Pathway 
Enrichment 
BIOCARTA HIV Induced T Cell Apoptosis 8 3.80E-04 4.30E+00 
BIOCARTA 
CTL mediated immune 
response against target 
cells 
8 2.30E-03 3.50E+00 
BIOCARTA 
Lck and Fyn tyrosine 
kinases in initiation of 
TCR Activation 
7 3.60E-03 3.70E+00 
BIOCARTA T Helper Cell Surface Molecules 8 4.60E-03 3.20E+00 
BIOCARTA T Cytotoxic Cell Surface Molecules 8 4.60E-03 3.20E+00 
BIOCARTA 
The Co-Stimulatory 
Signal During T-cell 
Activation 
8 3.10E-02 2.40E+00 
BIOCARTA IL 17 Signaling Pathway 6 1.10E-01 2.20E+00 
3 1.78 T Cell Signaling 













Table VI-4. Continued 





T Cell Receptor and 






Activation of Csk by 
cAMP-dependent 
Protein Kinase Inhibits 
Signaling through the T 
Cell Receptor 
6 2.70E-01 1.70E+00 
BIOCART
A 
HIV Induced T Cell 
Apoptosis 8 3.80E-04 4.30E+00 
BIOCART
A 
Bystander B Cell 





Antigen Dependent B 


















Table VI-4. Continued 






disease 15 6.80E-03 2.20E+00 
KEGG 
Pathway Type I diabetes mellitus 14 3.20E-02 1.90E+00 
KEGG 
















Pathway 6 1.10E-01 2.20E+00 
BIOCART
A Complement Pathway 7 1.50E-01 1.90E+00 

















Table VI-4. Continued 





Stress Induction of HSP 






5 3.80E-01 1.60E+00 
BIOCART
A 
FAS signaling pathway ( 










A HIV-I Nef 12 5.30E-01 1.10E+00 
KEGG 
Pathway Galactose metabolism 7 9.30E-02 2.20E+00 
KEGG 
Pathway 
Starch and sucrose 






Amino sugar and 
nucleotide sugar 
metabolism 












Table VI-4. Continued 






cardiomyopathy (HCM) 13 2.90E-01 1.30E+00 
KEGG 













10 5.40E-01 1.10E+00 
BIOCARTA 
Apoptotic Signaling in 
Response to DNA 
Damage 
7 2.20E-01 1.70E+00 
BIOCARTA 
Induction of apoptosis 
through DR3 and DR4/5 
Death Receptors 
7 5.80E-01 1.20E+00 

















Table VI-4. Continued 
Cluster Enrich-ment Score Function Database Pathway DEG Count P-Value 
Pathway 
Enrichment 
BIOCARTA Monocyte and its Surface Molecules 4 4.10E-01 1.70E+00 




BIOCARTA Adhesion Molecules on Lymphocyte 3 5.90E-01 1.60E+00 
BIOCARTA Cyclins and Cell Cycle Regulation 7 3.40E-01 1.50E+00 
BIOCARTA Cell Cycle 6 6.20E-01 1.20E+00 
12 0.27 Cell Cycle Regulation 
BIOCARTA 
Influence of Ras and 
Rho proteins on G1 to S 
Transition 
5 7.70E-01 1.00E+00 
BIOCARTA 
cdc25 and chk1 
Regulatory Pathway in 
response to DNA 
damage 
3 4.40E-01 2.10E+00 

















Table VI-4. Continued 









8 3.10E-02 2.40E+00 
BIOCART
A 
Effects of calcineurin in 
Keratinocyte 
Differentiation 




Signaling Pathway 3 4.40E-01 2.10E+00 
BIOCART
A 
Role of EGF Receptor 
Transactivation by 
GPCRs in Cardiac 
Hypertrophy 
5 4.80E-01 1.40E+00 
BIOCART
A BCR Signaling Pathway 7 5.80E-01 1.20E+00 
BIOCART
A 
Fc Epsilon Receptor I 









Signaling Pathway from 












Table VI-4. Continued 







6 8.30E-01 9.00E-01 
BIOCARTA Links between Pyk2 and Map Kinases 5 8.40E-01 8.90E-01 
BIOCARTA 
Angiotensin II mediated 
activation of JNK 
Pathway via Pyk2 
dependent signaling 
5 8.60E-01 8.60E-01 
BIOCARTA TPO Signaling Pathway 4 8.90E-01 8.30E-01 
KEGG 




signaling system 7 9.00E-01 7.80E-01 
BIOCARTA Signaling of Hepatocyte Growth Factor Receptor 5 9.30E-01 7.50E-01 





















Table VI-4. Continued 













Agrin in Postsynaptic 




through IL1R 7 4.20E-01 1.30E+00 
BIOCART
A 

















parasite load on day 5 in the GT1 group was significantly higher than that of the PTG and CTG 
groups. The mean value of the parasite loads in GT1, PTG and CTG were 2.05×107, 4.89×106, 





The purpose of this study was to reveal how the host responds to infection by distinct T. gondii 
strains using the murine model.  Our results showed that the host responses were dynamic and 
different among the three T. gondii strains tested. At the early stage of acute infection (i.e., from 
day 1 through day 3), the number of DEGs in the type I strain GT1 infection was lower than 
those of the type II PTG and type III CTG infections. However, by day 4, all three strain types 
showed a comparable number of DEGs. While DEGs associated with CTG infection then 
reached a plateau, the numbers associated with GT1 and PTG continued to increase on day 5 to 
an approximately equal level, which is maintained by GT1 infection through day 7, while 
dropping to zero for PTG infection at this point. The dynamic changes are more prominent in the 
up-regulated genes (Fig. VI-1B). Due to the lack of data in day 6, it is not clear the number of 
DEGs associated with PTG infection started to decline on day 5 or day 6, but likely peaked 
between day 5 and day 6. For this strain type, it seems that the period of day 5 to day 7 is an 
important window when the host response underwent drastic changes to T. gondii infection. 
These changes may be the consequence of negative feedback of host responses to dampen 
detrimental responses of T. gondii infection. The degree of expression and composition of genes 
affected may play a key role in determining different outcomes of infection with three distinct 
strains.  
 
Though a wide range of functional groups were found to be significantly changed by T. gondii 
infection, immune response is the major groups affected (Figure VI-2). Regarding inflammatory 
and immune response, the number of genes affected follow the same trend for all genes counted 
(Figure VI-1A and Figure VI-2A). However, the majority of genes for inflammatory and 
immune response are up-regulated from day 1 to day 7. GT1 strain infection induced a 
remarkable increase in expression of the inflammation and immune response associated genes 
compared with PTG and CTG strains infection on day 7 (Figure VI-2). Clinically, the mice 
infected with the GT1 strain had a significantly higher parasite load than that of PTG and CTG 
strains on day 5 (Figure VI-6), and the animals started to show severe symptoms of infection on 
day 7, while those infected by the type II or III did not have obvious symptoms of disease. In 
accordance with our previous data (Xiao et al. 2011), many genes such as CCL2, CCL3, CCL4, 
CCL7, CCL8, CCL12, CCL22, CXCL10, CXCL11, Myd88 and TNF, were highly expressed in 
GT1 infection at later stage of acute infection, which may contribute to a lethal inflammatory 
response to this highly virulent strain. Many of the genes of inflammatory and immune response, 
such as Iigp1/Irga6, Irgm1, CXCL10/IP-10, INF-γ, iNOS, CXCL13, CCL2, CCL3, CCL7, 
CCL8, CCL12, CCL22, CXCL11, IL-1b, Myd88, and TNF, showed bimodal responses with the 
first peak expression at day 3 (except Iigp1/Irga6 at day 2), and then a second peak expression 
mostly at day 5. These responses may reflect oscillations which are common in the immune 
system (Stark et al. 2007). In addition to bimodal responses, expression levels of these genes 
vary widely among the infections of the three different T. gondii strains (Figure VI-3), which 
may contribute to different outcome in infected hosts. Of these genes, Iigp1/Irga6, CXCL10/IP-
10, INF-γ and iNOS are known host factors that are important to control T. gondii infection. 
 120 
One of the genes found to be most highly upregulated during infections with all three strain types 
was Iigp1/Irga6, a member of the interferon-inducible immunity-related GTPases (IRG 
proteins/p47 GTPases), which are key factors in murine defense against T. gondii infection 
(Dupont et al. 2012). In INF-γ-stimulated cells, the IRGs have been found to accumulate on T. 
gondii parasitophorous vacuole membranes (PVM) in a stepwise manner, resulting in 
constriction and ultimate disruption of the PVM, followed by parasite clearance. Mus musculus 
expresses at least 19 of these genes, which are clustered on chromosomes 11 and 18. Several 
other members of this class were also found to be highly upregulated in this study, including 
Irgb6, Irgm1 and Igrm3. Irgb6 and Irga6 have been identified as two of the earliest IRGs 
recruited to the PVM, and their presence is also necessary for localization of subsequent IRGs, 
making them highly important to this defense mechanism. Irgm1 and Irgm3 also play a key role 
by associating with host intracellular membranes, specifically those of the lysosomes and the 
Golgi apparatus in the case of Irgm1 and the endoplasmic reticulum in the case of Irgm3, 
protecting them from disruption by the effector IRGs like Irga6 and Irgb6 and thus preventing 
deleterious autoimmune effects. Deletion of either Irgm1 or Irgm3 has previously been shown to 
result in strongly increased susceptibility of mice to T. gondii infection. Parasite defense against 
the IRG immune response involves the virulence factors ROP18 and ROP5, which in Type I 
strains inactivate IRG proteins in a collaborative manner. During infection by virulent T. gondii 
strains including Type I strains such as GT1, the rhoptry kinase ROP18 is secreted into the host 
cytoplasm where, with catalytic activity enabled by interaction with the rhoptry pseudokinase 
ROP5, it phosphorylates IRGs at specific conserved threonine residues, thereby preventing their 
colonization of the PVM. Type III strains such as CTG do not express ROP18 and thus are 
unable to prevent parasite clearance in this manner, while Type II strains such as PTG lack the 
proper allele or alleles of ROP5 needed to enhance the kinase activity of ROP18, and thus are 
also deficient in protecting against clearance (Fleckenstein et al. 2012). In the current 
experiment, both effector and regulatory IRGs showed similar patterns of expression, with 
upregulation occurring early (day 2) in the course of PTG and CTG expression and later (days 3 
through 5) during GT1 infection. Then upregulation was found to diminish to insignificant levels 
between days 5 and 7 in PTG infection while being maintained through day 7 for CTG and GT1 
infections.  
 
In addition to the IRG proteins, Mus musculus also expresses a second family of IFNg-activated 
GTPases known as the p65 guanylate-binding proteins (GBPs), the 11 active genes encoding 
which are clustered in tandem on chromosomes 3 and 5. Loss of the chromosome 3 GBPs has 
been shown to dramatically increase susceptibility of mice to T. gondii. Like the IRGs, GBPs 
also accumulate on the PVM shortly after invasion by T. gondii, an action which is inhibited by 
virulent strains of the parasite. Unlike the IRGs, which cause direct disruption of the PVM, GBPs 
act by recruiting protein complexes to the membrane, such as the inflammosome, autophagy 
apparatus, and NOX2 NADPH oxidase, which have antimicrobial functions. GBPs are also 
blocked from binding to “self” intracellular membranes by IRGM proteins in a similar manner to 
IRGs. Furthermore, ROP18 has recently been found to interact with both murine and human 
GBPs in vitro (Sibley, unpublished). In the current study, the majority of known GBPs from both 
the chromosome 3 and 5 clusters were found to be upregulated during infection with all three 
strain types. It is noteworthy that all of the GBPs clustered on chromosome 5 followed 
essentially the same pattern of expression as was observed for the IRGs, whereas the 
chromosome 3 GBPs were only found to be upregulated starting at day 5 for all strain types, with  
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Figure VI-4. Comparison of microarray and qRT-PCR expression data. Expression levels of five genes as determined by qRT-
PCR (X-axis) plotted against expression levels determined via microarray (Y-axis). Genes include Cxcl13 (triangles), TNF (dashes), 
IL-12B (circles), iNOS (small dashes) and IFNg (squares). Trendline for data is shown (R2=0.7964). 
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Figure VI-5. Parasite load in spleen tissue. Parasites per gram of spleen tissue from days 2-5 post infection of mice with GT1 
(diamonds), PTG (squares) or CTG (triangles) strains, as determined by qPCR
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the exception of Gbp1, a chromosome 3 GBP that followed the chromosome 5 expression pattern 
closely. Thus far, only the contribution of chromosome 3 GBPs to defense against T. gondii 
infection has been assessed experimentally, so that the importance of the chromosome 5 GBPs in 
this regard is not certain. The data presented here would appear to suggest a more central role for 
the chromosome 5-encoded GBPs in the immune response to T. gondii than their chromosome 3 
counterparts, underscoring the necessity of more thorough investigation into this potentially 
important group of proteins.   
 
It is likely that these differential patterns of IRG and GBP expression reflect the varied 
pathogenic strategies of the Type I, II and III lineages. By avoiding the IRG defense system in 
early-infected host cells, Type I strains may be able to replicate more freely within PVs, without 
the strong activation of the inflammatory immune response resulting from the PVM disruption, 
parasite clearance and programmed host cell death associated with the earlier stages of Type II 
and III infections. Thus, it is not until the later stages of acute infection, when host cells are lysed 
by replicating tachyzoites and the parasite burden begins to expand exponentially as subsequent 
rounds of infection occur, that strong activation of the host immune response occurs. IFNg itself 
was not found to be strongly upregulated during the early stages of any infection type, but the 
upregulation of many IFNg-responsive genes suggests functionally significant increases in the 
activity of this cytokine. The reduced upregulation of IRGs and GBPs observed towards the end 
of the experimental period for PTG infections in contrast to CTG and GT1 infections may be 
related to unique mechanisms of host gene regulation employed by Type II strains. For example, 
Type II strains are known to express different alleles of at least two important regulators of host 
transcription, ROP16 and GRA15, which act on the JAK-STAT3/6 and NF-kB pathways, 
respectively, and have been shown to alter the expression of a number of host cytokines during 
infection (Saeij et al. 2006, Rosowski et al. 2011). More investigation into these possible 
mechanisms is of interest.  
 
In summary, using a mouse model and cDNA microarray technology, we found that mice 
infected with type I, II and III strains of T. gondii displayed distinct gene expression profiles. In 
the late stage of acute infection, the differentially expressed genes and affected functional groups 
had a remarkable difference between the type I infection and the type II / III infection, which 
may partly explain the different outcomes after infection with three distinct lineages of T. gondii. 
We also identified several potential target genes that may be critical in regulating the 
inflammatory and immune response to type I and type II infections. These results present an 
overall picture of host responses to three distinct lineages of T. gondii. Future experiments, such 
as using gene-knockout mice, are needed to validate the roles of the candidate regulatory genes 
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Chapter VII. Future directions  
 
 
In this work, we have begun to examine the population genetics of T. gondii with emphasis on 
understanding the role played by mice in shaping the structures of T. gondii populations. Our 
findings should provide a basis for the considerable research that remains to be done in this area, 
and also suggest novel directions for future work in other related areas. The following are a 
number of specific ideas for research projects with potential importance for understanding the 
evolution, pathogenesis and epidemiology of T. gondii.  
 
Determine the extent of correlation between T. gondii type and severity of symptoms in 
human infection. 
 
Data regarding T. gondii genotypes responsible for human infections are very limited at present. 
However, the information that is available shows a disproportionate abundance of atypical 
strains associated with more severe clinical cases. While many atypical strains, particularly from 
South and Central America, have been bioassayed and found to be highly mouse virulent, these 
represent only a small fraction of all isolates. Thus, the mouse virulence of the majority of 
atypical isolates remains unknown. The work described in chapter five of this dissertation 
provides evidence that the ROP5 and ROP18 genotypes can provide a reasonable indication of 
the mouse virulence phenotypes of T. gondii strains, and this data indicates that most of the 
atypical strains associated with human infections are most likely mouse virulent. However, we 
also found that a significant number of strains have virulence phenotypes that are not predicted 
by the ROP5/ROP18 genotype. Thus, in order to more accurately determine the extent to which 
mouse virulence correlates with human disease, it is necessary to perform mouse virulence 
assays on any available human isolates or isolates that share these genotypes. Understanding this 
relationship is of importance in that it would facilitate prediction of the likelihood and potential 
severity of toxoplasmosis outbreaks in human populations, based on T. gondii genotypes 
identified in non-human hosts from the same vicinities.  
 
Development of serological test to distinguish between major T. gondii lineages in human 
infections  
 
The work presented in chapter six of this thesis builds on previous findings that infection with 
the three archetypal lineages of T. gondii results in markedly different host responses in mice. It 
is also well established that different strains of T. gondii express different proteins that are 
secreted into host cells, or varied forms of homologous proteins. Thus, it is likely that infection 
by specific strains of T. gondii would result in the development of particular serum protein 
profiles in infected hosts, and that certain proteins might be useable as targets for distinguishing 
strain types associated with infections using antibody-based serological testing. Indeed, 
preliminary evidence for this has been obtained using 2-D Western blotting of proteins extracted 
from mice infected with each of the archetypal T. gondii lineages. This data indicated the 
presence of several serum proteins unique to specific T. gondii strains. Future work in this area 
should involve expansion of this preliminary work to produce a more robust and reliable set of 
potential targets for serological testing. Of particular interest will be the ROP18 and ROP5 
proteins, as these may also provide information about the potential virulence of the infecting 
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strain. Protein identification should be followed by purification and identification of candidate 
proteins, followed by the production of antibodies specific to them. These antibodies could then 
be tested for efficacy in detection of infection by specific T. gondii strains in mice. Finally, these 
same tests could be applied to serum samples from human patients infected with known strains 
of T. gondii.  If this mouse-developed testing procedure did not prove effective in humans, 
human serum samples could be used as a basis for the development of human-specific tests. If 
successful, the development of such assays would allow for a better understanding of the 
relationship between strain type and human disease symptoms, and would thus also enable the 
early diagnosis of potentially more severe cases of toxoplasmosis, allowing for appropriate 
measures to be taken regarding clinical treatment. 
 
Determine pathogenic mechanisms of T. gondii strains with unexpected mouse virulence 
phenotypes.  
 
As noted in chapter five of this dissertation, while the ROP5/ROP18 genotype is largely 
predictive of mouse virulence, this is not always the case. A number of strains, such as 
CASTELLS, show highly virulent phenotypes despite possessing alleles of ROP5 and/or ROP18 
that are associated with avirulence according to the classical model of T. gondii pathogenesis in 
mice. Conversely, other strains possessed of classically virulent ROP5 and ROP18 alleles display 
avirulent phenotypes, based on previous findings. It is of interest first to determine  whether or 
not the published mouse virulence data is accurate, and if so, to identify the unique molecular 
mechanisms that govern virulence in these strains. This could potentially be achieved using a 
forward genetics approach similar to that used to identify the major virulence determinants of the 
archetypal lineages. In this case, an atypical virulent strain could be crossed with a control 
archetypal strain in a feline host. Offspring  strains could then be assayed for mouse virulence 
and virulence-associated loci could be identified via QTL-mapping. The control strain used for 
the cross would depend on the particular genotype of the atypical strain. For example, if the 
strain possessed an avirulent ROP18 allele, crossing with a Type III strain would be appropriate, 
as no virulent ROP18 alleles would be present in the cross, allowing for identification of other 
virulence-associated loci. Once such loci were identified, the specific gene/s involved and the 
associated mechanisms of action could be investigated using standard molecular reverse genetics 
approaches. Understanding these atypical mechanisms of pathogenesis could aid in the future 
identification of potentially virulent strains, help to develop new drug treatments, and provide 
new insight into selective pressures that have contributed to the evolution of the parasite.  
 
Determine precise mechanisms governing success of reinfection of mice. 
 
The work presented in chapter four of this dissertation indicates a correlation between mouse 
virulence of a T. gondii strain and the strain’s likelihood of being able to successfully reinfect an 
already chronically infected mouse. This could provide an advantage to more virulent strains 
sufficient to promote their expansion within populations in which the domestic life cycle is 
prominent. As this phenomenon may have been and likely continues to be an important factor in 
governing the evolution of T. gondii, it is of interest to understand the mechanism or mechanisms 
by which more mouse virulent strains are able to overcome the protective immunity normally 
conferred by a previous establishment of chronic infection. In order to accomplish this, a detailed 
analysis of reinfection by virulent and avirulent strains needs to be undertaken. This would 
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involve quantification of parasite load, cytokine and antibody production, as well as microarray 
analysis of gene expression by both parasite and host during the initial stage of infection. This 
approach should allow for the identification of specific differences between sequential infection 
by virulent and avirulent strains. This work should also be aimed at identifying the stage of 
infection at which the challenging strain is inhibited, such as host cell invasion, replication, 
egress, cyst formation etc. This could be accomplished using microscopic analysis of tissues 
extracted from naïve or previously infected mice challenged with fluorogenic virulent and 
avirulent T. gondii strains and counting numbers of infected cells, number of parasites per host 
cell and number of cysts at various time points. A better understanding of the mechanisms of 
protective immunity and how it may be overcome by certain parasite strains would enhance our 
knowledge of specific principles underlying parasite fitness and therefore driving parasite 
evolution, and could also potentially allow for the development of vaccines aimed at enhancing 
protective immunity in humans.   
 
Analyze expansion patterns of Type II strains using microsatellite analysis.  
 
Through the extensive genotyping efforts presented in this dissertation, we have a fairly detailed 
picture of the global T. gondii population structure (though of course gaps still exist). However, 
this data provides only limited information regarding the directions in which strain 
expansion/migration has occurred. Elucidation of evolutionary relationships between different 
strain types is difficult due to continued recombination, but it should be more feasible to conduct 
experiments aimed at inferring relationships between different populations of the same strain 
type. As noted, the Type II archetypal lineage is the most abundant strain type worldwide, and is 
the most frequently identified genotype in Europe, the Middle East, and North America. While 
PCR-RFLP analysis is only capable of distinguishing between two variants of the Type II 
lineage, a higher resolution technique could allow subsets of this line to be further differentiated. 
Microsatellite analysis seems to be the technique best suited for this particular task, as 
microsatellite DNA repeats are highly variable and thus provides high resolution analysis of 
genetic differences between strains. Furthermore, the technique is relatively simple and rapid, 
and therefore suitable for high throughput analysis of genomic DNA samples from large 
numbers of isolates at low cost, comparable to PCR-RFLP. This is in contrast to other potential 
high resolution genotyping techniques such as intron sequencing, which would be quite costly 
when large sample numbers are involved. By analyzing multiple microsatellite loci for length 
polymorphisms from Type II (as determined by PCR-RFLP analysis) strains isolated from 
different geographic regions, it should be possible to ascertain the relative ages of these 
populations. For example, it seems likely that the Type II population of North America is a result 
of European migration to the Americas. Thus, we would hypothesize that the European 
population of Type II strains would be older and therefore more polymorphic with regard to 
microsatellite repeat number. This technique could be applied to Type III and other prominent 
strains as well, and to other geographic regions with somewhat clonal population structures. It 
would presumably be less effective with regard to strains from South and Central American 
populations, where it appears that much more sexual recombination has occurred, thus blurring 
evolutionary relationships between genotypes and separate populations of single genotypes. This 
work would be valuable in understanding the historical pathways of T. gondii expansion, giving 
us insight into the evolution of the parasite and the impact of human global migration on T. 
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Appendix A. Expanded PCR-RFLP genotyping reveals new diversity among 





Toxoplasma gondii is among the most widespread eukaryotic parasites known. It chronically 
infects approximately one third of the world’s human population and has been isolated from an 
extremely diverse array of mammals and birds from every continent besides Antarctica (Dubey 
et al. 2010). Understanding the structure of the worldwide T. gondii population enhances our 
understanding of the factors that have shaped that structure and led to the proliferation of one of 
the most evolutionarily successful pathogens on Earth. To this end, numerous studies have been 
performed in which various aspects of T. gondii population genetics have been analyzed using a 
variety of methods. Genotyping of T. gondii isolates has been carried out using intron 
sequencing, microsatellite DNA analysis, and PCR-RFLP analysis of single-nucleotide 
polymorphisms (SNPs).  Of these, PCR-RFLP has been the most widely used. Though intron 
sequencing has the advantage of distinguishing strains at higher resolution than PCR-RFLP, the 
latter technique has the advantage of being less expensive and time-consuming to carry out. It 
can also be performed in any laboratory in the world equipped with basic molecular biology 
tools, and does not require access to a sequencing facility. Furthermore, despite providing higher 
resolution at particular loci, intron sequencing generally does not allow for broad coverage of the 
genome being examined unless many introns are sequenced, which is likely to become 
prohibitively costly and time-consuming, particularly for large sample sets. Thus, genotyping 
information is often limited to a localized portion of the genome. Furthermore, unlike both 
microsatellite and intron sequence analysis, both of which formulate genotypes based on largely 
nonfunctional DNA, PCR-RFLP allows for the analysis of more biologically relevant loci, such 
as surface antigen and virulence genes. It is perhaps for these reasons that most of the genotyping 
work thus completed has used the PCR-RFLP method.  
 
The use of a standardized method for genotyping is highly desirable because it allows for the 
collation of data between separate studies so that broader patterns of diversity may be examined. 
To this end, we recently compiled all of the PCR-RFLP genotype data that had been published as 
of the end of 2012 using a widely-employed set of ten genetic markers, which included a total of 
1,475 isolates comprising 189 distinct genotypes. These isolates were collected from all 
continents with the exception of Antarctica, and from a variety of animal species, both wild and 
domestic. Our analysis revealed distinct population structures for each major geographic region 
examined, with striking contrast between the highly diverse, endemic structure of the 
South/Central American region and the more clonal populations found in all other areas, wherein 
only a few dominant genotypes account for the overwhelming majority of isolates. The data 
obtained using this approach have given us the most complete picture to date of the global T. 
gondii population structure. However, this technique has shortcomings in that several 
chromosomes are not represented by the ten genetic markers employed, while most of the 
chromosomes that are included are only represented by a single locus, precluding analysis of 
chromosomal recombination. Furthermore, the standard markers used were originally designed 
to differentiate the 3 archetypeal T. gondii lineages, and thus may generate some degree of bias 
towards classifying strains according to this clonal population structure model. In order to better 
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understand the global diversity of T. gondii we have developed 9 additional  novel PCR-RFLP 
markers (12 including ROP5, 16 and 18, see Chapter IV) designed to differentiate strains in a 
manner independent of the archetypal lineages which, combined with the ten standard markers, 
provide representation of all 14 nuclear T. gondii chromosomes and the apicoplast chromosome, 
with at least two loci examined on chromosomes of over 40kDa in length, potentially allowing 
for analysis of chromosomal recombination. These additional PCR-RFLP markers provide an 
analysis of the worldwide T. gondii population structure that is both comprehensive in 
geographical scope and also of higher resolution than previous RFLP-based studies.  
 
 
Materials and methods 
 
PCR-RFLP Protocols  
PCR-RFLP protocols were designed for 12 genetic loci based on sequence data from 44 strains 
of T. gondii. Loci included Ia-P89, AK2, II-C35, BSR4, AK126, SRS4, UPRT-1, ROP1, MIC5, 
ROP16, ROP18 and ROP5. Polymorphic sites were identified for each locus and restrictions 
enzymes were selected to differentially digest PCR amplified DNA. External and internal 
primers and restriction enzymes for each locus are presented in Table A-1.  All DNA samples 
from T. gondii isolates were amplified in 96-well PCR plates via multiplex PCR using all 
external primers simultaneously according to Su et al. (2010). Amplification for multiplex PCR 
used FastStart DNA Polymerase (Roche). The thermocyler program was as follows: 4 minutes at 
95C, 30 cycles of 30 seconds at 95C, 1 minute at 55C, and 2 minutes at 74C. This was followed 
by nested PCR amplification using PAQ5000 DNA polymerase (Stratagene) with individual 
marker primers and a thermocycler program of 4 minutes at 95C, 35 cycles of 30 seconds at 95C, 
1 minute at 58C, and two minutes at 72C. Restriction enzyme digestions were carried out using 
PCR amplified DNA in 96-well plates. Digested products were separated via electrophoresis in 
2.5% agarose gels stained with ethidium bromide and visualized under UV light. Each gel 
contained a set of standard T. gondii reference strains including GT1, PTG, CTG. MAS, COUG, 
TgCtBr5, TgCtBr64 and TOUCAN which aided in genotype identification. Each plate also 
contained multiple no-template negative-controls.  
 
T. gondii isolate DNA 
DNA samples were provided by numerous laboratories from around the world. Specific 
information regarding isolate origins is provided in Shwab et al. (2014). Genomic DNA stocks 
were stored at -20C prior to analysis.  
 
Network Analysis  
Allelic data from multilocus analysis of PCR-RFLP markers were used to generate a network of 
T. gondii strain polymorphisms from 330 samples. Multilocus PCR-RFLP typing data were 
coded for all genetic loci. For a given locus, presence or absence of DNA restriction fragments 
was coded as either 1 or 0, respectively. SplitsTree v4.4 was used to generate an unrooted 




Table A-1. External and internal primers and restriction enzymes for PCR-RFLP markers 
Marker External Primers (5' to 3') Internal Primers (5' to 3') Restriction Enzymes 
Ia-P89 Ia-P89-Fext: TCAAACACCGAGTCGTCATC           




AK2 AK2-Fext: GGCCGAAGTGAAGCATAAAC           
AK2-R-extTAAAAGTGCAGAGCGGACAA  
AK2F-int: CATGGCTTCGAGAACACTCA                 
AK2R-int: CGTCTGCTGGAATGCCAAG 
NheI+BcoDI 
II-C35 II-C35-Fext: CGCCGAAAGGACATATGAGT          
II-C35-Rext: AACGATTTGGAAAGGTGTGC   
II-C35-Fint: TTCATTCCCGAGTTCCTGAC              
II-C35-Rint: GACACGCGCTACAAATCTGA 
Fnu4HI+HpyCH4III 
BSR4 BSR4-Fext: CAGTTGTTGGCAGTTTGCAT      
BSR4-Rext: GCGTAGCTGAAGTCCGTTTC    
BSR4-Fint: CAAGGCTAACCGTAGCGGGT                                 
BSR4-Rint: CTCTTCAGGAACTTGGGGAA 
Hpy188I+RsaI 
AK126 AK126-Fext: ACAAGGGCACAGCAACAT              
AK126-Rext: AACAATCGGCAAAGGTAG 
AK126-Fint: CATGGCACGAGCTGCGGTAC            
AK126-Rint: GTTGTCATCGGTCAGTCG 
Tsp509I 
SRS4 SRS4-Fext:  CGAGACCTTCTTTCGTTG                
SRS4-Rext:  CAGGAGGCAGGATGATGT 
SRS4-Fint: CGGCAAGGAAAGCAACCC                 
SRS4-Rint: CTTCAAGCCCACCGTGTT 
BbsI+MslI 
UPRT1 UPRT1extF: TCCACAGGGCTTCTAAAAT      




ROP1 ROP1-Fext: GCATTCCAGGCAGTCTTAGG     
ROP1-Rext: CATCCTCTGGAAGCTCTTGG   
ROP1-Fint: CGTGACATATACTGCACTG                 
ROP1-Rint: CATCGTGAAACGTGTCATC 
TspRI+MspA1I 
MIC5 MIC5-Fext: ACAGCGAAGGAACTTCGAGA             
MIC5-Rext: GTTTGCGTGCTTGCTACAGA   
MIC5-Fint: GCGGTGGTCAGATTCCTCTA                                 
MIC5-Rint: GCCCAGTGTCGATAGCAAAT 
NlaIII+HaeIII 
ROP16 ROP16F-ext: ATCTGCTTATCCGGCGACTA 
ROP16R-ext: TCCGTTGGCATTTATCATCA 
ROP16F-int: TACCAAACCCAGCTTTCACC             
ROP16R-int: TCGTCAACAGCTGACTCCAC 
NlaIII+TaqaI 
ROP18 ROP18-DelFext: CTCGTCGACCACACAGCTAA  
ROP18-UPSRext: GAGTGCTTTCTGTCGCTCCT   
ROP18-DelFint: AGTTCCCTTCCCTGGTGTCT  













Identification of genotypes at novel PCR-RFLP loci 
 
PCR-RFLP protocols were developed in order to identify SNPs present at 12 genetic loci not 
previously analyzed using this technique. Figure A-1 shows the locations of these markers 
throughout the 14 nuclear chromosomes and apicoplast chromosome of T. gondii. Figure A-2 
depicts the RFLP patterns at each of these loci for a set of eight diverse reference strains 
representing a number of major distinct phylogenetic clusters of T. gondii isolates identified 
previously (Su et al. 2010). These reference strains include GT1 (archetypal Type I), PTG 
(archetypal Type II), CTG (archetypal Type III), MAS, COUG (TgCgCa1), TgCatBr5, 
TgCatBr64 and TOUC (TgRsCr1). Precise phylogenetic relationships between these strains are 
illustrated in the network analysis presented in Figure A-3, discussed below. These reference 
strains capture the majority of the genetic diversity identified at each locus, however in some 
instances additional alleles were identified that were not present in any of these reference strains. 
Two alleles were identified for the AK126 and ROP1 markers. Three alleles were identified for 
the Ia-P89, AK2, SRS4 and ROP16 markers. Four alleles were identified for ROP18. Five alleles 
were identified for the UPRT-1, BSR4 and MIC5 markers. Seven alleles were identified for II-
C35, and eight separate alleles were identified for ROP5.  In some cases, alleles were very rare 
and were limited to a few or even only a single strain out of the 330 analyzed.  
 
Genotyping of T. gondii isolates at 12 novel loci  
 
A total of 330 strains were successfully genotyped using the developed methodology for the 12 
markers described. When combined with the genotypic data for the 10 standard loci as described 
in Su et. al (2010), this new genotypic data revealed 183 distinct genotypes, compared to only 
142 genotypes from the same set of isolates using the 10 standard markers alone. Table E-3 
(Appendix E) shows the complete genotypic data at all 22 loci for each isolate. New diversity 
was identified among several genotypes that are dominant within major geographic regions. 
Genotypes #4 and #5, dominant in North America, were divided into three and two subtypes, 
respectively, genotype #6, dominant in South America, was divided into three subtypes, and 
genotype #20, identified frequently on the Indian subcontinent and the Middle East, was divided 
into three subtypes. Interestingly, genotype #9, she most commonly identified type from China 
and southeast Asia (sometimes referred to as Chinese I) was found to segregate into two 
subtypes, differing only at the ROP18 locus among the loci examined. One subtype, designated 
4a in Table A-1, possesses ROP18 genotype #2, which includes the  archetypal Type II allele, 
associated in previously published studies with a mouse-virulent phenotype, while the second 
subtype, 4b, possesses ROP18 genotype #3, associated with the avirulent Type III form of the 
gene. 
 
Comparison of network analyses for a subset of 140 strains representing major phylogenetic 
groups identified previously (REF) using the set of 10 markers from Su et al. (2010) (Figure A-
3A) and the full set of those markers combined with the 12 presented here (Figure A-3B) 
revealed marked rearrangement of the majority of these groups, with the notable exception of the 
archetypal Type II-related clade (indicated in green), which remained relatively conserved 
regardless of the marker set used for analysis. Network analysis of all 330 strains genotyped in 
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this study revealed distinct phylogenetic clusters formed by the 183 genotypes identified, as 
shown in Figure A-3C. Nine clusters are delineated in this figure, including strains closely 
associated with the archetypal Types I, II and III (clusters 1,2 and 3, respectively), along with 
several clusters of strains loosely related to Type I and primarily isolated from South America, 
including clusters 4, 5 and 9, the latter of which includes a subcluster including highly mouse-
virulent strains identified in Guiana (GUY-MAT, GUY-DOS, GUY-BAS1, GUY-KOE, RUB 
and VAND, Carme et al. 2003). Clusters 7 and 8, located between archetypal Types II and III, 
are less highly resolved from one another phylogenetically which may be an indication of more 





The nature of parasitic relationships generally necessitates a highly nuanced and specific co-
evolution between host and  symbiont. This is especially true in the case of pathogens that have 
developed the ability to produce chronic infections, usually through a selective process wherein 
virulence of the pathogen is modulated by evolution of both parasite pathogenicity factors and 
the host immune response until an equilibrium is achieved such that the parasite is able to 
survive indefinitely within the host without being eradicated and without attenuating the fitness 
of the host to an extent significant enough to impose selective pressure towards stronger anti-
parasite defense mechanisms. In such instances, it is unsurprising that particular pathogens have 
a pronounced tendency to develop a high level of specificity for a particular type of host. It is in 
this light that the case of T. gondii may be viewed as particularly remarkable. Among the 
pathogens of eukaryotic organisms, T. gondii is perhaps the most versatile and ubiquitous. 
Unlike other members of its protozoan phylum, including the malarial Plasmodium species, each 
of which are known to infect only a very limited range of host species, T. gondii has been 
identified in the tissues of myriad animal hosts from both the mammalian and avian classes, 
findings which collectively suggest the ability of the parasite to utilize any endothermic 
organism as a viable host. Moreover, T. gondii has been found to  be capable of infecting a wide 
variety of cell types, including muscular, neuronal, epidermal and lymphocytic cells from 
numerous host species - all cell types yet examined, in fact - further underscoring the pathogenic 
versatility of the protozoan. Even its closest known relative, Hammondia hammondi, though 
quite similar  
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Figure A-1. Chromosomal positions of new and standard PCR-RFLP markers. Approximate positions of PCR-RFLP markers 
among the 14 nuclear T. gondii chromosomes and the apicpolast chromosome (APICO marker). Chromosome numbers are identified 
by roman numerals. Numbers to the left of each chromosome represent genetic distances in centimorgans. Names of new markers are 
enclosed in boxes while standard markers are not. Adapted from Khan et al. Nucleic Acids Res. 2005 May 23;33(9):2980-92.  
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Figure A-2. Reference strain RFLP patterns for 12 PCR-RFLP markers. Restriction fragments of reference strains GT1, PTG, 
CTG, MAS, COUG, TgCatBr5, TgCatBr64 and TOUCAN for the 12 described PCR-RFLP markers using primers and restriction 
enzymes as given in Table 1. Strain IDs are presented above each column of gels and identified genotypes are indicated below each 
























Figure A-3. Network analysis of strains using standard and expanded PCR-RFLP marker sets. Neighbor-joining networks were 
generated for strain sets using Splitstree v.2.2. (a) Network of 140 T. gondii strains representing known major clades using the 10 
PCR-RFLP markers described in Su et al. (2010). Strain IDs are color coded by association with major clades. Reference strains are 
enclosed in boxes. Archetypal I, II and III clades are indicated. (B) Network of the same set of 140 strains from panel B using the 12 
PCR-RFLP markers described in the current study in addition to those of Su et al. (2010). Color coding is the same as in panel B and 
reference strains are similarly indicated. (C) Network of 330 strains using the total marker set from Su et al. (2010) and the current 
study. Archetypal Type I, II and III clades are indicated via color coding (red, green and blue, respectively) and reference strains are 
















Figure A-3 continued 
 165 
 





genetically to T. gondii, is much more restricted in host range. The difference here between T. 
gondii and other apicompexans such as H. Hammondi appears to lie not in its ability to infect 
multiple cell types, but in its ability to progress to subsequent infection events within these cell 
types and thus to proliferate indefinitely. However, the true key to the evolutionary success of T. 
gondii is likely a novel and relatively recent adaptation wherein the parasite is able to be orally 
transmitted between secondary hosts via carnivory. Prior to the advent of transmission between 
secondary hosts, the life cycle of the ancestral apicomplexan would necessarily have included the 
feline definitive host (as in the case of H. hammondi and its canine host), since transmission of 
the parasite from an infected secondary host could only occur through ingestion by this definitive 
host. Thus, infection of secondary hosts other than those preyed upon by felids would have 
represented a propagational dead end. Acquiring the possibility of transmission between 
secondary hosts opened an entirely new and separate life cycle to T. gondii which did not require 
any interaction with feline hosts, and this event combined with the extremely broad host range of 
the parasite thus allowed for asexual proliferation across virtually any food web involving 
endotherms.  This in turn paved the way for clonal expansion of the parasite on a massive scale, 
likely facilitated by its introduction into remote areas of the globe by human interaction. 
Numerous factors have thus contributed to the complex patterns of expansion of T. gondii that 
have shaped the unique global population structure of the parasite as it currently exists. 
 
Combined with the 10 standard markers published in Su et al. (2010), the markers developed for 
this study provide representation of each of the 14  T. gondii nuclear chromosomes as well as the 
apicoplast chromosome, resulting in a simple and inexpensive method for generating relatively 
high resolution genotypic data. The currently presented set of markers also has the benefit of 
being designed to distinguish alleles identified from sequence data derived from a set of strains 
representing a diverse array of genotypes rather than being designed to distinguish the three 
archetypal lineages, so that a greater degree of accuracy in determining phylogenetic 
relationships between strains is expected using these markers in combination with the 10 markers 
presented in Su et al. (2010). When comparison is made between network analyses of the strains 
analyzed in this study using the ten markers from Su et al. (2010) and using the combined set of 
22 markers described here, we see marked rearrangement of the positioning of the majority of 
strains. The notable exception to this is in the Type II-related clade, which remains largely 
unchanged with the addition of the expanded marker set. This suggests a lesser degree of 
recombination between strains in this and other phylogenetic groups than among the other 
clades. This is consistent with the hypothesis that parasite expansion has been primarily clonal in 
regions where Type II-related strains are dominant, including much of the northern hemisphere. 
Interestingly, the dominant Asian strain type, ToxoDB genotype #9 (Chinese I) was in this study 
separated into two subtypes, differing only at the ROP18 locus (Table S1). Subtype #9a 
possesses ROP18 genotype 2, associate with the virulent Type II allele,  while subtype #9b 
possesses ROP18 genotype 3, associated with the avirulent Type III allele. It has been previously 
noted that genotype #9 strains include both virulent and avirulent forms (Li et al. 2014), and the 
identification here of two subgroups differing at the ROP18 locus seems likely to be relevant to 
this observation.  
 
Though it is clear from the data presented here and elsewhere that the South American T. gondii 
population differs dramatically in structure from elsewhere in the world, the reasons for this 
discrepancy are not well understood. It may be considered that the high degree of strain 
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variability found in South America provides evidence that the parasite originated in this region, 
and thus has resided there longer than in other regions of the world and has therefore had more 
time to evolve a diversity of forms. By contrast, T. gondii populations found on other continents 
would likely then be the result of  more recent founding events, seeded by limited numbers of 
strains carried either by wild migratory animals, or by intercontinental transport of domesticated 
host animals by humans. This scenario would thus explain the reduced diversity observed outside 
of South and Central America. Additionally, it is possible that the inordinately high host species 
diversity found in the tropical regions of South and Central America has also promoted the 
diversification of parasite strains exposed to varying selective pressures within different host 
organisms. Genotyping information from other geographic regions with high species diversity, 
such as the tropical rainforests of Africa and southeast Asia, could provide valuable insight as to 
the influence of host species variability on the T. gondii population structure. However, such data 
is unfortunately quite scarce. The tools presented here should prove useful in future studies 
aimed at better understanding the diversity that exists within the global T. gondii population and 






























Appendix B. Altered gene expression correlates with dramatically increased 





The pathogenesis of T. gondii may vary widely in response to myriad factors relating to the 
parasite, the host and the environment. In the case of human infections, T. gondii typically 
persists indefinitely and asymptomatically in the muscle and brain tissues of the host (Dubey 
2010). In addition to chronic infections, acute T. gondii infections may also occur in some human 
patients, frequently manifesting as ocular toxoplasmosis or encephalitis which can in the worst 
cases result in blindness and death, respectively (Dubey 2010, Holland 2003). Such cases are 
most commonly observed in persons with compromised immune systems, such as those suffering 
from AIDS or in cases of congenital infection. It is also possible for severe acquired infection to 
occur in immunocompetent adults, however, including both systemic and ocular toxoplasmosis 
(Darde et al. 1998, Grigg et al. 2001). The factors that contribute to the manifestation of such a 
condition, whether related to the genetic background of the host or the parasite or to some 
external factor, are not well understood.  
 
Variations in disease presentation are also observed within other host species. Mice in particular 
have been studied extensively as a model host for T. gondii. In general, mice have increased 
susceptibility to the parasite compared to other host species, and may be killed by low doses of 
strains that would only result in asymptomatic chronic infections in more resistant hosts such as 
rats (Dubey 2010).  Large differences in pathogenesis have also been observed in mice in 
response to variations in both parasite strain type and mouse lineage, indicating the importance 
of both host and parasite genetic background in determining disease severity (Williams et al. 
1978, Sibley and Boothroyd 1992, Khan et al. 2009). Research has shown that the host immune 
response plays an important role in controlling both acute and chronic infection of T. gondii. 
Numerous studies in mice have indicated the importance of cytokines, such IL-12, TNF-α, IFN-
γ, and production of reactive nitric oxide radicals (via iNOS) as mediators of host resistance to T. 
gondii infection (Gazinelli et al. 1993, Hunter et al. 1994, Reichmann et al. 2000). IFN-γ is 
secreted initially by natural killer (NK) cells and subsequently by CD4+ and CD8+ T cells. It is 
the major effector mechanism that controls both the acute stage of T. gondii replication and the 
reactivation of chronic stage tissue cysts (Dupont et al. 2014). IFN-γ mediated resistance is 
achieved in part by activating macrophages which produce antimicrobial nitric oxide (NO) and 
activate immunity-related GTPases (IRGs) (Reichmann et al. 2000, Howard et al. 2011).  IL-12, 
produced primarily by dendritic cells (DCs), is the most important cytokine in inducing and 
maintaining production of IFN-γ in T cells, and neutralization of endogenously produced IL-12 
with monoclonal antibodies has been demonstrated to significantly increase the mortality of mice 
(Liu et al. 2006). However, if dysregulated, the above mentioned mediators may also cause Th1-
mediated immunopathology, leading to mortality (Liesenfeld et al. 1996, Egan et al. 2011). IL-
10 has been shown to be the dominant immunoregulatory mechanism preventing Th1-mediated 
immunopathology (Gazzinelli et al. 1996). Th17 cells may also have a potential pathogenic role 
in CNS inflammation during T. gondii encephalitis and this pathogenic effect can be suppressed 
by IL-27, suggesting IL-27 can complement the immunoregulatory effect of IL-10 during T. 
gondii infection (Stumhofer et al. 2006). The balance of immune responses by IL-12, TNF-α, 
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IFN-γ, and iNOS and counter-inflammatory regulation of IL-10 and IL-27 is important to the 
resistance and pathogenesis of T. gondii infection (Dupont et al. 2012). However, at present there 
is a lack of understanding relating to hierarchical networks and immune pathways that regulate 
the host immune response to T. gondii. Identification of host genes that influence disease severity 
in response to T. gondii is essential for predicting disease outcome and identifying personalized 
treatment strategies.    
 
In this study, we have compared the host response to T. gondii infection between two lines of 
inbred mice. C57BL/6 mice (C6) mice have been previously demonstrated to be more 
susceptible to T. gondii infection than DBA/2 (D2) mice, though the reasons for this variation 
have not been adequately explored (McLeod et al. 1989, Fux et al. 2003). In order to elucidate 
the genetic basis for the observed differences in susceptibility of the two lines, we have analyzed 
the gene expression profiles of mice in response to infection and identified differential 
expression of a relatively small number of immunity-related loci despite observing a high 
discrepancy between the two mouse lines with regards to rate of disease progression, parasite 
load and overall mortality. These data indicate that altered regulation of a limited number of host 
genes may be responsible for large differences in the outcome of toxoplasmosis in mice. Such 
information raises the possibility that subtle genetic or epigenetic differences may also have a 
significant impact on disease progression in human hosts.  
 
 
Materials and Methods 
 
Strain maintenance and inoculum preparation 
 
A Stock of tachyzoites of the archetypal Type II strain TgMe49 (ME49, Howe and Sibley 1995) 
preserved in liquid nitrogen in a solution of 50% D10 medium (DMEM supplemented with 
glucose, L-glutamine, and sodium pyruvate with defined fetal bovine serum, non-essential amino 
acids, HEPES and 10 mM gentamicin) / 50% glycerol were added to 25 mL cell culture flasks 
containing human foreskin fibroblast (HFF) cells in D10 medium and incubated in a 37.1 C/ 5% 
CO2 environment and subsequently transferred to new HFF cell culture flasks as necessary until 
the culture had reached a two day rate of passage. To prepare the parasites for mouse infection, 
tachyzoites and cell culture medium were transferred to centrifuge tubes and centrifuged at low 
speed to pellet, followed by removal of the supernatant and resuspension of the pellet in 
phosphate-buffered saline (PBS), followed by two additional rounds of centrifugation and 
resuspension to remove excess cellular debris. Concentrations of suspended tachyzoites were 
then determined via hemocytometer counting.  
 
 Establishment of chronic infections in mice for use as inoculum sources, and inoculation of two 
inbred mice lines for examination of host response to T. gondii infection 
 
Concentration of ME49 tachyzoites was adjusted via dilution with PBS to approximately 1 
cell/uL. 200 uL of each strain suspension were then used to infect one six-week-old CD1 outbred 
mouse via intraperitoneal (IP) injection with a 1 mL syringe and 25-gauge needle. Thus, the 
mouse was inoculated with an estimated 200 tachyzoites of ME49. Four weeks post-inoculation, 
the mouse was terminated via cervical dislocation following isoflurane-induced loss of 
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consciousness.  Brain tissue was then extracted from the mouse and homogenized via addition of 
2 mL sterile PBS followed by serial passage through increasingly smaller-gauged syringe 
needles. Homogenate was examined for tissue cysts via microscopy. 10 uL of the homogenate 
were added to microscope slides in triplicate, and the number of visible tissue cysts on each slide 
was counted to estimate cyst concentrations. Cyst concentration was then adjusted to 5 cysts/200 
uL via dilution in PBS and then used to infect new mice via oral gavage.  5 cysts of ME49 were 
administered to ten three-month-old C57BL/6 inbred mice, as well as eight three-month-old 
DBA/2 inbred mice. Three mice from each inbred line were terminated three days post-infection 
and spleen, ileum and mesenteric lymph nodes were extracted from each. The remaining mice 
were monitored for four weeks’ time (28 days post-infection). After this time period, surviving 
mice were terminated and brain and spleen tissues were extracted. Mice that displayed severe 
disease symptoms were euthanized prior to the end of the 28-day period and their brain and 
spleen tissues were also extracted.  
 
Parasite DNA extraction from infected spleen tissue and determination of parasite load in 
infected spleen tissue 
 
Parasite load in mouse spleen tissue was determined as described previously (Hill et al. 2012) 
with modifications. Briefly, 100 µl of homogenized spleen tissue at a concentration of 0.1 g/ml 
in PBS was diluted with 100 µl of PBS, then 50 µl of 10 mg/ml proteinase K was added, and the 
mixture was incubated at 55°C for 2 h. DNA was extracted using a Qiagen DNeasy Blood and 
Tissue Kit (catalog number 69504; Qiagen, Valencia, CA). For qPCR standard controls, the 
spleen of an uninfected mouse was homogenized and diluted in PBS, and T. gondii tachyzoites 
were spiked into the homogenized spleen to make a series of concentrations of 1×107 to 1×103 
tachyzoites/ml. All homogenized spleen samples were adjusted to a volume of 0.1 g/ml in PBS, 
and genomic DNA was purified using the same procedure as detailed above. The concentration 
of parasites in mouse spleen was estimated by qPCR using a TaqMan probe targeting the ITS1 
sequence (GenBank accession number AY143141). The primers for PCR amplification were 
ITS1-Fx (GAAGGGGCTCAATTTCTGG) and ITS1-Rx 
(TGTTCCTCAGATTTGTTGTTTGA), which amplify a 117-bp sequence. The ITS1 probe was 
5’-5-FAM-CGTGTCTCTGTTGGGATACTGATTTCCAGG- BHQ-1-3’, with the 5’ end labeled 
with 6-carboxyfluorescein (FAM) and the 3’ end labeled with Black Hole Quencher-1(BHQ-1) 
(Integrated DNA Technologies, Inc., Coralville, IA). The qPCR mixture had a total volume of 25 
µl containing 10.9 µl of H2O, 12.5 µl of 2×TaqMan Fast Advanced Master Mix(catalog number 
4444964; Applied Biosystems, Foster City, CA), 0.15 µl of 50 µM ITS1-Fx and ITS1-Rx 
primers, 0.3 µl of 50 µM ITS1 probe, and 1 µl of purified DNA. The reaction was carried out 
using the iCycler thermal cycler (iQ5, Bio-Rad Laboratories, Inc. Hercules, CA) under the 
following conditions: 94°C for 10 min, followed by 40 cycles of 95°C for 15 sec, 60°C for 60 
sec. The CT value of each sample was compared to values of the standard controls to estimate 
the concentration of parasite per gram of spleen.  
 
Microarray analysis of transcriptomes of infected C57BL/6 and DBA/2 mice 
 
Microarray analysis was performed by the method described previously (Hill et al. 2012). In 
brief, total RNA from peritoneal cells was extracted using Qiagen RNeasy Plus Mini Kit (catalog 
#74131; Qiagen,Valencia, CA) following the manufacturer’s instructions. The quality of RNA 
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was tested by agarose gel electrophoresis, and the concentration of RNA was determined by 
reading the absorbance at 260/280 nm. Affymetrix Mouse Exon 1.0 ST array containing 35,556 
transcripts was used. RNA samples were processed according to the Affymetrix protocol for one-
cycle DNA synthesis using a Message Amp II-Biotin Enhanced Kit (P/N AM1791; Ambion, 
Austin, TX). Five micrograms of fragmented cRNA was hybridized to the Affymetrix GeneChip. 
Arrays were processed using the Affymetrix Hyb/Stain kit PN900720. Arrays were immediately 
scanned using the Affymetrix 7G scanner. Array images were visually inspected for anomalies. 
The individual chip scans were quality checked for the presence of control genes and background 






 Disease symptoms and mortality of orally-infected mice 
 
C57BL/6 mice died more rapidly than DBA/2 following oral infection with 5 tissue cysts of T. 
gondii (Figure B-1), with mortality beginning on day 12 post-infection and ending with 
termination of the seventh and final mouse on day 17. By contrast, no mortality was observed 
among DBA/2 mice until day 14. Furthermore, all 7 infected C57BL/6 mice succumbed to 
disease, whereas only 1 out of 5 DBA/2 mice died before the end of the 28-day course of the 
experiment. Symptoms also appeared earlier in C57BL/6 mice than in DBA/2 mice. This 
discrepancy in disease severity between the two mouse lineages also correlated with  differences 
in parasite load (Figure B-2). Three days post-inoculation, parasite DNA concentration was an 
average of 120 times higher in spleen tissue from infected C57BL/6 mice compared with DBA/2 
mice, suggesting that the differences in mortality rate between the two host lines may be due to 
increased ability of the parasite to proliferate in the more susceptible strain.  
 
Microarray analysis of gene expression in spleen tissue from infected C57BL/6 and DBA/2 mice.  
 
Microarray-based comparison of total mRNA from spleen tissue of infected C57BL/6 and 
DBA/2 mice was used to analyze 35,556 genes and indicated 523 transcripts that varied in 
expression level between the two mouse lineages by a factor of 2 or greater, 306 of which were 
upregulated  and 217 of which were downregulated in DBA/2 mice compared to BL/6 mice. 
Table B-1 indicates 14 genes with the highest degree of differential regulation. These genes 
include several members of the serpin class of protease inhibitors, a lectin-like receptor 
expressed by natural killer cells (Klrd1), and a number of genes of unknown function. The 
largest variation in gene expression between the two mouse lines involved H2-Ea, a gene of the 
H-2 class II major histocompatibility complex (MHC) family of genes, which had approximately 
225-fold higher expression in DBA/2 mice than in C57BL/6 mice. A heat map of overall gene 
























Figure B-2. Parasite load in infected spleen tissue of C57BL/6 and DBA/2 mice. The log 
parasites/g of spleen for BL2 mice was 7.21± 0.39, 120 times higher than that in DBA/2 mice 
































In this study, we have compared gene expression profiles of two mouse lineages undergoing 
acute infection with T. gondii. C57BL/6 mice were found to succumb to T. gondii infection at a 
much higher rate and to have much higher parasite loads in spleen tissue than the more resistant 
DBA/2 mice. Despite these markedly different responses to infection with regard to rapidity and 
severity of symptom presentation, parasite load and mortality, the expression of only a small 
number of genes was found to differ by a factor of two or more between the two lines. This 
suggests that altered transcription of small numbers of key genes, rather than more sweeping, 
genome-wide changes in expression profiles, may be responsible for the dramatic variance in 
resistance to T. gondii observed among mouse lineages.  
 
The genes found to exhibit the highest degree of altered expression include several members of 
the highly diverse serpin class of protease inhibitors. Specifically, SerpinA1A, SerpinA1B and 
SerpinA1E are downregulated in C57BL/6 mice compared to DBA/2 mice. Of these, Serpins 
A1A and A1B are known to inhibit neutrophil elastase, involved in the inflammatory response of 
neutrophils and macrophages in humans and mice (Belaaouaj et al. 2000, Shapiro et al. 2003). 
SerpinA1A is essential for murine embryonic development despite the presence of the highly 
similar A1B paralog in mice (Wang et al. 2011). In humans, inactivation of the SerpinA1 
ortholog does not result in embryonic lethality, but is the major genetic contributor to chronic 
pulmonary disease/emphysema (Wang et al. 2011). As a group the murine alpha 1 protease 
inhibitors, clustered on chromosome 12, have an unusually high rate of nonsynonymous 
mutations, particularly in surface exposed residues, suggesting diversifying selection which may 
enhance interaction of these proteins with more diverse protease targets (Borriello and Krauter 
1991).  
 
Also identified as being differentially expressed was Klrd1, a lectin-like receptor expressed by 
NK cells. Also known as CD94, this receptor is expressed on NK cell subsets in both mice and 
humans, and interacts primarily with a nonclassical MHC class I molecule (HLA-E in humans, 
Qa-1b in mice) (Cho et al. 2011). Such interaction may induce functional maturation in NK cells 
(Yu et al. 2009). NK cells with high expression of Klrd1 have been found to have a greater 
capacity for IFN-g production and for lysis of targets cells (Yu et al. 2009), and also suppress the 
CD8+ T cell response, limiting immunopathology in chronic infections (Cho et al. 2011). These 
features suggest possible relevance of this protein in the control of T. gondii infection. 
 
Another differentially expressed gene was identified as the melanoma antigen MelA, an 
ecotropic murine leukemia virus (MuLV) envelope protein identified as being highly expressed 
in melanoma cells (Hayashi et al. 1992). Its expression during T. gondii infection is of possible 
interest. Other differentially regulated genes included Trim12a (tripartite motif-containing 
protein 12A) and the putative protein D730005E14Rik, both of which currently remain 
uncharacterized. The large difference in expression of H2-Ea, the E-alpha subunit of the MHC 
Class II E-complex was expected, as this gene has previously been found to be unexpressed in 
C57BL/6 mice due to a deletion within the promoter sequence, while the functional gene is 
expressed in DBA/2 mice (Jones et al. 1981). Further investigation into the roles played by this 




Table B-1. Differential gene expression in C57BL/6 and DBA/2 mice infected with T. gondii 
Transcript 
ID 




10450161 H2-Ea-ps 2.75E-07 -224.988 
10542214 Klrd1 8.42E-06 5.85938 
10582545 Mela 1.19E-06 -24.718 
10402399 Serpina1a 1.13E-05 -7.33244 
10402390 Serpina1b 2.08E-06 -18.3078 
10402409 Serpina1e 8.92E-07 -9.88549 
10566326 Trim12a 1.07E-05 16.976 
10341070 unknown 3.38E-06 14.644 
10415081 unknown 1.11E-05 -21.7788 
10520121 unknown 1.11E-05 -21.7788 
10578405 unknown 1.11E-05 -21.7788 
10586076 unknown 1.11E-05 -21.7788 











Figure B-3. Microarray gene expression profiles of mice infected with T. gondii. Expression 
of individual genes in spleen tissue of three replicates each of C57BL/6 (left, 2) and DBA/2 
(right, 1) mice three days following infected with the ME49 strain of T. gondii.  Red indicates 











In order to make full use of the data obtained here, it will be necessary first to confirm the 
microarray-based estimates of expression levels for a subset of genes in order to ascertain that 
the microarray data are reliable. Assuming this is the case, the full set of 523 differentially 
regulated genes will need to be analyzed in order to identify those most likely to affect the 
immune response to T. gondii. It will also be of value to obtain and analyze histological data 
from harvested spleen tissue in order to better assess the differences in the immune response and 
pathology associated with T. gondii infection in these two mouse lineages and better understand 













The ROP18 allele is underexpressed in archetypal Type III strains of T. gondii, presumably due 
to the presence of a 2,242bp upstream promoter sequence (UPS) not found in the Type I and II 
alleles and without homology to any other sequences in the T. gondii genome (Boyle et al. 2008, 
Khan et al. 2009). Fusion of the type II and III promoter sequences to a firefly luciferase ORF 
resulted in approximately 6-fold higher production of luciferase driven by the Type II promoter 
than by the Type III promoter (Boyle et al. 2008). Furthermore, the presence of the UPS appears 
to reflect the ancestral state of the parasite, as a similar sequence is found in the promoter region 
of the outgroup Neospora caninum ROP18 homologue, suggesting that the UPS was lost at some 
point through deletion or rearrangement in a common ancestor of the Type I and II alleles (Khan 
et al. 2009). Analysis of the coding sequence of the Type III allele predicts that the gene should 
maintain functionality due to the intact nature of key sequence elements, suggesting that the gene 
has continued to play a role in the selective fitness of Type III strains despite the low level of 
expression, possibly by aiding in establishment of infection in more susceptible host species 
(Khan et al. 2009). In order to ascertain the functionality of the gene product of the Type III 
ROP18 allele (ROP18III) and to more definitively identify the UPS as the cause of 
underexpression of this allele, we undertook the development of a transgenic parasite strain 
which would express ROP18III using the ROP18I promoter sequence.  
 
 




Primers were designed to amplify the 2.8kb genomic region upstream of the ROP18 ORF in the 
Type I strain GT1, the 1.7kb ORF of ROP18 from the Type III strain CTG, including a 3’ 27 bp 
HA tag sequence in the reverse primer, and the 1.4kb region downstream of the CTG ROP18 
ORF (based on ToxoDB genomic sequence). Primers were designed to include restriction 
enzyme recognition sites for use in plasmid construction. Fragments were amplified using 
FastStart DNA Polymerase (Roche) and a 35 cycle thermocyler program using a 55C annealing 
temperature and 72C, 2 minute extension temperature. Primer sequences are shown in Table C-1 
(ROP185PGT1F-PsiI, ROP18R1-ApaI, ROP18F2-ApaI, ROP18R2-HA-PspXI, ROP18F3-
PspXI, ROP183PCTGR-SpeI). PCR products were purified using a Wizard DNA cleanup kit 
(Promega) and inserted into the plasmid pDHFR, containing the pyrimethamine resistance gene 
dihydrofolate reductate (DHFR) and an ampicillin resistance gene (AMP) in a stepwise manner 
using standard molecular cloning techniques. Plasmids were cloned in E. coli cells. The final 






Table C-1. Primers used in generation and testing of transgenic strains 






































Figure C-1. Map of plasmid construct for transformation of T. gondii. Plasmid derived from 
pDHFR. Contains 2.8kb 5’ sequence of ROP18I, 1.7kb ORF of ROP18III with 3’ 27bp HA tag 
sequence, 1.4kb ROP18III 3’ sequence, dihydrofolate reductase (DHFR) and ampicillin 

















Transformation of T. gondii cells 
 
Tachyzoites of the Type III strain CTG were grown in cell culture as described. Cells were 
pelleted by spinning for 15 minutes at 2000xg, followed by resuspension in 250uL of 
electroporation buffer containing 1mg/mL ATP and 1.54mg/mL glutathione. 150 uL plasmid 
construct was mixed with tachyzoites in electroporation cuvette on ice, followed by 
electroporation at 1.5KeV and 25 ohms, followed by incubation for 15 minutes at room 
temperature. Electroporated cells were then added to a 25mL cell culture flask containing 
confluent HFF cells in 5mL dialyzed DMEM + 5uL 1000X pyrimethamine. As controls, 
tachyzoites were also electroporated without the addition of plasmid, and electroporated cells 
were grown in the absence of pyrimethamine. Parasites receiving the plasmid construct that were 
able to grow in the presence of pyrimethamine were harvested via pelleting and diluted to a 
concentration of approximately 1 tachyzoite per 100uL in D10 medium (estimated via 
hemacytometer counting). 100uL of suspension was then added to each well of two 24-well cell 
culture plates containing confluent HFF cells in D10 medium + pyrimethamine. Plates were then 
monitored for parasite grown over the course of one week. Parasites from wells in which only 
one focus of infection was identified (thus representing isogenic cultures) were passed to 
separate T25 cell culture flasks containing HFF cells in D10+pyrimethamine.  In this manner, 9 
pyrimethamine-resistant transgenic strains were isolated. Genomic DNA was extracted from 
each transformant culture and amplified using primers specific to the Type I ROP18 promoter 
sequence and Type III ROP18 3’ sequence (Table C-1, ROP18pDHFRF-Check, 
ROP18PDHFRR-Check) in order to verify the presence of the full length construct. In this 
manner, two positive transgenic strains were identified (Figure C-2). 
 
ROP18 expression in transgenic strains 
 
In order to determine the degree of ROP18 expression in the two positive transgenic strains 
identified, qRT-PCR was employed. Total RNA was extracted from cultures of the two 
transgenic strains as well as CTG and GT1 control strains using the Qiagen RNeasy kit. qRT-
PCR was carried out using the Verso 1-Step qRT-PCR Kit (Thermo) with primers specific to the 
ROP18 ORF (Table C-1, ROP18QF, ROP18QR). In this manner, it was determined that 
expression of ROP18 in the two transgenic strains was not significantly different from that of the 
wild type CTG strain. All three of these strains produced significantly less ROP18 transcript than 
did the GT1 strain (Figure C-3). Comparisons between expression levels of strains were done 
using Student’s T-Tests (P<0.01). 
 
Mouse virulence of transgenic strains 
 
In order to assess the virulence of mutant strains, triplicate CD1 outbred mice were injected 
intraperitoneally with 100 or 1000 tachyzoites of transgenic strains 3 and 27 harvested from cell 
culture. Mice were monitored for one month prior to termination, but no disease symptoms or 
mortality resulted (data not shown). Following termination after one month, brain tissue was 
homogenized and examined microscopically for the presence of tissue cysts, which were 
identified in all mice injected with 1000 tachyzoites and 5 of 6 mice injected with 100 






Figure C-2. PCR identification of transgenic T. gondii clones. Genomic DNA from 10 
pyrimethamine resistant transformant strains was used for template with construct-specific 
primers. Strain IDs are given above gel lanes. “-“ indicates no template negative control, “P” 
indicates plasmid construct positive control, “GT1” and “CTG” indicate control genomic DNA 









Figure C-3. Relative expression of ROP18 in control and transgenic T. gondii lines. ROP18 
expression was determined using qRT-PCR on total RNA extracted from tachyzoites of wild 
type strains GT1 and CTG and transgenic strains 3 and 27. Expression levels are presented 
relative to expression in CTG, which is designated as 1. Error bars represent one standard 























Though the transformants 3 and 27 produced PCR products when amplified with primers 
targeting the transgenic ROP18 construct, they did not show increased levels of ROP18 
expression nor did they prove virulent to mice. This may indicate a problem with the design of  
the construct, or the PCR results may have been false positives, possibly indicating amplification 
of the native ROP18 allele rather than the transgenic allele. Alternatively, the genomic context of 
the insertion may have precluded expression of the transgene, possibly through epigenetic 
mechanisms. It is also possible that other genetic elements in the vicinity of the native ROP18 
locus may be important for efficient expression of the gene. If future studies are conducted to 
continue this line of research, it may be worthwhile to attempt to perform a targeted replacement 
of the Type III ROP18 promoter region with that of Type I via homologous recombination rather 
than simply attempting to effect random insertion of the hybrid gene construct as has been done 
here. Additionally, expression of a reporter gene such as GFP in place of the ROP18III ORF in 
the current construct might be attempted prior to this as a simpler and more direct way to test the 
viability of the construct for gene expression in general. Another possibility is simply to express 
the ROP18III allele from a different promoter already known to be effective in transgenic T. 
gondii work, simply to ascertain whether or not higher levels of the ROP18III gene product 
would be effective in conferring a virulent phenotype to a Type III strain, as has been shown to 

















































































































































TgCkUsIL1, 2, 3, 4, 5, 6, 7, 8, 9, 
10, 11, TgGoUs1, PE, PIH, 
PTG, B70, C980, R18, 0761, 
GJL, MUC, PSC, 3440, FUK, 
Tg132, Tg17, TgCatStK3a, 
TgCkIt3, TgDoUs2, 3,TgShUs6, 
7, 15, 16, 18, 19, 20, 33, 41a, 
42b, 44, 46, 48, 49b, 50, 51, 53, 
TgWtdUs1, 3, 4, 5, TgFox, 
TgFxSv13, 38, 62, 70, 93, 105, 
107, 114, 169, 
176,TgDgAu3,TgSoUs 5, 
20,TgSoUs27, 36, TgPgUs1, 2, 
3, 4, 6, 7, 8, 9, 12, 13, 
TgPgUs17, 19, 21-24, 28-31, 33-
35, 38, 43, 50-54, 56, 62-64, 66-
68, 72-74, 77, 81, 83, 85, 86, 88, 
91, 94, 95, 98, 99, TgPgUs112, 
113, TgPgUs129, 137, 144, 160, 
161, 163, 165, 169, 170, 172, 
178, 180, 181, TgCatEg 55, 115, 
TgNmBr1, TgGoatUS1, 11, 12, 
14, 15, 16, 18, 19, 21, 
TgMmUs2, TgCatUs1, 
TgCoGa1, TgBbPa3, 5, 
TgCoWI1, TgSoUS41, 
TgDoUS5, TgBsCoUS1, 2, 3, 
TgHlUs1, TgVaUS2, 
TgPigUS183, 184, 185, 186, 
187,188, 189, 190, 191, 193, 194 
Dubey, Patitucci et al. 
2006; Rajendran et al. 
2012; Dubey, Morales 
et al. 2007; Dubey, 
Sundar, Nolden et al. 
2007; Dubey, Webb et 
al. 2007; Howe and 
Sibley, 1995; Dubey, 
Moura et al. 2009; 
Dubey, Huong et al. 
2008; Dubey, Fair et al. 
2008; Dubey, Sundar et 
al. 2008; Dubey, 
Velmurugan, Ulrich et 
al. 2008; Prestrud, 
Dubey et al. 2008; 
Prestrud, Asbakk et al. 
2008; Al-Qassab et al. 
2009; Sundar et al. 
2008; Dubey, Hill et al. 
2008; Velmurugan et 
al. 2009; Dubey, 
Thulliez et al. 1995; 
Gamble et al. 2005; 
Dubey, Gamble et al. 
2002; Dubey, Hill et al. 
2005; Al-Kappany et al. 
2010; Dubey, Passos et 
al. 2011; Dubey, 
Rajendran et al. 2011; 
Dubey, Velmurugan et 








































































































TgCkCh3, 15, 18, 20, 
TgCkCr11, TgCkNi3, 8, 13, 
44,  48, 2x, TgCkBr158, 
161, 164, TgDgBr11, 
TgCkBr31, 56,  TgDgSl 5, 6, 
10, TgCkGy26, 27, VEG, 
EDZ, STRL, ASH, B74, 
CTG, F958, C37, C56, 
K117C, K125B, COR, AFI, 
P51, LEG-NJA, LGE97-3, 
TgCatStK2, 3b, 4, 6, 
TgCkEg12, 13, 14, 16, 17, 
TgCkDROC-3, 6, 8, 9, 
TgCkMal-2, 3, 4, TgCkBF-
1, TgShUs13, 17, 21, 36, 
40b, 41b, 42a, 43, 
TgWtdUs13, 15, TgFxSv81, 
83, 121, 144, TgPgUs18, 41, 
61, 70, 71, 87, TgPgUs109, 
110, 111, TgPgUs130, 132, 
133, 134, 135, 136, 138, 
139, 140, 141, 142, 143, 
144, 145, 146, 147, 148, 
149, 150, 151, 152, 153, 
154, 155, 156, 157, 158, 
159, 162, 164, 166, 167, 
168, 171, 173, 174, 175, 
176, 177, 179 
Dubey, Patitucci et al. 2006; 
Rajendran et al. 2012; 
Dubey, Su et al. 2006; 
Dubey, Sundar et al. 2006; 
Dubey, Sundar et al. 2007; 
Dubey, Gennari et al. 2007; 
da Silva et al. 2003; 
Dubey,Velmurugan et al. 
2008; Dubey, Graham et al. 
2003; Dubey, Rajapakse et 
al. 2007; Dubey JP,  
Applewhaite 2007; Howe 
and Sibley, 1995; Ajzenberg 
et al. 2004; Dubey, Moura 
et al. 2009; Velmurugan et 
al. 2008; Dubey, Sundar et 
al. 2008; Dubey, 
Velmurugan, Ulrich et al. 
2008; Prestrud, Asbakk et 
al. 2008; Dubey,Thulliez et 
al. 1995; Velmurugan et al. 
2009; Gamble et al. 2005; 
Dubey, Gamble et al. 2002; 
Dubey, Velmurugan, 
Alvarado-Esquivel et al. 
2009; Yai et al. 2009; 
Dubey, Rajendran et al. 
2010; Al-Kappany et al. 
2010; Dubey, Rajendran et 
al. 2011; Dubey, 
Velmurugan et al. 2011; 
Rajendran et al. 2012; 
Dubey, Hill et al. 2012; 









































































































 TgCkMx1, TgCkMx2, 
TgCkMx3, TgCkMx4, 
TgCpBr2, TgCpBr4, 
TgCpBr5, TgCpBr6,  
TgCpBr7, TgCkBr231, 
TgCatEg 94, 
TgCatEg6, 11, 13, 15, 
17, 19, 22, 24, 35, 36, 
37, 43, 47, 48, 50, 58, 
61, 62, 66, 69, 70, 71, 
72, 73, 74, 80, 82, 83, 
84, 86, 87, 92, 93, 95, 
100, 102, 105, 108, 
110, 111, 114, 
TgGoatUS4, 10, 23, 29, 
TgWtdUs32, 
TgMmUs6, TgRaGa1, 
TgWyUs1, 2, 3, 
TgSkMs1, TgGoMs1, 
TgEsMt1, TgWfmMt1, 
2, TgBbPa1, 4, 
TgBlUS1, TgCkGr12, 
16, 23, 24, 29, 
TgCkAr2, 6, 24, 
TgCkPe2, 
TgPigUS195, 196, 198, 
199 
Dubey, Patitucci et al. 2006; 
Rajendran et al. 2012; Dubey, 
Su et al. 2006; Dubey, Sundar 
et al. 2006; Dubey, Sundar et 
al. 2007; Dubey, Gennari et al. 
2007; da Silva et al. 2003; 
Dubey,Velmurugan et al. 
2008; Dubey, Graham et al. 
2003; Dubey, Rajapakse et al. 
2007; Dubey JP,  Applewhaite 
2007; Howe and Sibley, 1995; 
Ajzenberg et al. 2004; Dubey, 
Moura et al. 2009; 
Velmurugan et al. 2008; 
Dubey, Sundar et al. 2008; 
Dubey, Velmurugan, Ulrich et 
al. 2008; Prestrud, Asbakk et 
al. 2008; Dubey,Thulliez et al. 
1995; Velmurugan et al. 2009; 
Gamble et al. 2005; Dubey, 
Gamble et al. 2002; Dubey, 
Velmurugan, Alvarado-
Esquivel et al. 2009; Yai et al. 
2009; Dubey, Rajendran et al. 
2010; Al-Kappany et al. 2010; 
Dubey, Rajendran et al. 2011; 
Dubey, Velmurugan et al. 
2011; Rajendran et al. 2012; 
Dubey, Hill et al. 2012; 































































































TgCkCh2, 4, 5, 7, 8, 9, 12, 13, 14, 
17, 19, 21, 22, TgCyW3, 
TgSkW1, 0790, DEG, Tg51, 
BEV, CHA, FUN, Tg96, GANGI, 
TgCkIt1, 2, TgCkEg15, 19, 
TgCkMal-5, TgCkKen-1, 
TgDoCA1, TgShUs4, 9, 10, 12, 
14, 23, 24, 25, 26, TgFxSv19, 27, 
42, 43, 48, 50, 61, 64, 87, 106, 
120, 136, 140, 148, 175, 177, 178, 
TgSoUs 3, 4, 18, 19, 21, 
TgSoUs26, 29, 30, 37, TgPgUs27, 
32, 36, 37, 39, 44, 48, 49, 59, 69, 
93, 97, TgPgUs 100, 101, 102, 
103, 104, 105, 106, 107, 108, 114, 
115, 116, 117, 118, 119, 120, 121, 
122, 123, 124, 125, 126, 127, 128, 
QHO, TgCkBr221, 225, 226, 228, 
230, TgSandcatQA1, TgCatEg 1, 
2, 3, 4, 5, 8, 9, 10, 12, 14, 16, 20, 
21, 23, 25, 26, 28, 29, 30, 31, 32, 
33, 38, 39, 41, 42, 44, 45, 46, 49, 
51, 52, 54, 56, 59, 60, 63, 64, 68, 
75, 76, 77, 78, 79, 81, 85, 90, 91, 
96, 97, 98, 99, 101, 103, 104, 107, 
109, 112, 113, TgOvBr2, 5, 
TgGoatUS2, 9, 22, 27, 
TgMmUs1, 3, 4, TgCatUs8, 
TgSoUS42, 43, TgVaUS4, 
TgVvUS1, TgVaUS6, H2, PRU 
Dubey, Patitucci et al. 
2006; Rajendran et al. 
2012; Dubey, Sundar, 
Nolden et al. 2007; 
Howe and Sibley 1995; 
Ajzenberg et al. 2004; 
Dubey Huong et al. 
2008; Velmurugan et al. 
2008; Dubey, Mergel et 
al. 2009; Dubey, Sundar 
et al. 2008; Prestrud, 
Asbakk et al. 2008; 
Sundar et al. 2008; 
Dubey, Thulliez et al. 
1995; Velmurugan et al. 
2009; Gamble et al. 
2005; Zhou et al. 2009; 
Dubey, Rajendran et al. 
2010; Dubey, Pas et al. 
2010; Al-Kappany et al. 
2010; da Silva et al. 
2011; Dubey, Rajendran 
et al. 2011; Dubey, 
Velmurugan et al. 2011; 
Huang et al. 2012; Su et 























































































TgCkNi18, 39, 42, TgDgSl1, 2, 3, 
7, 8, 9, 15, 17, 19, 20, 24, 
TgRaW5, TgCyW1, 2, B41, R961 
(LDS), P10, TgShUs3, 8, 11, 29, 
30, 31, 34, 38, 45, TgWtdUs2, 6, 
TgWtdUs7, 9, 11, 12, 14, 
TgSoUs1, 2, TgSoUs35, TgPgUs 
16, 20, 25, 26, 40, 42, 47, 60, 65, 
75, 78, 79, 80, 82, 84, 90, 96, 
TgGoatUS13, 17, 24, TgMmUs5, 
TgCatUs2, 3, 4, 5, 6, TgBbPa2 
Dubey, Sundar et al. 
2006; Dubey, 
Rajapakse et al. 
2007; Dubey, 
Sundar, Nolden et 
al. 2007; Howe and 
Sibley 1995; Dubey, 
Sundar , Hill et al. 
2008; Dubey, 
Velmurugan, Ulrich 
et al. 2008; Sundar 
et al. 2008; Dubey, 
Thulliez et al. 1995; 
Dubey, Rajendran et 
al. 2011; Dubey, 





































ARI, RAY, WTD-1, WTD-3, 
Tg61(T61), 0729, 0791, RMS-
MAU, TgCatCa2, TgRaCa2, 
TgSkCa1, TgShUs37, TgSoUs6, 
7, 9, 10, 12, 13, 14, 22, 23, 24, 25, 
TgSoUs8,  11, 15, 16, 17, 32, 33, 
34, 31, 38, TgPgUs89, 
TgGoatUS25, 28, TgWtdUs16, 
17, 18, 19, 20, 22, 23, 24, 26, 27, 
28, 29, 30, 31, 33, 34, 35, 36, 
TgCatGa1, 2, 3, 4, TgCatMs1, 
TgRaTx1, TgRaGa8, 
TgWolfWI1, TgSoUS40, 44, 
TgDoUS4, 6, TgTaUS1, 
TgBbAk1, TgVaUS3, 
TgWolfMN1, 3, 4, TgVaUS5 
Howe and Sibley 
1995; Ajzenberg et 
al. 2004; Dubey, 
Quirk et al. 2008; 
Dubey, Sundar, Hill 
et al. 2008; Sundar, 
Cole et al. 2008; 
Dubey, Thulliez et 
al. 1995; 
Velmurugan et al. 
2009; Dubey, 
Rajendran et al. 
2011; Dubey, 
Velmurugan et al. 
2011; Dubey, 


















































Strain IDs References 
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TgCatBr2, 12, 17, 21, 30, 
TgCkBr144, TgDgBr3, 7, 
TgCatBr42, 47, 53, 54, 55, 
62, 71, 75, TgCkBr123, 
124, TgCkBr10, 
TgCkBr98, 101, 102, 104, 
TgCkBr55, 79, 86, 87, 
GPHT, FOU, BOF, 
TRK1, PSP-KOM, WIK, 
TgBrCp14, TgShBr8, 9, 
10, 11, TgGtBr2, 3, 4, 9, 
TgCkBr201, 203, 207, 
534N, PL8, S1PF2 
Dubey, Navarro et al. 2004; Su 
et al. 2006; Dubey, Sundar et 
al. 2007; Dubey, Gennari et al. 
2007; Pena et al. 2006; Pena et 
al. 2008; Dubey, Gennari et al. 
2006; Dubey, Velmurugan et 
al. 2008; Dubey, Graham et al. 
2002; Dubey, Navarro et al. 
2003; da Silva et al. 2003; 
Dubey, Graham et al. 2003;  
Howe and Sibley 1995; 
Ajzenberg et al. 2004; Yai et al. 
2009; Ragozo et al. 2010; 
Soares et al. 2011; Ferreira et 


























TgCkCr8, 12, 13, 14, 15, 
16, 17, 18, 19, 20, 21, 22, 
23, 24, 25, 26, 27, 
TgCkNi14, 15, 20, 25, 30, 
TgCkBr111, 112, 
TgCkBr182, TgCkGy23, 
24, TgRaW4, G622M, 
TgShUs40a, TgPgUs5, 10, 
14, TgCkBr196, 
TgRaGa2, TgCkAr16, 18, 
TgCkGa6 
Dubey, Su et al. 2006; 
Rajendran et al. 2012; Dubey, 
Sundar et al. 2006; Dubey, 
Sundar et al. 2007: de Oliveira 
et al. 2009; Dubey, 
Velmurugan et al. 2008; 
Dubey, Applewhaite et al. 
2007; Dubey, Sundar, Nolden 
et al. 2007; Howe and Sibley 
1995; Dubey, Sundar, Hill et al. 
2008; Dubey, Hill et al. 2008; 
Velmurugan et al. 2009; Soares 
et al. 2011; Dubey, 
Velmurugan et al. 2011; 


















































































TgCatBr3, 4, TgDgBr4, 12, 
TgCatBr58, 59, 60, 73, 74, 
TgCkBr131,132, 133,134, 
TgCkBr11, 7, 17, 
TgPgUs15-a.k.a.P89, 45, 




195, TgCatUs7, TgOpGa1, 
TgCkVe1 
Dubey, Navarro et al. 2004; 
Su et al. 2006; Dubey, Gennari 
et al. 2007; Pena et al. 2006; 
Pena et al. 2008; Dubey, 
Gennari et al. 2006; Dubey, 
Velmurugan 2008; Dubey, 
Graham et al. 2002; Dubey, 
Thulliez et al. 1995; 
Velmurugan et al. 2009; Yai et 
al. 2009; Ragozo et al. 2010; 
Soares et al. 2011; Dubey et 

























TgDgCo4, TgCtPRC2, 4, 5, 
6, 7, 8, 9, 10, 11, 12, 13, 
14, 15, 16, 17, TgDgVi5, 6, 
7, 8, TgDgSl 21, TgShUs1, 
TgCatMx2, TgCatMx5, 
TgC1, 2, 3, 4, 5, 6, 7, 8, ZS, 
GYS, PYS, ZC, FS, NY5, 
NY19, NY11, NY8, NY13, 
TgWolfAK1, TgCatBj1-11, 
TgPigeonMx1 
Dubey, Cortés-Vecino et al. 
2007; Dubey, Zhu et al. 2007; 
Dubey, Huong et al. 2007; 
Dubey, Rajapakse et al. 2007; 
Dubey, Sundar, Hill et al. 
2008; Dubey, Velmurugan, 
Alvarado-Esquivel et al. 2009; 
Zhou et al. 2009; Zhou et al. 
2010; Dubey, Velmurugan et 
al. 2011; Qian et al. 2012; 
Alvarado-Esquivel et al. 2011.  
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TgCtCo2, 7, TgCkBr146, 
RH88, VEL, GT1, CT-1, 
OH3, S11, BK, ENT, 
MOR, FR-93, SH, CN, NT, 
TgPHs1, TgPXx, TgPXd, 
TgpNx, TgPLh, TgPxda, 
TgPxdb1, Tgpyh, TgPNY, 
TgPGZ, ATIH, P, PiL, 
GiL, S10 
Dubey, Su et al. 2006; 
Rajendran et al. 2012; Dubey, 
Sundar, Gennari et al. 2007; 
Howe and Sibley. 199; Zhou 
et al. 2009; Zhou et al. 2010; 
Mercier et al. 2010; Ajzenberg 









































































TgCatBr1, 7, TgCatBr39, 51, 
52, 56, 61, 68, 77, 78, 





Dubey, Navarro et al. 
2004; Su et al. 2006; Pena 
et al. 2006; Pena et al. 
2008; Dubey, Navarro et 
al. 2003; Dubey, 
Velmurugan et al. 2008; 
da Silva et al. 2003; 
Dubey, Graham et al. 
2003; Yai et al. 2009; da 
Silva et al. 2011; Dubey, 
Passos et al. 2011; Dubey, 
Velmurugan et al. 2011; 














I Chicken, Human 
TgCkGy2, 3, 5, 6, 9, 12, 16, 19, 
20, 25, 28, 32, IPP-BAT 
Dubey, Applewhaite et al. 



















TgCkBr165, TgCkBr167, 170, 
TgCkBr174, 176, TgCkBr179, 
180, TgCkBr183, TgCkBr184, 
185, PSP-ERO, TgCatStK7, 
TgGtBr10, TgRhHmBr1, 
TgCkGr25, 26 
de Oliveira et al. 2009; 
Dubey, Velmurugan et al. 
2008; Ajzenberg et al. 
2004; Dubey, Moura et al. 
2009; Ragozo et al. 2010; 
Pena et al. 2011; 






















































































90, TgDgCo9, 12, 15, 
18, TgCyW6, 
TgCkVe3, TgCkCo2 
Dubey, Patitucci et al. 2006; 
Rajendran et al. 2012; Dubey, Su 
et al. 2006; Dubey, Navarro et al. 
2004;  Su et al. 2006; Dubey, 
Sundar, Gennari et al. 2007; 
Dubey, Gennari et al. 2007; da 
Silva et al. 2003; Dubey, 
Velmurugan et al. 2008; Dubey, 
Graham et al. 2003; Dubey, 
Cortés-Vecino et al. 2007; Dubey, 
Sundar, Nolden et al. 2007; 























TgCkBr119, 120, 122, 





Dubey, Gennari et al. 2007; Howe 
and Sibley 1995; Dubey, Huong 
et al. 2008; Velmurugan et al. 
2008; Dubey, Fair et al. 2008; 
Dubey, Velmurugan et al. 2011; 













Chicken TgCkNi1, 11, 22, 23, 
26, 29, 33, 36, 38, 46, 
47y 
Dubey, Sundar, Pineda et al. 


















TgCkBr147, 148, 151, 
154, 160, 162, 163, 
TgCkBr81, MAS, IPP-
URB, TgOvBr1, 6, 
TgCkAr27, 28, 
TgCkPe4, 6. 
Dubey, Sundar, Gennari et al. 
2007; da Silva et al. 2003; Dubey, 
Velmurugan et al. 2008; Dubey, 
Graham et al. 2003; Howe and 
Sibley 1995; Ajzenberg et al. 
2004; da Silva et al. 2011; 






















































Strain IDs References 







Dog, Cat TgCtCo12, 13, TgDgCo3, 
TgCtPRC1, 3, TgDgVi1, 2, 
3, 4 
Dubey, Su et al. 2006; 
Rajendran et al. 2012; 
Dubey, Cortés-Vecino et al. 
2007; Dubey, Zhu et al. 





















TgCatBr5, 11, 16, 
TgCatBr84, TgCkBr28, 33, 
50, 52, 58, TgCpBr10, 
TgCpBr31, TgOvBr4, 
TgRabbitBr1, TgMmBr03 
(MM03), TgCkBr205, 209 
Dubey, Navarro et al. 2004; 
Su et al. 2006; Pena et al. 
2006; Pena et al. 2008; da 
Silva et al. 2003; Dubey, 
Velmurugan et al. 2008; 
Dubey, Graham et al. 2003; 
Yai et al. 2009; da Silva et al. 
2011; Dubey, Passos et al. 
2011; Araújo et al. 2010; 






















TgDgSl 4, 11, 12, 13, 14, 
16, 18, 22, 23, 
TgSandcatUAE1, 3, 
TgCatEg7,18,34,65 
Dubey, Rajapakse et al. 
2007; Dubey, Pas et al. 2010; 




















TgCatBr10, 22, 23, 28, 31, 
32, 37, TgCkBr95, TgCpBr 
29, TgRrBr09 (RR09) 
Dubey, Navarro et al. 2004; 
Su et al. 2006; Dubey, 
Navarro et al. 2003; Dubey, 
Velmurugan et al. 2008; Yai 

















I Chicken TgCkBr38, 27, 44, 51, 65, 66, 78, 80 
da Silva et al. 2003; Dubey, 
Velmurugan et al. 2008; 























































Strain IDs References 











TgCkNi4, 6, 10, 17, 21, 34, 37, 
TgDgCo19 
Dubey, Sundar et al. 2006; 
Dubey, Cortés-Vecino et 
al. 2007  
24 6 I I I I II
I I I I I I II
I Chicken TgCkCr2, 28, 29, 30, 31, 32 Dubey, Su, et al. 2006; 
Rajendran et al. 2012 












I I I 
Chicken TgCkBr110, TgCkGy8, 10, 14, 
15, 35 
Dubey, Sundar et al. 2007; 

















I Chicken, Cat TgCkBr149, 150, 152, 157, 
TgCatBr65, 66 
Dubey, Sundar, Gennari et 
al. 2007; Pena et al.2006; 
Pena et al. 2008                                                                                                                                                                                                   
27 5 I I I I I I I II
I I I I 
Chicken 
TgCkNi7, 9, 40, 41, 43 
Dubey, Sundar, Pineda et 
al. 2006  







TgCtCo1, TgCkBr115, 142, 
145, CAST, TgCkCo5 
Dubey, Su et al. 2006; 
Rajendran et al. 2012; 
Dubey, Sundar, Gennari et 
al. 2007; Howe and Sibley 
1995 











TgCkBr114, TgDgCo1, 2, 10, 
20, TgCkCo20 
Dubey, Sundar, Gennari et 
al. 2007; Dubey, Cortés-
Vecino et al. 2007; 
Rajendran et al. 2012 













I Chicken TgCkBr113, TgCkGy7, 11, 13, 
31 
Dubey, Sundar, Gennari et 
al. 2007; Dubey,  
Applewhaite et al. 2007 














TgCkGy1, 4, 29, 30, 33 























































Strain IDs References 








 I I I I I 
Dog, 
Raccoon 
TgDgBr8, 9, 10, TgRaW2, 3 
Dubey, Gennari et al. 
2007; Dubey, Sundar, 








1 I I I I 
Chicken, 
Capybara 
TgCkBr41, 42, 49, 60, 62, 
TgCpBr34, TgCpBr35 
daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 














TgDgBr5, TgCatBr44, 48, 69, 
70, TgCpBr8,13, 15 
Dubey, Gennari et al. 
2007;  Pena et al. 2006; 
Pena et al. 2008; Yai et 
al. 2009 
35 4 I I I I I I I II
I I I II
I Chicken 
TgCkCr3, 4, 5, 6 
Dubey, Su et al. 2006; 
Rajendran et al. 2012 







TgCkBr59, 30, 34, 67 
daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 
al. 2003 











1 I I II
I I 
Chicken 
TgCkBr36, 32, 84, 85 
daSilva et al. 2003; 
Dubey, Velmurugan et al. 









I I I I II
I I I II
I 
Cat, Dog, 
Chicken TgCtCo4,10,11, TgDgCo17, 
TgCkCo6, 10, 12, 13, 21, 23, 24, 
8, 15 
Dubey, Su et al. 2006; 
Rajendran et al. 2012; 
Dubey, Cortés-Vecino et 





















TgShUs47, 52, TgGoatUS7 
Dubey, Sundar, Hill et al. 
2008; Dubey, Rajendran 








































































TgCtCo5x, TgCkBr75, 76, 92 
Dubey, Su et al. 2006; 
Rajendran et al. 2012; 
daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 
al. 2003 
41 5 I I I II
I I II
 I I I I I 
Chicken, 
Capybara 
TgCkBr136, 138, 139, 
TgCpBr9, TgCpBr12 
Dubey, Gennari et al. 
2006; Dubey, 
Velmurugan et al. 2008; 
Yai et al. 2009 




 I I I u-
1 I Cat 
TgCatBr9,19 
Dubey, Navarro et al. 
2004; Su et al. 2006 
43 3 I I II
 I II
 I I I I u-
1 I Chicken 
TgCkCr7, 9,10 
Dubey, Su et al. 2006; 
Rajendran et al. 2012 





 I I u-
3 I Dog 
TgDgCo5, 6, 11 
Dubey, Cortés-Vecino et 
al. 2007          










I I I II
I Chicken 
TgCkBr126, 127, 117 
Dubey Gennari et al. 
2006; Dubey, 
Velmurugan et al. 2008 










I I Dog 
TgDgCo8, 14, 16 
Dubey, Cortés-Vecino et 





























































Strain IDs References 














TgCatBr25, TgCkBr99, 100 
Dubey, Navarro et al. 
2004; Su et al. 2006; 
Dubey, Navarro et al. 
2003; Dubey, Velmurugan 
et al. 2008 





















TgCkBr181, TgCkGy21, 22, 
TgCkVe 4, 5, 10, TgCkAr7 
de Oliveira et al. 2009; 
Dubey, Velmurugan et al. 
2008; Dubey,  
Applewhaite et al. 2007; 



















TgCatPr5, 7, 11 



















TgCkNi16, 45, 7x 








 I I I I 
Dog, 
Chicken 
TgDgBr6, 17, TgCkBr46 
Dubey, Gennari et al. 
2007; daSilva et al. 2003; 
Dubey, Velmurugan et al. 













TgCkNi12, 32, TgRsCr1 
Dubey, Sundar, Pineda et 
al. 2006; Dubey, 









































































Capybara TgDgBr14, 15, TgCkBr96, 
TgCpBr19, TgCpBr21, 
TgCpBr22 
Dubey, Gennari, Sundar et 
al. 2007; Dubey, Navarro 
et al. 2003; Dubey, 
Velmurugan et al. 2008; 





























Dubey, Sundar, Hill et al. 
2008; Dubey, 
Velmurugan, Ulrich et al. 
2008; Sundar, Cole et al. 
2008 
55 2 I I I I II
I I u-
1 I I I I Cat 
TgCatBr79, 80 
Pena et al. 2006; Pena et 
al. 2008 





I I I Cat 
TgCatBr45, 46 
Pena et al. 2006; Pena et 
al. 2008 










de Oliveira et al. 2009; 


































































Strain IDs References 








I I I 
Dog, Cat 
TgDgBr2, TgCatBr83 
Dubey, Gennari et al. 
2007; Pena et al. 2006; 
Pena et al. 2008 






1 I I I I 
Chicken 
TgCkBr40, 47 
daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 
al. 2003 









I I Human GUY-KOE, VAND Howe and Sibley 1995 








2 I Cat 
TgCtCo5, 6 
Dubey, Su et al. 2006; 
Rajendran et al. 2012 











I I Cat 
TgCtCo3, 9 
Dubey, Su et al. 2006; 
Rajendran et al. 2012 












Dubey, Graham et al. 
2002; Dubey, Velmurugan 
et al. 2008 













Dubey, Graham et al. 
2002; Dubey, Velmurugan 

















TgCatBr82, TgCkBr89, 477Co, 
244N, 262N, 331N, 384N, 
581N, 692N, 704N, 527N, 
176Co, 539O, 571O, 441N, 
508N, 358N, 607O, 616O, 
622O 
Pena et al. 2006; Pena et 
al. 2008; daSilva et al. 
2003; Dubey, Velmurugan 
et al. 2008; Dubey, 
Graham et al. 2003; 


























































Strain IDs References 













2 I Cougar 
TgCgCa1(Cougar), TgCgCa2 
Howe and Sibley 1995; 
Dubey, Quirk et al. 2008 


















Dubey, Gennari et al. 
2007; Pena et al. 2006; 
Pena et al. 2008; Yai et 
al. 2009 


















Dubey, Applewhaite et 
al. 2007 













Dubey, Navarro et al. 
2003; Dubey, 
Velmurugan et al. 2008 










1 I I I II
I Chicken 
TgCkBr107, 108 
Dubey, Sundar, Gennari 
et al. 2007 
















TgCkBr26, 69, 180N 
daSilva et al. 2003; 
Dubey, Velmurugan et 
al. 2008; Dubey, Graham 
et al. 2003; Ferreira et al. 
2011 



















I Human, Sheep 
ROD, TgShUs5 
Howe and Sibley, 1995; 









































































I I I 
Sheep, 
Dog 
TgShUs22, 28, TgDgMx2 
Dubey, Sundar, Hill et al. 
2008; Dubey, 
Velmurugan, Alvarado-



























Dubey, Sundar, Hill, et al. 
2008; Dubey, 
Velmurugan, Ulrich et al 
2008; Dubey, 
Velmurugan, Alvarado-
















daSilva et al. 2003; 
Dubey, Velmurugan et al. 















1 I I II
I I Chicken 
TgCkBr155, 159 
Dubey, Sundar, Gennari et 
al. 2007 
77 1 I I I I I I u-





Dubey, Sundar, Gennari et 
al. 2007 







daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 
al. 2003; de Oliveira et al. 
2009                                         
79 1 I I I I II






Dubey, Cortés-Vecino et 
al. 2007        
80 1 I I I II
I I II
 I I I u-
1 I Cat 
TgCatBr26 
Dubey, Navarro et al. 
























































Strain IDs References 









de Oliveira et al. 2009; 
Dubey, Velmurugan et al. 
2008     
82 1 I I I II
I I II
I II




daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 
al. 2003 








I Monkey ENVL-MAC Ajzenberg et al. 2004 




1 I I II
I I Dog PBr Howe and Sibley, 1995 






1 I I II
 I Cat 
TgCatBr72 
Pena et al. 2006; Pena et 
al. 2008 






1 I I II
I I Cat 
TgCatBr50 
Pena et al. 2006; Pena et 
al. 2008 









Dubey, Sundar, Gennari et 
al. 2007 
 










de Oliveira et al. 2009; 
Dubey, Velmurugan et al. 
2008       
















Dubey, Huong et al. 
2008 








































































Strain IDs References 
91 1 I I II
 I I I II
 I I I I Chicken 
TgCkCr1 
Dubey, Su et al. 2006; 
Rajendran et al. 2012 





 I I II
 I Cat 
TgCatBr40 
Pena et al. 2006; Pena et 
al. 2008 









daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 
al. 2003 








Dubey, Graham et al. 
2002; Dubey, Velmurugan 
et al. 2008 





 I I II
I I Human GUY-MAT Howe and Sibley, 1995 












Dubey, Sundar, Gennari et 
al. 2007 
 








I I Human GUY-DOS Howe and Sibley, 1995 











I Human RUB Howe and Sibley, 1995 






1 I I II
I I Human TOU-ALI  Ajzenberg et al. 2004 









I I Human GUY-BAS1 Ajzenberg et al. 2004 





 I I u-
2 I Cat 
TgCtCo15 
Dubey, Su et al. 2006; 
Rajendran et al. 2012 













Dubey, Sundar, Pineda et 
al. 2006 






1 I I II
I I Cat 
TgCatBr34 
Dubey, Navarro et al. 























































Strain IDs References 














I I Chicken 
TgCkBr143 
Dubey, Sundar, Gennari et 
al. 2007 








1 I I II
 I Dog 
TgDgBr18 
Dubey, Gennari et al. 
2007  












daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 
al. 2003 








 I I II
I I Cat 
TgCatBr57 
Pena et al. 2006; Pena et 
al. 2008 
















de Oliveira et al. 2009; 
Dubey, Velmurugan et al. 
2008  












I I Sheep 
TgShUs49a 
Dubey, Sundar, Hill et al. 
2008 















Rat TgCatBr64, TgShBr6, 7, 16, 
TgOvBr12, TgRtBr1 
Pena et al. 2006; Pena et 
al. 2008; Ragozo et al. 
2010; da Silva et al. 2011; 
Muradian et al. 2012 
112 1 I II
 
II







Dubey, López-Torres et al. 
2007 



















Dubey, Hill et al. 2008; 




























































Strain IDs References 









I I I 
Chicken 
TgCkBr166 
de Oliveira et al. 2009; 
Dubey, Velmurugan et al. 
2008 














I I Cat 
TgCatPr9 
Dubey, López-Torres et 
al. 2007 



















Dubey, Gennari et al. 
2006; Dubey, Velmurugan 
et al. 2008; Rajendran et 
al. 2012 













Pena et al. 2006; Pena et 
al. 2008 














Dubey, López-Torres et 
al. 2007. Dubey, 
Rajendran, Ferreira et al. 
2011 










1 I I u-
1 I Cat 
TgCatBr18 
Dubey, Navarro et al. 
2004; Su et al. 2006 
















Dubey, Navarro et al. 
2004; Su et al. 2006.  













































































Strain IDs References 















Dubey, Cortés-Vecino et 
al. 2007         


















Dubey JP, Applewhaite et 
al. 2007 













1 I Cat 
TgCatBr81 
Pena et al. 2006; Pena et 
al. 2008  




















Dubey, Graham et al. 
2002; Dubey, Velmurugan 
et al. 2008 








1 I I u-
1 I Cat 
TgCatBr6-20 
Dubey, Navarro et al. 










































 I Cat 
TgCtCo8 
Dubey, Su et al. 2006; 























de Oliveira et al. 2009; 































 I Sheep 
TgShUs32 






















































































































de Oliveira et al. 2009; 
Dubey, Velmurugan et al. 

















daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 











 I I II
I I Cat 
TgCatBr38 


















I I Chicken 
TgCkGh1 























daSilva et al. 2003; 
Dubey, Velmurugan et al. 
2008; Dubey, Graham et 

















































































I I Human 
SOU 












































Dubey, Moura et al. 
2009 







 I I Chicken 
TgCkBr222 
Dubey, Rajendran, 
Costa et al. 2010 








Dubey, Rajendran et 
al. 2011 






I I I I Sheep TgShBr1, 2 Ragozo et al. 2010 
145 1 I 
 I  I  II
I  I  II




Opposum TgOpBr1 Pena et al. 2011 
146 15
 










I Chicken TgCkBr210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 
223, 224, 227, 229, 233 
Dubey, Rajendran, 
Costa et al. 2010 








Bear TgBbUS1  
Dubey, Rajendran, 
Ferreira et al. 2010 





 I I II


























































Strain IDs References 








 I I I I Goat TgGtBr1, 6, 7, 12 Ragozo et al. 2010 










I I I I 
Sheep, 
Goat 
TgShBr3, 4, TgGtBr5 Ragozo et al. 2010 








 I I II
I I Sheep TgShBr12, 13, 14 Ragozo et al. 2010 











Dubey, Rajendran, Costa 
et al. 2010 















 I Goat 
TgGoatUS20 
Dubey, Rajendran et al. 
2011 













Alvarado-Esquivel et al. 
2009  













Dubey, Rajendran et al. 
2011 
















Kestrel TgCkBr202, 204, TgFsUS1 
Soares et al. 2011; Dubey, 
Velmurugan, et al. 2011 













































































Strain IDs References 












TgCkBr200 Soares et al. 2011 
















I Sheep TgShBr5 Ragozo et al. 2010 









I I I II
I 
II
I I Chicken TgCkBr199 Soares et al. 2011 










 I I II
I I Capybara 
TgCpBr1 Yai et al. 2009 


















Costa et al. 2010 











I I I II
I I Chicken TgCkBr208 Soares et al. 2011 















TgCpBr27 Yai et al. 2009 




















I  Jaguarundi 
TgJagBr1  Pena et al. 2011 
167 2 II












Dubey, Rajendran et 
al. 2011; Dubey, 



















 I Cat 
TgCatEg57 












































































































Dubey, Rajendran et 
al. 2011 
171 2 u-























I I Chicken TgCkBr188, 189, 190, 191, 










1 I I II
I I Capybara 













I I Chicken 











I I I u-
1 I Capybara 


















I I Cat 
TgCatEg88 
Al-Kappany et al. 
2010 





crow TgHcUS1, 2 Dubey et al. 2011c. 
178 1 I I I II
I I II
I II
 I I II






























































Strain IDs References 











I Chicken TgCkCo17, 22 Rajendran et al. 2012 
180 1 I II
I 
II





I I I Striped 
Skunk TgSKMs3 
Dubey, Velmurugan 









































































I I I II
I Chicken TgCkCo9 Rajendran et al. 2012 
189 1 u-
1 I II
 I I I I I I II
I I Chicken TgCkPe5 Rajendran et al. 2012 











I Chicken TgCkGa01 Rajendran et al. 2012 






I Chicken TgCkGa04 Rajendran et al. 2012 
























I I I II
I I 
Human LGE-2007-CUV Su et al. 2012 










P24, PF26, PL15, PM2 Mercier et al. 2010 

















Pig P105 WGA 
Howe and Sibley 
1995 
Note: N= the number of isolates belonging to the same genotype. At locus SAG1, type II and III alleles are indistinguishable. 
nd: no data 
Some genotype numbers are assigned to potential new PCR-RFLP types but not yet confirmed or published, therefore not listed in this 
table. 
  




Table D-2. ROP18, ROP5 and ROP16 genotypes of T. gondii strains 













TgCtCo2 10 1 1 1 1 75 nonlethal 
GT1 10 1 1 1 1 100 lethal 
TgCtCo7 10 1 1 1 1 100 lethal 
TgCkBr146 10 1 1 1 1 ND ND 
TgCkNi9 27 1 1 1 1 100 lethal 
TgCkCr3 35 1 1 1 1 100 lethal 
TgCkCr4 35 1 1 1 1 100 lethal 
TgCkCr5 35 1 1 1 1 100 lethal 
TgCkCr6 35 1 1 1 1 ND ND 
TgCatBr80 55 1 1 1 1 100 lethal 
TgShUS28 73 1 1 1 1 100 lethal 
TgCkBr169 78 1 1 1 1 100 lethal 
TgDgCo13 79 1 1 1 1 50 nonlethal 
TgCkCr1 91 1 1 1 1 67 nonlethal 
TgShUS32 131 1 2 1 2 0 nonlethal 
TgCatBr54 6 1 3 1 3 75 nonlethal 
TgCatBr12 6 1 3 1 3 100 lethal 
TgCatBr17 6 1 3 1 3 100 lethal 
TgCatBr2 6 1 3 1 3 100 lethal 
TgCatBr21 6 1 3 1 3 100 lethal 
TgCatBr30 6 1 3 1 3 100 lethal 
TgCatBr42 6 1 3 1 3 100 lethal 
TgCatBr47 6 1 3 1 3 100 lethal 
TgCatBr53 6 1 3 1 3 100 lethal 
TgCatBr55 6 1 3 1 3 100 lethal 
TgCatBr62 6 1 3 1 3 100 lethal 
TgCatBr71 6 1 3 1 3 100 lethal 
TgCatBr75 6 1 3 1 3 100 lethal 
TgCkBr144 6 1 3 1 3 100 lethal 
GPHT 6 1 3 1 3 ND ND 
TgCkBr59 36 1 3 1 3 100 lethal 
TgCtCo10 38 1 3 1 3 100 lethal 
TgCtCo11 38 1 3 1 3 100 lethal 
TgCtCo4 38 1 3 1 3 100 lethal 
TgDgCo17 38 1 3 1 3 100 lethal 
TgCkBr136 41 1 3 1 3 80 nonlethal 
TgCkBr126 45 1 3 1 3 100 lethal 
TgDgBr6 51 1 3 1 3 100 lethal 
TgCatBr45 56 1 3 1 3 100 lethal 
TgCatBr46 56 1 3 1 3 100 lethal 
TgDgBr2 58 1 3 1 3 ND ND 
TgCkBr40 59 1 3 1 3 100 lethal 
TgCkGy18 68 1 3 1 3 0 nonlethal 
TgCkBr141 77 1 3 1 3 100 lethal 
 
  




Table D-2 continued 
Strain ID ToxoDB 
Genotype# 





TgCkBr54 82 1 3 1 3 100 lethal 
TgCatBr50 86 1 3 1 3 0 nonlethal 
TgCkBr186 88 1 3 1 3 100 lethal 
TgBBeCa1 90 1 3 1 3 50 nonlethal 
TgDgBr18 106 1 3 1 3 75 nonlethal 
TgCatPR8 118 1 3 1 3 100 lethal 
TgShBr1 144 1 3 1 3 ND ND 
TgGtBr1 149 1 3 1 3 ND ND 
TgPgBr24 nd 1 3 1 3 ND ND 
TgOvBr7 171 1 3 2 4 ND ND 
TgCatBr6-20 126 1 4 1 5 ND ND 
BOF 6 1 6 1 6 8.3 nonlethal 
PTG 1 2 2 2 7 40 nonlethal 
DEG 3 2 2 2 7 0 nonlethal 
TgDgSl1 4 2 2 2 7 0 nonlethal 
TgDgSl15 4 2 2 2 7 0 nonlethal 
TgDgSl17 4 2 2 2 7 0 nonlethal 
TgDgSl19 4 2 2 2 7 0 nonlethal 
TgDgSl2 4 2 2 2 7 0 nonlethal 
TgDgSl20 4 2 2 2 7 0 nonlethal 
TgDgSl24 4 2 2 2 7 0 nonlethal 
TgDgSl3 4 2 2 2 7 0 nonlethal 
TgDgSl7 4 2 2 2 7 0 nonlethal 
TgDgSl8 4 2 2 2 7 0 nonlethal 
TgDgSl9 4 2 2 2 7 0 nonlethal 
B41 4 2 2 2 7 71.4a nonlethal 
TgSoUS8 5 2 2 2 7 ND ND 
WTD-1 5 2 2 2 7 ND ND 
TgSoUS1 39 2 2 2 7 ND ND 
TgCtCo8 128 2 2 2 7 0 nonlethal 
TgCkBr168 129 2 2 2 7 0 nonlethal 
TgWtdUS8 74 2 3 2 8 0 nonlethal 
SOU 139 2 3 2 9 ND ND 
TgCkBr116 9 2 5 2 10 0 nonlethal 
TgCtPRC10 9 2 5 2 10 0 nonlethal 
TgCtPRC11 9 2 5 2 10 0 nonlethal 
TgCtPRC12 9 2 5 2 10 0 nonlethal 
TgCtPRC16 9 2 5 2 10 0 nonlethal 
TgCtPRC2 9 2 5 2 10 0 nonlethal 
TgCtPRC4 9 2 5 2 10 0 nonlethal 
TgCtPRC6 9 2 5 2 10 0 nonlethal 
TgCtPRC7 9 2 5 2 10 0 nonlethal 
TgCtPRC8 9 2 5 2 10 0 nonlethal 
TgCtPRC9 9 2 5 2 10 0 nonlethal 
TgDgCo4 9 2 5 2 10 ND ND 
  




Table D-2 continued 
Strain ID ToxoDB 
Genotype# 





TgDgSl21 9 2 5 2 10 ND ND 
TgDgVi5 9 2 5 2 10 ND ND 
TgDgVi7 9 2 5 2 10 ND ND 
TgDgVi8 9 2 5 2 10 ND ND 
TgCgCa1 66 2 5 2 10 90 nonlethal 
TgCkGy2 12 3 1 1 11 50 nonlethal 
IPP-BAT 12 3 1 1 11 ND ND 
TgCatStk7a 13 3 1 1 11 ND ND 
TgCkCr2 24 3 1 1 11 0 nonlethal 
TgCkCr29 24 3 1 1 11 ND ND 
TgCkCr30 24 3 1 1 11 ND ND 
TgCkCr31 24 3 1 1 11 ND ND 
TgCkCr32 24 3 1 1 11 ND ND 
TgCkGy8 25 3 1 1 11 0 nonlethal 
TgCkBr110 25 3 1 1 11 25 nonlethal 
TgCkBr142 28 3 1 1 11 25 nonlethal 
TgCkGy7 30 3 1 1 11 0 nonlethal 
TgCkBr113 30 3 1 1 11 75 nonlethal 
TgCkNi45 50 3 1 1 11 0 nonlethal 
TgCkBr166 114 3 1 1 11 0 nonlethal 
TgCatCa1 130 3 1 1 11 ND ND 
TgHcUS1 177 3 1 1 11 ND ND 
TgCkBrCr28 nd 3 1 1 11 ND ND 
B73 127 3 2 2 12 ND ND 
CTG 2 3 3 1 13 0 nonlethal 
TgCkBr161 2 3 3 1 13 0 nonlethal 
TgDgSl6 2 3 3 1 13 0 nonlethal 
TgDgSl5 2 3 3 1 13 ND ND 
G622M 7 3 3 1 13 66.7b nonlethal 
TgCkCr13 7 3 3 1 13 ND ND 
TgCkCr14 7 3 3 1 13 ND ND 
TgCkCr15 7 3 3 1 13 ND ND 
TgCkCr16 7 3 3 1 13 ND ND 
TgCkCr17 7 3 3 1 13 ND ND 
TgCkCr18 7 3 3 1 13 ND ND 
TgCkCr19 7 3 3 1 13 ND ND 
TgCkCr20 7 3 3 1 13 ND ND 
TgCkCr21 7 3 3 1 13 ND ND 
TgCkCr22 7 3 3 1 13 ND ND 
TgCkCr24 7 3 3 1 13 ND ND 
TgCkCr25 7 3 3 1 13 ND ND 
TgCkCr26 7 3 3 1 13 ND ND 
TgCkCr27 7 3 3 1 13 ND ND 
TgCatBr3 8 3 3 1 13 0 nonlethal 
TgCatBr4 8 3 3 1 13 0 nonlethal 
  




Table D-2 continued 
Strain ID ToxoDB 
Genotype# 





TgCatBr58 8 3 3 1 13 0 nonlethal 
TgCatBr59 8 3 3 1 13 0 nonlethal 
TgCatBr60 8 3 3 1 13 0 nonlethal 
TgCatBr73 8 3 3 1 13 0 nonlethal 
TgCatBr74 8 3 3 1 13 0 nonlethal 
P89 8 3 3 1 13 76 nonlethal 
TgCkNi1 16 3 3 1 13 50 nonlethal 
TgCtCo13 18 3 3 1 13 0 nonlethal 
TgCtCo12 18 3 3 1 13 43 nonlethal 
TgCkNi4 23 3 3 1 13 100 lethal 
TgCkBr114 29 3 3 1 13 0 nonlethal 
TgDgCo20 29 3 3 1 13 30 nonlethal 
TgDgCo1 29 3 3 1 13 ND ND 
TgDgCo10 29 3 3 1 13 ND ND 
TgDgCo2 29 3 3 1 13 ND ND 
TgCkGy1 31 3 3 1 13 0 nonlethal 
TgDgCo14 46 3 3 1 13 0 nonlethal 
TgDgCo16 46 3 3 1 13 0 nonlethal 
TgDgCo8 46 3 3 1 13 100 lethal 
TgCkGy22 48 3 3 1 13 25 nonlethal 
TgCkNi32 52 3 3 1 13 0 nonlethal 
TgRsCr1 52 3 3 1 13 0 nonlethal 
TgWtdUS10 54 3 3 1 13 0 nonlethal 
TgCtCo3 62 3 3 1 13 0 nonlethal 
TgCkBr26 71 3 3 1 13 ND ND 
ROD 72 3 3 1 13 90b nonlethal 
TgCkBr173 81 3 3 1 13 0 nonlethal 
ENVL-MAC 83 3 3 1 13 ND ND 
TgCkBr156 87 3 3 1 13 0 nonlethal 
TgCkNi35 102 3 3 1 13 25 nonlethal 
TgCatPr9 115 3 3 1 13 0 nonlethal 
M7741 133 3 3 1 13 11 nonlethal 
TgCatBr38 136 3 3 1 13 40 nonlethal 
TgCkNi27 140 3 3 1 13 0 nonlethal 
TgCatStK1 141 3 3 1 13 ND ND 
TgShBr3 150 3 3 1 13 ND ND 
TgCatBr65 186 3 3 1 13 0 nonlethal 
TgCatBr66 186 3 3 1 13 0 nonlethal 
TgCkBr149 186 3 3 1 13 0 nonlethal 
TgCkBr150 186 3 3 1 13 0 nonlethal 
TgCkBr157 186 3 3 1 13 0 nonlethal 
TgCkBr152 186 3 3 1 13 25 nonlethal 
TgCatBr64 111 3 3 2 14 100 lethal 
TgCkGh2 132 3 3 2 14 0 nonlethal 
TgShBr12 152 3 3 2 14 ND ND 
  




Table D-2 continued 
Strain ID ToxoDB 
Genotype# 





TgCkNg1 15 3 4 2 15 0 nonlethal 
CASTELLS 15 3 4 2 15 100 lethal 
TgCkBr160 17 3 4 2 15 25 nonlethal 
TgCkBr163 17 3 4 2 15 50 nonlethal 
TgCkBr162 17 3 4 2 15 67 nonlethal 
TgCkBr155 76 3 4 2 15 0 nonlethal 
TgCkBr159 76 3 4 2 15 0 nonlethal 
PBR 84 3 4 2 15 43.1c nonlethal 
TgCtPRC13 9 3 5 2 16 0 nonlethal 
TgCtPRC15 9 3 5 2 16 0 nonlethal 
TgCtPRC17 9 3 5 2 16 0 nonlethal 
TgCtPRC5 9 3 5 2 16 0 nonlethal 
TgDgVi6 9 3 5 2 16 ND ND 
TgDgSl12 20 3 5 2 16 0 nonlethal 
TgDgSl13 20 3 5 2 16 0 nonlethal 
TgDgSl14 20 3 5 2 16 0 nonlethal 
TgDgSl16 20 3 5 2 16 0 nonlethal 
TgDgSl22 20 3 5 2 16 0 nonlethal 
TgDgSl23 20 3 5 2 16 0 nonlethal 
TgDgSl4 20 3 5 2 16 ND ND 
TgCkGh1 137 3 7 2 17 0 nonlethal 
CAST 28 4 1 1 18 100 viruelnt 
TgCtCo1 28 4 1 1 18 100 viruelnt 
TgCkBr112 7 4 3 1 19 50 nonlethal 
TgCkBr111 7 4 3 1 19 75 nonlethal 
TgDgCo9 14 4 3 1 19 67 nonlethal 
TgCatBr15 14 4 3 1 19 100 lethal 
TgCkBr153 14 4 3 1 19 100 lethal 
TgCtCo14 14 4 3 1 19 100 lethal 
TgDgCo12 14 4 3 1 19 100 lethal 
TgDgCo15 14 4 3 1 19 100 lethal 
TgDgCo18 14 4 3 1 19 100 lethal 
TgCtPRC1 18 4 3 1 19 0 nonlethal 
TgDgCo3 18 4 3 1 19 ND ND 
TgDgVi1 18 4 3 1 19 ND ND 
TgDgVi2 18 4 3 1 19 ND ND 
TgDgVi3 18 4 3 1 19 ND ND 
TgDgVi4 18 4 3 1 19 ND ND 
TgCkBr38 22 4 3 1 19 100 lethal 
TgRaw3 32 4 3 1 19 75 nonlethal 
TgCkBr41 33 4 3 1 19 ND ND 
TgCatBr44 34 4 3 1 19 60 nonlethal 
TgCatBr69 34 4 3 1 19 75 nonlethal 
TgCatBr70 34 4 3 1 19 80 nonlethal 
TgCatBr48 34 4 3 1 19 100 lethal 
  




Table D-2 continued 
Strain ID ToxoDB 
Genotype# 





TgCkBr36 37 4 3 1 19 ND ND 
TgCkBr75 40 4 3 1 19 100 lethal 
TgCatBr19 42 4 3 1 19 100 lethal 
TgCatBr9 42 4 3 1 19 100 lethal 
TgCkCr7 43 4 3 1 19 60 nonlethal 
TgDgCo11 44 4 3 1 19 100 lethal 
TgDgCo5 44 4 3 1 19 100 lethal 
TgDgCo6 44 4 3 1 19 100 lethal 
TgDgBr15 53 4 3 1 19 100 lethal 
TgCtCo5 61 4 3 1 19 89 nonlethal 
TgCtCo6 61 4 3 1 19 100 lethal 
TgCatBr76 67 4 3 1 19 100 lethal 
TgCkBr93 69 4 3 1 19 ND ND 
TgCkBr107 70 4 3 1 19 75 nonlethal 
TgCkBr108 70 4 3 1 19 100 lethal 
TgCatBr26 80 4 3 1 19 80 nonlethal 
TgCkBr109 96 4 3 1 19 100 lethal 
TgCtCo15 101 4 3 1 19 100 lethal 
TgCatBr34 104 4 3 1 19 100 lethal 
TgCkBr143 105 4 3 1 19 75 nonlethal 
TgCatBr41 117 4 3 1 19 100 lethal 
TgCatBr20 120 4 3 1 19 100 lethal 
TgCatBr67 121 4 3 1 19 40 nonlethal 
TgDgCo7 122 4 3 1 19 100 lethal 
TgCkGy34 123 4 3 1 19 50 nonlethal 
TgCkBr8 125 4 3 1 19 ND ND 
TgCkBr74 138 4 3 1 19 ND ND 
TgCPBr26 148 4 3 1 19 100 lethal 
TgCPBr27 165 4 3 1 19 100 lethal 
TgCPBr25 175 4 3 1 19 100 lethal 
TgCatBr61 11 4 3 2 20 0 nonlethal 
TgCatBr39 11 4 3 2 20 50 nonlethal 
TgCatBr77 11 4 3 2 20 60 nonlethal 
TgCatBr68 11 4 3 2 20 75 nonlethal 
TgCatBr51 11 4 3 2 20 80 nonlethal 
TgCatBr1 11 4 3 2 20 100 lethal 
TgCatBr52 11 4 3 2 20 100 lethal 
TgCatBr56 11 4 3 2 20 100 lethal 
TgCatBr7 11 4 3 2 20 100 lethal 
TgCatBr78 11 4 3 2 20 100 lethal 
TgOvBr3 11 4 3 2 20 ND ND 
TgCkBr13 63 4 3 2 20 100 lethal 
TgCkBr19 64 4 3 2 20 100 lethal 
TgCkBr37 107 4 3 2 20 100 lethal 
TgCatBr57 108 4 3 2 20 100 lethal 
  




Table D-2 continued 
Strain ID ToxoDB 
Genotype# 





TgCkBr177 109 4 3 2 20 100 lethal 
TgCkBr45 135 4 3 2 20 100 lethal 
TgGtBr5 150 4 3 2 20 ND ND 
TgCatBr72 85 4 3 3 21 100 lethal 
MAS 17 4 4 1 22 100 lethal 
TgCatBr11 19 4 4 1 22 100 lethal 
TgCatBr16 19 4 4 1 22 100 lethal 
Mortality data is from references in Shwab et al. (2014) except where indicated.  
a (Khan et al. 2011), 
b (Howe et al. 1996)  
c (Fux et al. 2003) 
 
ND = No data 
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Table D-3. Expanded RFLP genotypes of 330 T. gondii strains. 



















































































PTG 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 
CTG 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 3 3 
TgCkBr161 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 3 3 
TgDgSl5 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 3 3 
TgDgSl6 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 3 3 
TgDgSl10 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 N 3 3 
TgCkBr158 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 N 3 
TgCkBr164 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 N 3 
TgCkCr11 2 2 2 3 3 3 3 3 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 N 3 
DEG 3 3 2 2 2 2 2 2 2 2 2 2 1 1 1 2 1 2 2 2 2 2 2 2 2 
TgDgSl1 4 4a 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 2 2 2 2 
TgDgSl15 4 4a 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 2 2 2 2 
TgDgSl2 4 4a 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 2 2 2 2 
TgDgSl20 4 4a 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 2 2 2 2 
TgDgSl3 4 4a 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 2 2 2 2 
TgDgSl7 4 4a 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 2 2 2 2 
TgDgSl9 4 4a 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 2 2 2 2 
TgDgSl19 4 4b 2 2 2 2 2 2 2 2 1 2 1 3 3 6 1 2 2 2 2 2 2 2 2 
TgDgSl17 4 4b 2 2 2 2 2 2 2 2 1 2 1 3 3 N 1 2 2 2 2 2 2 2 2 
TgDgSl8 4 4b 2 2 2 2 2 2 2 2 1 2 1 3 3 N 1 2 2 2 2 2 2 2 2 
TgDgSl24 4 4c 2 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 ? 2 2 2 2 2 
B41 4 4d 2 2 2 2 2 2 2 2 1 2 1 2 2 2 1 2 2 2 2 3 2 2 2 
TgSoUS8 5 5a 4 2 2 2 2 2 2 2 1 2 1 2 2 2 1 2 2 2 2 2 2 2 2 
WTD-1 5 5b 4 2 2 2 2 2 2 2 1 2 1 3 3 2 1 2 2 2 2 3 2 2 2 
TgSoUS6 5 5b 4 2 2 2 2 2 2 2 1 2 1 3 N N 1 N N N 2 3 N N 2 
GPHT 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr12 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr17 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr2 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr21 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
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Table D-3 continued 



















































































TgCatBr30 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr42 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr47 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr53 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr54 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr62 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr71 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCatBr75 6 6a 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCkBr144 6 6b 1 1 1 3 1 2 4 1 1 1 1 3 3 3 3 1 3 4 1 1 1 1 3 
TgCatBr55 6 6c 1 1 1 3 1 2 4 1 1 1 1 1 1 1 2 1 2 5 1 1 1 1 3 
BOF 6 6d 1 1 1 3 1 2 4 1 1 1 1 1 1 1 3 1 3 4 1 1 1 1 6 
TgCkCr12 7 7a 1 3 3 3 3 3 3 3 3 3 1 1 2 1 2 2 1 2 2 2 1 N 1 
TgCkCr18 7 7b 1 3 3 3 3 3 3 3 3 3 1 3 2 3 2 1 1 2 2 2 1 3 3 
G622M 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr13 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr14 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr15 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr16 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr17 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr19 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr20 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr21 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr22 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr24 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr25 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr26 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr27 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 3 3 
TgCkCr23 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 N 3 
TgCkCr8 7 7c 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 1 2 2 2 1 N 3 
TgCkBr112 7 7d 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 3 4 1 1 1 4 3 
 
       
       
                   
225 
Table D-3 continued 



















































































TgCkBr111 7 7e 1 3 3 3 3 3 3 3 3 3 1 3 3 3 2 1 3 5 1 1 1 4 3 
P89 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgCatBr3 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgCatBr4 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgCatBr58 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgCatBr59 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgCatBr60 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgCatBr73 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgCatBr74 8 8 1 3 3 3 3 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 3 3 
TgDgVi7 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 2 2 2 5 
TgCtPRC11 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC12 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC16 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC2 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC4 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC7 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC8 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC9 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgDgCo4 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgDgSl21 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgDgVi8 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 2 5 
TgCtPRC10 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 N 3 2 2 5 
TgCtPRC6 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 N 3 2 2 5 
TgDgVi5 9 9a 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 N 3 2 2 5 
TgCkBr116 9 9a 4 2 2 3 3 2 2 N 2 2 1 3 3 4 1 2 2 4 N 3 2 2 5 
TgCtPRC14 9 9a/b 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 N 3 2 N 5 
TgCtPRC13 9 9b 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 3 5 
TgCtPRC5 9 9b 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 2 3 2 3 5 
TgCtPRC15 9 9b 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 N 3 2 3 5 
TgCtPRC17 9 9b 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 N 3 2 3 5 
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TgDgVi6 9 9b 4 2 2 3 3 2 2 3 2 2 1 3 3 4 1 2 2 4 N 3 2 3 5 
GT1 10 10a 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TgCkBr146 10 10a 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TgCtCo7 10 10a 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TgCtCo2 10 10b 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 4 1 1 1 
TgCatBr1 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr39 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr51 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr52 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr56 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr61 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr68 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr7 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr77 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgCatBr78 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
TgOvBr3 11 11 1 1 2 3 3 3 1 3 1 2 3 3 3 4 2 1 1 3 1 1 2 4 3 
IPP-BAT 12 12 1 3 3 1 1 3 2 3 3 1 3 3 3 3 2 2 2 2 2 2 1 3 1 
TgCkGy2 12 12 1 3 3 1 1 3 2 3 3 1 3 3 3 3 2 2 2 2 2 2 1 3 1 
TgCatStk7a 13 13 1 1 1 1 1 3 2 3 3 1 3 3 3 3 2 2 2 2 2 1 1 3 1 
TgCkBr165 13 13 1 1 1 1 1 3 2 3 3 1 3 3 3 3 2 2 2 2 2 1 1 N 1 
TgCatBr15 14 14 1 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 3 4 1 5 1 4 3 
TgCkBr153 14 14 1 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 3 4 1 5 1 4 3 
TgCtCo14 14 14 1 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 3 4 1 5 1 4 3 
TgDgCo12 14 14 1 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 3 4 1 5 1 4 3 
TgDgCo15 14 14 1 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 3 4 1 5 1 4 3 
TgDgCo18 14 14 1 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 3 4 1 5 1 4 3 
TgDgCo9 14 14 1 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 3 4 1 5 1 4 3 
TgCkNg1 15 15a 4 1 2 3 3 3 3 1 1 3 1 3 2 1 1 1 2 3 1 3 2 3 4 
CASTELLS 15 15b 4 1 2 3 3 3 3 1 1 3 1 1 2 1 3 1 2 3 1 3 2 3 4 
TgCkNi1 16 16 1 1 2 3 3 1 3 1 3 3 1 3 2 3 4 2 1 2 2 4 1 3 3 
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TgCkBr160 17 17a 4 1 2 3 3 3 4 1 1 3 1 3 2 1 1 1 2 3 1 3 2 3 4 
TgCkBr162 17 17a 4 1 2 3 3 3 4 1 1 3 1 3 2 1 1 1 2 3 1 3 2 3 4 
TgCkBr163 17 17a 4 1 2 3 3 3 4 1 1 3 1 3 2 1 1 1 2 3 1 3 2 3 4 
MAS 17 17b 4 1 2 3 3 3 4 1 1 3 1 1 1 4 2 1 2 3 1 1 1 4 4 
TgCkBr147 17 17c 4 1 2 3 3 3 4 1 1 3 1 1 1 4 2 1 2 3 1 3 2 4 4 
TgCkBr148 17 17c 4 1 2 3 3 3 4 1 1 3 1 1 1 4 2 1 2 3 1 3 2 4 4 
TgCkBr151 17 17c 4 1 2 3 3 3 4 1 1 3 1 1 1 4 2 1 2 3 1 3 2 4 4 
TgCkBr154 17 17c 4 1 2 3 3 3 4 1 1 3 1 1 1 4 2 1 2 3 1 3 2 4 4 
TgCtCo12 18 18a 1 1 1 3 1 3 2 1 3 3 1 3 2 4 3 1 3 4 2 4 1 3 3 
TgCtCo13 18 18b 1 1 1 3 1 3 2 1 3 3 1 3 N 4 3 1 3 4 2 4 1 3 3 
TgDgVi3 18 18c 1 1 1 3 1 3 2 1 3 3 1 3 2 4 3 1 3 4 1 2 1 4 3 
TgDgVi4 18 18d 1 1 1 3 1 3 2 1 3 3 1 3 2 4 3 1 2 4 1 4 1 4 3 
TgCtPRC1 18 18e 1 1 1 3 1 3 2 1 3 3 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgDgCo3 18 18e 1 1 1 3 1 3 2 1 3 3 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgDgVi2 18 18e 1 1 1 3 1 3 2 1 3 3 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgDgVi1 18 18f 1 1 1 3 1 3 2 1 3 3 1 3 2 4 3 N 3 4 1 4 1 4 3 
TgCatBr11 19 19 1 3 3 3 3 3 1 1 1 4 1 3 3 5 2 1 1 3 1 1 1 4 4 
TgCatBr16 19 19 1 3 3 3 3 3 1 1 1 4 1 3 3 5 2 1 1 3 1 1 1 4 4 
TgCatBr5 19 19 1 3 3 3 3 3 1 1 1 4 1 3 3 5 2 1 1 3 1 1 1 4 4 
TgDgSl4 20 20a 4 2 2 3 3 2 2 3 2 5 1 3 2 4 5 2 2 4 2 3 2 3 5 
TgDgSl13 20 20b 4 2 2 3 3 2 2 3 2 5 1 3 2 4 2 2 N 4 2 3 2 3 5 
TgDgSl16 20 20b 4 2 2 3 3 2 2 3 2 5 1 3 2 4 2 2 N 4 2 3 2 3 5 
TgDgSl22 20 20b 4 2 2 3 3 2 2 3 2 5 1 3 2 4 2 2 N 4 2 3 2 3 5 
TgDgSl23 20 20b 4 2 2 3 3 2 2 3 2 5 1 3 2 4 2 2 N 4 2 3 2 3 5 
TgDgSl12 20 20b 4 2 2 3 3 2 2 3 2 5 1 3 2 4 N 2 N 4 2 3 2 3 5 
TgDgSl14 20 20b 4 2 2 3 3 2 2 3 2 5 1 3 2 4 N 2 N 4 2 3 2 3 5 
TgDgSl18 20 20b/c 4 2 2 3 3 2 2 3 2 5 1 3 2 4 2 2 N 4 2 3 2 N 5 
TgDgSl11 20 20c 4 2 2 3 3 2 2 3 2 5 1 3 N 4 N 2 N 4 N 3 2 1 N 
TgCatBr10 21 21 1 3 3 3 3 3 1 1 1 3 3 3 3 5 2 1 1 4 1 1 1 4 4 
TgCatBr22 21 21 1 3 3 3 3 3 1 1 1 3 3 3 3 5 2 1 1 4 1 1 1 4 4 
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TgCatBr23 21 21 1 3 3 3 3 3 1 1 1 3 3 3 3 5 2 1 1 4 1 1 1 4 4 
TgCatBr28 21 21 1 3 3 3 3 3 1 1 1 3 3 3 3 5 2 1 1 4 1 1 1 4 4 
TgCatBr31 21 21 1 3 3 3 3 3 1 1 1 3 3 3 3 5 2 1 1 4 1 1 1 4 4 
TgCatBr32 21 21 1 3 3 3 3 3 1 1 1 3 3 3 3 5 2 1 1 4 1 1 1 4 4 
TgCatBr37 21 21 1 3 3 3 3 3 1 1 1 3 3 3 3 5 2 1 1 4 1 1 1 4 4 
TgCkBr38 22 22 4 1 2 3 3 3 4 1 3 3 3 3 3 1 2 1 2 5 1 1 1 4 3 
TgCkNi4 23 23 1 1 2 3 1 3 2 1 3 4 1 3 2 4 3 1 3 4 2 4 1 3 3 
TgDgCo19 23 23 1 1 2 3 1 3 2 1 3 4 1 3 2 4 3 1 3 4 2 4 1 N 3 
TgCkCr2 24 24 1 1 1 1 3 1 1 1 1 1 3 1 1 1 2 2 1 2 2 2 1 3 1 
TgCkCr29 24 24 1 1 1 1 3 1 1 1 1 1 3 1 1 1 2 2 1 2 2 2 1 3 1 
TgCkCr31 24 24 1 1 1 1 3 1 1 1 1 1 3 1 1 1 2 2 1 2 2 2 1 3 1 
TgCkCr32 24 24 1 1 1 1 3 1 1 1 1 1 3 1 1 1 2 2 1 2 2 2 1 3 1 
TgCkCr30 24 24 1 1 1 1 3 1 1 1 1 1 3 1 1 1 2 2 1 2 N 2 1 3 1 
TgCkBr110 25 25 1 3 3 1 3 3 3 3 3 1 1 3 3 3 2 2 2 2 2 2 1 3 1 
TgCkGy8 25 25 1 3 3 1 3 3 3 3 3 1 1 3 3 3 2 2 2 2 2 2 1 3 1 
TgCkNi9 27 27 1 1 1 1 1 1 1 3 1 1 1 1 1 1 2 1 3 1 1 4 1 1 1 
TgCkBr142 28 28a 1 1 1 1 1 1 2 1 3 1 3 3 3 1 2 1 2 4 1 3 1 3 1 
CAST 28 28b 1 1 1 1 1 1 2 1 3 1 3 1 1 4 2 1 3 4 1 1 1 4 1 
TgCtCo1 28 28b 1 1 1 1 1 1 2 1 3 1 3 1 1 4 2 1 3 4 1 1 1 4 1 
TgCkBr114 29 29a 1 1 2 3 1 3 2 1 3 3 1 3 2 4 3 1 3 1 1 1 1 3 3 
TgDgCo1 29 29b 1 1 2 3 1 3 2 1 3 3 1 3 2 4 3 1 3 1 1 4 1 3 3 
TgDgCo10 29 29b 1 1 2 3 1 3 2 1 3 3 1 3 2 4 3 1 3 1 1 4 1 3 3 
TgDgCo2 29 29b 1 1 2 3 1 3 2 1 3 3 1 3 2 4 3 1 3 1 1 4 1 3 3 
TgDgCo20 29 29b 1 1 2 3 1 3 2 1 3 3 1 3 2 4 3 1 3 1 1 4 1 3 3 
TgCkBr113 30 30 1 3 3 1 3 3 3 3 3 1 3 3 3 3 2 2 1 3 1 2 1 3 1 
TgCkGy7 30 30 1 3 3 1 3 3 3 3 3 1 3 3 3 3 2 2 1 3 1 2 1 3 1 
TgCkGy1 31 31 1 3 3 3 1 3 3 3 3 1 3 3 3 3 2 1 2 2 2 2 1 3 3 
TgRaw3 32 32 1 3 3 3 3 2 1 1 1 1 1 3 3 5 2 1 3 3 1 1 1 4 3 
TgCkBr41 33 33 4 1 2 3 1 3 4 1 1 1 1 1 1 1 2 1 2 4 1 1 1 4 3 
TgCatBr44 34 34 4 1 2 3 3 3 2 1 1 4 1 1 1 5 2 1 2 3 1 1 1 4 3 
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TgCatBr48 34 34 4 1 2 3 3 3 2 1 1 4 1 1 1 5 2 1 2 3 1 1 1 4 3 
TgCatBr69 34 34 4 1 2 3 3 3 2 1 1 4 1 1 1 5 2 1 2 3 1 1 1 4 3 
TgCatBr70 34 34 4 1 2 3 3 3 2 1 1 4 1 1 1 5 2 1 2 3 1 1 1 4 3 
TgCkCr3 35 35 1 1 1 1 1 1 1 3 1 1 3 3 2 1 2 1 3 1 1 4 1 1 1 
TgCkCr4 35 35 1 1 1 1 1 1 1 3 1 1 3 3 2 1 2 1 3 1 1 4 1 1 1 
TgCkCr5 35 35 1 1 1 1 1 1 1 3 1 1 3 3 2 1 2 1 3 1 1 4 1 1 1 
TgCkCr6 35 35 1 1 1 1 1 1 1 3 1 1 3 3 2 1 2 1 3 1 1 4 1 1 1 
TgCkBr59 36 36 1 1 1 3 1 3 2 1 3 1 3 3 3 1 2 1 3 4 1 5 1 1 3 
TgCkBr36 37 37 1 2 2 3 3 3 4 1 1 3 1 3 3 1 4 1 2 5 1 1 1 4 3 
TgCtCo10 38 38 1 3 3 3 1 1 1 3 1 1 3 2 1 1 2 2 1 1 1 2 1 1 3 
TgCtCo11 38 38 1 3 3 3 1 1 1 3 1 1 3 2 1 1 2 2 1 1 1 2 1 1 3 
TgCtCo4 38 38 1 3 3 3 1 1 1 3 1 1 3 2 1 1 2 2 1 1 1 2 1 1 3 
TgDgCo17 38 38 1 3 3 3 1 1 1 3 1 1 3 2 1 1 2 2 1 1 1 2 1 1 3 
TgSoUS1 39 39 2 2 2 2 2 2 2 2 1 2 2 2 2 2 1 2 2 2 2 2 2 2 2 
TgCkBr75 40 40a 4 1 2 3 3 3 3 3 1 3 1 3 3 5 2 1 1 3 1 5 1 4 3 
TgCtCoX5 40 40b 4 1 2 3 3 3 3 3 1 3 1 3 2 1 1 1 2 3 1 3 2 N 4 
TgCkBr136 41 41 1 1 1 3 1 2 1 1 1 1 1 3 3 4 2 1 3 4 1 1 1 1 3 
TgCatBr19 42 42 1 1 1 3 3 2 1 1 1 4 1 3 3 5 2 1 3 4 1 1 1 4 3 
TgCatBr9 42 42 1 1 1 3 3 2 1 1 1 4 1 3 3 5 2 1 3 4 1 1 1 4 3 
TgCkCr7 43 43a 1 1 2 1 2 1 1 1 1 4 1 3 2 4 1 1 1 4 1 4 1 4 3 
TgCkCr9 43 43b 1 1 2 1 2 1 1 1 1 4 1 3 2 4 1 1 1 4 1 4 1 4 5 
TgCkCr10 43 43c 1 1 2 1 2 1 1 1 1 4 1 3 2 4 3 1 1 4 1 4 1 4 5 
TgDgCo5 44 44a 1 1 2 3 1 3 2 1 1 6 1 3 2 4 3 1 3 1 1 4 1 4 3 
TgDgCo11 44 44b 1 1 2 3 1 3 2 1 1 6 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgDgCo6 44 44b 1 1 2 3 1 3 2 1 1 6 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgCkBr126 45 45 1 3 3 3 1 2 2 3 1 1 3 3 3 1 2 1 3 4 1 1 1 1 3 
TgDgCo14 46 46a 1 3 3 3 1 3 2 1 3 3 1 3 3 4 2 1 3 4 1 1 1 3 3 
TgDgCo16 46 46b 1 3 3 3 1 3 2 1 3 3 1 3 3 4 3 1 3 4 1 1 1 3 3 
TgDgCo8 46 46c 1 3 3 3 1 3 2 1 3 3 1 3 2 4 3 1 3 4 1 4 1 3 3 
TgCatBr25 47 47 1 3 3 3 3 2 4 1 1 2 1 3 1 4 2 1 3 3 1 3 3 4 4 
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TgCkGy22 48 48 1 3 3 3 3 3 3 3 3 3 3 3 3 3 2 1 1 3 1 2 1 3 3 
TgCatPR5 49 49 2 2 2 1 2 2 2 2 3 2 N 1 1 4 1 2 2 2 2 2 2 4 5 
TgCkNi45 50 50 2 3 3 1 3 1 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 3 1 
TgDgBr6 51 51 4 1 2 3 1 3 2 1 1 1 1 1 1 1 2 1 2 4 1 1 1 1 3 
TgCkNi32 52 52 4 1 2 3 1 3 5 1 1 3 1 3 2 1 3 1 3 5 1 1 1 3 3 
TgRsCr1 52 52 4 1 2 3 1 3 5 1 1 3 1 3 2 1 3 1 3 5 1 1 1 3 3 
TgDgBr15 53 53 4 1 2 3 3 3 2 1 1 3 1 3 3 3 2 1 2 3 1 1 1 4 3 
TgWtdUS10 54 54 2 2 2 3 3 3 3 3 3 3 2 1 1 2 2 2 2 2 2 2 1 3 3 
TgCatBr80 55 55 1 1 1 1 3 1 4 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 
TgCatBr45 56 56 1 1 1 3 1 2 4 1 3 1 1 1 1 4 2 1 3 4 1 1 1 1 3 
TgCatBr46 56 56 1 1 1 3 1 2 4 1 3 1 1 1 1 4 2 1 3 4 1 1 1 1 3 
TgCkBr171 57 57 1 1 1 3 1 2 4 1 3 2 3 3 3 3 2 N 1 2 2 1 1 N 3 
TgDgBr2 58 58 1 1 1 3 1 3 4 3 3 1 1 3 3 3 3 1 3 4 1 1 1 1 3 
TgCkBr40 59 59 1 1 1 3 3 2 4 1 1 1 1 1 1 1 3 1 3 3 1 1 1 1 3 
GUY-KOE 60 60a 1 1 2 1 3 3 3 1 3 3 1 3 2 7 1 1 2 5 1 1 1 4 8 
VAND 60 60b 1 1 2 1 3 3 3 1 3 3 1 3 3 4 2 1 1 3 1 3 1 4 8 
TgCtCo5 61 61 1 1 2 3 1 3 2 3 1 5 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgCtCo6 61 61 1 1 2 3 1 3 2 3 1 5 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgCtCo3 62 62 1 1 2 3 1 3 2 3 3 3 1 3 2 4 3 1 3 1 1 1 1 3 3 
TgCtCo9 62 62 1 1 2 3 1 3 2 3 3 3 1 3 2 4 3 1 3 N 1 1 1 N 3 
TgCkBr13 63 63 1 1 2 3 3 3 1 3 1 2 1 3 3 3 2 1 1 4 1 3 2 4 3 
TgCkBr19 64 64 1 1 2 3 3 3 4 1 1 5 1 3 3 3 2 1 3 3 1 1 2 4 3 
TgCkBr89 65 65 1 1 2 3 3 3 4 1 1 3 1 1 1 1 4 1 2 5 1 1 1 4 4 
TgCgCa1 66 66 1 2 2 3 2 2 2 4 1 5 1 1 3 4 3 2 2 4 2 3 2 2 5 
TgCatBr76 67 67 1 3 3 3 1 3 1 3 3 4 3 3 3 4 2 1 1 3 1 1 1 4 3 
TgCkGy18 68 68 1 3 3 3 1 3 3 3 3 3 3 N 3 3 2 2 2 2 2 2 1 1 3 
TgCkBr93 69 69 1 3 3 3 3 2 1 3 1 2 1 3 3 5 2 1 3 3 1 1 1 4 3 
TgCkBr107 70 70 1 3 3 3 3 2 4 1 1 1 3 3 3 3 2 1 3 4 1 1 1 4 3 
TgCkBr108 70 70 1 3 3 3 3 2 4 1 1 1 3 3 3 3 2 1 3 4 1 1 1 4 3 
TgCkBr26 71 71 1 3 3 3 3 3 2 1 3 3 1 3 3 5 2 1 3 3 1 5 1 3 3 
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ROD 72 72 1 3 3 3 3 3 3 3 3 5 3 2 1 3 2 2 1 2 2 2 1 3 3 
TgShUS28 73 73 2 3 3 1 1 1 3 3 3 1 1 2 1 1 2 2 1 4 1 2 1 1 1 
TgWtdUS8 74 74 2 3 3 3 2 2 2 3 2 2 1 2 2 2 1 2 2 2 2 2 2 2 3 
TgCkBr48 75 75 4 1 2 3 3 3 2 1 1 3 3 3 3 5 2 1 2 3 1 1 2 4 4 
TgCkBr155 76 76 4 3 3 3 3 3 4 1 1 3 1 2 1 3 2 2 2 3 1 2 2 3 4 
TgCkBr159 76 76 4 3 3 3 3 3 4 1 1 3 1 2 1 3 2 2 2 3 1 2 2 3 4 
TgCkBr141 77 77 1 1 1 1 1 1 4 1 1 3 3 1 1 1 2 1 1 4 1 3 1 1 3 
TgCkBr169 78 78 1 1 1 1 1 3 2 1 3 1 3 1 1 3 2 1 2 4 1 1 1 1 1 
TgDgCo13 79 79 1 1 1 1 3 1 1 3 3 1 3 1 1 1 1 2 2 2 1 4 1 1 1 
TgCatBr26 80 80 1 1 1 3 1 2 1 1 1 4 1 1 1 1 2 1 3 4 1 1 1 4 3 
TgCkBr173 81 81 1 1 1 3 1 2 4 1 1 3 3 3 3 1 2 1 3 4 1 1 1 3 3 
TgCkBr54 82 82 1 1 1 3 1 3 2 1 1 1 3 3 3 1 3 1 2 4 1 1 1 1 3 
ENVL-MAC 83 83 1 1 1 3 1 3 2 3 3 1 3 3 3 3 2 2 2 2 2 2 1 3 3 
PBR 84 84 1 1 1 3 1 3 4 1 1 3 1 2 1 1 3 1 2 4 1 2 2 3 4 
TgCatBr72 85 85 1 1 1 3 3 2 4 1 1 2 1 1 1 1 3 1 3 4 1 N 3 4 3 
TgCatBr50 86 86 1 1 1 3 3 2 4 1 1 3 1 1 1 1 3 1 3 4 1 1 1 1 3 
TgCkBr156 87 87 1 1 1 3 3 3 1 1 3 1 3 2 1 1 2 2 1 2 2 2 1 3 3 
TgCkBr186 88 88 1 1 1 3 3 3 2 1 3 1 3 3 3 1 2 1 3 4 1 5 1 1 3 
TgCkId1 89 89 1 1 1 3 3 3 2 3 3 3 3 N N 3 N N 3 N 2 2 1 N 3 
TgBBeCa1 90 90 1 1 1 3 3 3 3 3 3 1 3 2 1 1 2 2 1 2 2 2 1 1 3 
TgCkCr1 91 91 1 1 2 1 1 1 2 1 1 1 1 3 2 1 4 1 1 4 1 4 1 1 1 
TgCatBr40 92 92 1 1 2 1 3 2 2 1 1 2 1 1 1 4 2 1 2 3 1 3 3 4 4 
TgCkBr61 93 93 1 1 2 1 3 2 4 1 1 3 1 1 1 4 3 1 1 3 1 1 2 4 4 
TgCkBr16 94 94 1 1 2 1 3 3 1 1 1 2 1 1 1 5 2 1 1 3 1 1 1 4 4 
GUY-MAT 95 95 1 1 2 1 3 3 2 1 1 3 1 3 3 1 1 1 2 5 1 1 1 4 8 
TgCkBr109 96 96 1 1 2 1 3 3 2 3 1 3 3 3 3 4 4 1 1 3 1 5 1 4 3 
GUY-DOS 97 97 1 1 2 1 3 3 2 3 1 3 1 3 3 4 1 1 2 3 1 1 1 4 8 
RUB 98 98 1 1 2 1 3 3 3 3 1 3 3 3 2 3 3 1 1 4 1 3 1 4 8 
TOU-Ali 99 99 1 1 2 1 3 3 4 1 1 3 1 1 1 4 2 1 2 3 1 3 1 4 4 
GUY-BAS1 100 100 1 1 2 1 3 3 4 1 3 3 1 3 2 4 3 1 1 5 1 1 1 4 8 
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TgCtCo15 101 101 1 1 2 3 1 3 2 1 1 5 1 3 2 4 3 1 3 4 1 4 1 4 3 
TgCkNi35 102 102 1 1 2 3 1 3 2 1 3 4 3 3 2 3 3 1 3 2 2 2 1 3 3 
TgCatBr34 104 104 1 1 2 3 1 3 4 1 1 3 1 3 3 1 2 1 3 3 1 3 1 4 3 
TgCkBr143 105 105 1 1 2 3 3 2 4 3 3 3 1 3 3 3 4 1 1 4 1 1 1 4 3 
TgDgBr18 106 106 1 1 2 3 3 2 4 1 1 2 1 1 1 4 5 1 2 3 1 3 1 1 3 
TgCkBr37 107 107 1 1 2 3 3 2 4 1 1 3 1 1 1 3 3 1 1 3 1 3 2 4 3 
TgCatBr57 108 108 1 1 2 3 3 3 2 1 1 3 1 3 3 4 2 1 2 4 1 3 2 4 3 
TgCkBr177 109 109 1 1 2 3 3 3 3 1 3 3 3 3 3 4 2 1 3 4 1 1 2 4 3 
TgCatBr64 111 111 1 1 4 3 3 3 4 1 3 3 1 3 3 4 2 1 2 4 1 3 2 3 3 
TgCatPR6 112 112 1 2 2 1 1 1 3 2 3 1 N 2 1 4 1 2 1 2 2 2 1 4 5 
TgCkBr166 114 114 1 3 3 1 3 3 3 1 3 1 1 3 3 3 2 1 1 4 1 2 1 3 1 
TgCatPr9 115 115 1 3 3 1 3 3 3 3 3 3 1 2 2 3 2 2 2 2 2 2 1 3 3 
TgCkBr130 116 116 1 3 3 3 1 3 2 3 3 3 3 3 3 3 2 1 1 4 1 1 1 N 3 
TgCatBr41 117 117 1 3 3 3 1 3 4 1 1 4 3 3 3 4 2 1 3 4 1 1 1 4 3 
TgCatPR8 118 118 1 3 3 3 3 1 1 3 3 1 N 2 1 1 2 2 1 2 2 2 1 1 3 
TgCatBr18 119 119 1 3 3 3 3 2 4 1 1 4 1 3 1 4 2 1 3 3 1 3 3 4 N 
TgCatBr20 120 120 1 3 3 3 3 3 1 1 3 3 3 3 3 3 2 1 1 4 1 1 1 4 3 
TgCatBr67 121 121 1 3 3 3 3 3 1 3 1 3 3 3 3 4 2 1 1 3 1 1 1 4 3 
TgDgCo7 122 122 1 3 3 3 3 3 1 3 3 1 3 3 3 1 2 2 1 3 1 2 1 4 3 
TgCkGy34 123 123 1 3 3 3 3 3 1 3 3 3 3 3 3 4 2 2 1 4 1 2 1 4 3 
TgCatBr81 124 124 1 3 3 3 3 3 2 3 1 4 1 3 3 4 3 1 1 3 1 3 1 4 4 
TgCkBr8 125 125 1 3 3 3 3 3 2 3 3 5 3 3 3 3 2 2 1 2 2 5 1 4 3 
TgCatBr6-20 126 126 1 N 1 3 3 2 4 1 1 4 1 3 3 5 2 1 1 3 1 1 1 1 4 
B73 127 127 2 2 2 2 2 2 2 2 3 3 3 2 1 2 1 2 2 2 2 2 2 3 2 
TgCtCo8 128 128 2 2 2 2 2 2 2 3 2 2 1 1 1 2 1 2 2 2 2 2 2 2 2 
TgCkBr168 129 129 2 2 2 2 3 2 2 2 2 2 2 1 1 6 1 2 2 2 2 3 2 2 2 
TgCatCa1 130 130 2 3 3 1 3 3 2 1 3 3 3 2 1 3 2 2 1 2 2 2 1 3 1 
TgShUS32 131 131 2 3 3 2 2 1 3 3 2 2 1 2 2 2 1 2 1 4 1 2 1 1 2 
TgCkGh2 132 132 2 3 3 3 2 2 2 3 3 2 3 2 1 3 2 2 2 2 2 2 2 3 3 
M7741 133 133 2 3 3 3 3 1 3 3 3 3 3 2 1 3 2 2 2 2 2 2 1 3 3 
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TgCkBr178 134 134 4 1 2 3 1 3 2 3 3 1 3 3 3 1 2 2 2 4 1 2 1 N 1 
TgCkBr45 135 135 4 1 2 3 3 3 2 1 3 3 1 3 3 3 2 1 3 4 1 5 2 4 3 
TgCatBr38 136 136 4 1 4 3 3 3 2 1 1 3 1 1 1 5 2 1 2 4 1 3 1 3 3 
TgCkGh1 137 137 4 2 2 3 3 2 2 3 2 3 1 3 2 4 5 2 N 4 2 3 2 3 7 
TgCkBr74 138 138 4 3 3 3 3 3 3 1 3 3 3 3 3 3 2 1 2 4 1 1 1 4 3 
SOU 139 139 2 2 2 3 3 3 2 2 3 3 1 1 1 2 2 2 2 2 2 2 2 2 3 
TgCkNi27 140 140 2 3 3 3 3 3 2 3 3 1 3 2 1 3 2 2 2 2 2 2 1 3 3 
TgCatStK1 141 141 2 3 3 3 3 3 3 3 3 1 3 2 1 3 2 2 2 2 2 2 1 3 3 
TgShBr1 144 144 1 1 1 3 1 3 4 3 1 1 1 1 1 4 4 1 2 5 1 1 1 1 3 
TgCPBr26 148 148 1 1 2 3 1 3 2 1 1 3 1 3 3 1 2 1 2 4 1 3 1 4 3 
TgGtBr1 149 149 1 1 2 3 3 2 2 1 1 1 1 1 1 5 3 1 2 4 1 1 1 1 3 
TgShBr3 150 150a 1 1 2 3 3 2 4 3 1 1 1 N 3 N N 1 3 4 1 N 1 3 3 
TgGtBr5 150 150b 1 1 2 3 3 2 4 3 1 1 1 1 1 1 4 1 3 4 1 1 2 4 3 
TgShBr12 152 152 1 1 4 3 3 3 2 1 1 3 1 3 3 5 2 1 2 3 1 3 2 3 3 
TgShBr5 160 160 1 3 3 3 3 3 1 3 3 4 3 3 3 5 2 1 1 4 1 1 1 N 3 
TgCPBr1 162 162 1 3 3 3 3 3 2 1 1 3 1 3 3 5 2 1 1 3 1 1 1 4 4 
TgCPBr27 165 165 1 3 3 3 3 3 4 1 1 3 3 3 3 5 2 1 3 4 1 1 1 4 3 
TgOvBr7 171 171 4 1 1 3 3 1 4 3 3 1 3 3 3 1 2 1 3 4 1 3 2 1 3 
TgCPBr25 175 175 4 1 2 3 3 3 3 1 1 4 1 1 1 5 2 1 2 5 1 5 1 4 3 
TgHcUS1 177 177 1 1 1 1 1 1 1 3 3 1 3 1 1 1 2 1 3 2 1 1 1 3 1 
TgCatBr65 186 186 2 3 3 3 3 3 1 3 3 1 3 2 1 1 2 2 1 2 2 2 1 3 3 
TgCatBr66 186 186 2 3 3 3 3 3 1 3 3 1 3 2 1 1 2 2 1 2 2 2 1 3 3 
TgCkBr149 186 186 2 3 3 3 3 3 1 3 3 1 3 2 1 1 2 2 1 2 2 2 1 3 3 
TgCkBr150 186 186 2 3 3 3 3 3 1 3 3 1 3 2 1 1 2 2 1 2 2 2 1 3 3 
TgCkBr152 186 186 2 3 3 3 3 3 1 3 3 1 3 2 1 1 2 2 1 2 2 2 1 3 3 
TgCkBr157 186 186 2 3 3 3 3 3 1 3 3 1 3 2 1 1 2 2 1 2 2 2 1 3 3 
TgCkBrCr28 N a N N N N N N N N N N N 1 1 1 N 2 1 N 2 2 1 3 1 
TgPgBr24 N b N N N N N N N N N N N 1 1 4 2 1 3 4 1 3 1 1 3 
TgCatBr27 N c N N N N N N N N N N N 3 3 5 2 1 1 4 1 1 1 4 4 
TgPgBr14 N d N N N N N N N N N N N 3 3 5 N 1 1 3 1 1 N 4 4 
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